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Abstract 
Resistance to antibiotics is one of the greatest menaces to the success of modern 
medication. It has lately become more dangerous because we can no longer be certain that 
any antibiotic chosen will work and because of the emergence of multidrug resistant bacteria. 
It is more and more clear that antimicrobial resistance is easy to make but hard to miss. 
Resistance is a major concern with any new agent, and will become even more important in 
the future if new classes of drugs are established. In pharmaceutical studies, natural products, 
either as pure compounds or as standardised extracts, provide limitless opportunities for 
novel drug leads because of the unmatched availability of chemical diversity. Hence, natural 
products require a powerful and deep assessment of their antibacterial qualities, to help in 
this unprecedented crisis.   
Accordingly, the main objective of this project was concentrating on the development 
of natural products that can act as an antibacterial agent, with a special reference to the 
MRSA bacteria, and involved an investigation of the role and mechanism of action of 
compounds derived from selected medicinal plants, these are Centella asiatica (L.), 
Imperata cylindrica (L.), Morinda citrifolia (L.), and Sauropus androgynus (L.), these plants 
have previously been implicated as having antibacterial properties. It is a fundamental 
necessity to uncover and understand the mechanism of action of the tested drug, and its 
biological pathways in the cell to obtain information for optimisation of lead compounds. 
During the course of this study, bioassay-guided plant extraction, isolation protocols, and 
many supporting analytical and biological methodologies were used and developed in order 
to evaluate the antibacterial activity of the four medicinal plants. Crude extracts were 
screened against Gram-positive and Gram-negative bacteria, including resistant strains. The 
isolation procedures were performed using advanced chromatographic techniques including 
RP-HPLC, guided by the Bioscreen-C results, in order to purify the most active compounds 
of extracts. These compounds were later identified by employing Mass Spectrometry (MS) 
and Nuclear Magnetic Resonance (NMR) techniques. Asiatic acid from Centella asiatica 
(L.), Quercetin from Imperata cylindrica (L.), and Aucubin from Morinda citrifolia (L.), 
were identified. Aucubin showed to have the highest activity among all other active 
compounds. 
Results suggested that extracts/compounds, from the medicinal plants under 
investigation, have a potency as an antibacterial agent, with the lowest MIC observed in the 
compound derived from Morinda citrifolia (L.) named as aucubin, which was later subjected 
to the label-free quantitative proteomics and pathway analysis by using Staphylococcus 
aureus (MSSA) as a drug discovery model. The label free proteomics technique conducted 
with an aid of several software packages, as an attempt to identify the fundamental principles 
of the mechanism of action of aucubin. Pathway enrichment analysis suggested that the 
bacterial central metabolism might be the main target of the aucubin, and the pyruvate 
metabolism pathway showed the highest enrichment score followed by 
glycolysis/gluconeogenesis pathway, these results yet to be validated. An antibacterial that 
have different mechanism of actions to conventional antibiotics are desirable as they will 
help slow the onset and spread of microbial drug resistance. Overall, current study suggested 
that the compounds isolated from Centella asiatica L., Imperata cylindrica L., Morinda 
citrifolia L., and Sauropus androgynus L. might have a potency as a cheap natural source of 
antibiotics.  
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1.1 Project background 
Bacteria, are the oldest forms of life on earth, they are remarkably diverse and exist in 
surprising numbers. Bacteria are group of micro-organisms that are single cells and 
approximately one micron in transverse diameter. Diseases caused by bacteria comprise some 
of the most common infections in the world, it is considered one of the threatening issues in 
medical field, past, present, and probably future (Relman, 2002). Bacteria have been classified 
according to phenotype, including shape, size, staining properties and biochemical properties. 
Recently, the classification has been dominated by genotype analysis, especially using 
conserved molecules such as 16S ribosomal RNA. On the other hand, bacteria can be classified 
as either pathogenic or nonpathogenic bacteria. Pathogenic bacteria cause bacterial infection, 
whereas the others do not. Nonpathogenic are commonly called normal flora. Some species of 
bacteria, such as Pseudomonas aeruginosa, are opportunistic pathogens and cause disease 
mainly in people suffering from immunosuppression (Entenza et al., 2014). 
Infections that are induced by bacteria are treated with drugs called antibiotics or 
antibacterials. Antibiotics can be described as a compound that works to either stop bacteria 
from growing (bacteriostatic agents) or by killing them entirely (bactericidal agents). The 
effectiveness of these compounds against the survival of bacteria stems from their ability to 
block critical bacterial cellular processes (Sommer & Dantas, 2011). The application of modern 
antibiotics therapy (Post-world war II) has had a deep impact on our societies and changed the 
features of the medicine and the patient care. Modern procedures in medicine rely on the use of 
antibiotics to control infections, organ transplants, surgery, care of premature neonates and to 
allow successful patient rehabilitation (WHO, 2014). The use of antibiotics has removed 
infectious diseases being the top priority healthcare concern in the western countries over the 
last few decades. However, infectious diseases remain the major causes of mortality in low-
income countries and the third highest cause of mortality worldwide (Thomas & Rima, 2011). 
The treatment of bacterial infections has been obstructed by resistance to antibiotics. First 
observed in Flemings' lab shortly after his discovery of penicillin (1928), the detection of 
resistance to antibiotics continued throughout the golden age of antibiotic discovery (1950s) 
where many new drugs and drug classes were discovered to keep up with the increasing rates of 
resistance (Johnson 2011). Bacterial resistance to antibiotic drugs is one of the most serious 
                                                                                                                                       Chapter 1 
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hazards to global public health and the problem knows no boundaries. Drug-resistant microbes 
of all kinds can move amongst people and animals, from one country to another without notice. 
The problem is clearly more severe in developing countries where drug availability is limited 
and resistance is high (Breu et al., 2008). The World Health Organisation (WHO) describes 
antibiotic resistance as a serious threat that is no longer predictable. It is occurring in every part 
of the world and has the potential to affect anyone, of any age, in any country (WHO, 2014). 
The Infectious Diseases Society of America, which represents the infectious disease specialists, 
who are in the front line of antibiotic use, has called for the delivery of a new antibiotic drugs 
in the upcoming years, due to the growing threat of antibiotic resistant pathogens which 
increasingly causes death and weakening disease (Venter, 2014). The new multi-drug 
pathogenic strains which accumulating large numbers of resistance elements, greatly limiting 
therapeutic options. Furthermore, the massive financial and logistical burden on health care 
sectors across the globe (Wright, 2012). 
Ultimately, our primary concern regarding resistance is that resistant bacteria are more 
difficult to get rid of and that complications and deaths resulting from infections caused by them 
will only increase in time. Very few really new antibiotics have been developed recent years’ 
term, and tradition natural sources of antibiotics such as soil bacteria and fungi may have given 
up all their arsenal of antibiotics (Carlos, 2010). Hence we need to look elsewhere for new 
sources of antibiotics, and plant material is an obvious choice. In pharmacognosy studies, 
natural products, which are mainly derived from plants, have been widely exploited as a resource 
in drug development. For thousands of years, natural products have played an important role 
throughout the world in treating and preventing human diseases and once served humankind as 
the source of all drugs. Higher plants provided most of these therapeutic agents. Until recently, 
the use of traditional medicine was a common practice in poor or developing countries, where 
it serves as an alternative medicine because of the lack of the modern health facilities         
(Calixto et al., 1998). 
In terms of the discovery of novel biologically active compounds, including antibacterial 
agents, what is needed are molecules that are diverse in their structure (and consequently diverse 
in their functions). Small organic molecules have always been of interest in pharmaceutical and 
biochemistry science, due to their potential to exert powerful effects on the roles of 
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macromolecules that make up living systems (Ji, Li, & Zhang, 2009). A collection of such 
compounds has the potential to provide hits against different biological targets. There are a 
number of potential sources of small molecules for use in biological screening. Most of the 
major categories of antibiotics in therapeutic use are natural products or semi-synthetic 
derivatives. In addition, the natural products have the ability to interact with target proteins and 
the hit rates in high-throughput screens are usually several times higher for natural products 
compared to small molecule from traditional synthetic sources (Galloway et al., 2009). 
Plants represent an inexhaustible source of novel chemical compounds, which are of 
potential use in medicine and other applications. Plants consist of many active compounds such 
as alkaloids, steroids, tannins, glycosides, volatile oils, fixed oils, resins, phenols and flavonoids, 
which found in their specific parts such as leaves, flowers, bark, seeds, fruits, root, etc. The 
beneficial medicinal effects of plant materials typically result from the combination of these 
secondary products. These compounds selectively inhibit the function of biological targets 
(Gupta, Naraniwal, & Kothari, 2012). Today, natural products (and their derivatives and 
analogs) still represent over 50 % of all drugs in clinical use, with higher plant-derived natural 
products representing 25 % of the total. Some relevant examples are galegine, from Galega 
officinalis L., which was the model for the synthesis of metformin and other antidiabetic drugs; 
papaverine from Papaver somniferum L., which formed the basis for verapamil used in the 
treatment of hypertension. Opium is better known as being the source of painkillers such as 
morphine and codeine (Cragg & Newman, 2014).  
The World Health Organization (WHO) estimates that 80 % of the people in developing 
countries rely on traditional medicine for their primary health care, and about 85 % of traditional 
medicine involve the use of plant extracts. This means that about 3.5 to 4 billion people in the 
world rely on plants as sources of drugs (Chandrawat et al., 2014). The use of plants for 
medicinal purposes represents the largest use of biodiversity in the world. Many more species 
of plants are used as medicines, than are used for food. This fact concludes a significant role for 
natural products in the new drug discovery (Maridass, 2010). Recently, researchers are involved 
in an intensive screening of plants used in traditional medicine in an attempt to discover new 
drugs.  
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Natural products have been a rich source of compounds in antibiotic drug discovery with 
most antibiotic drugs being derived from a natural product or natural product lead. However, 
the rapid onset of resistance to most antibiotics diminishes their effectiveness considerably in 
the last two decades. (Maria, 2012). More reasons to add to the current crisis in antibiotic 
development is the poor return of investment, which is substantial in drug development. Despite 
this, smaller pharmaceutical companies are attempting to address the medical need for new 
antibiotics. In addition, the structural complexity of many natural products has often been 
understood as an obstacle, since it may impose serious challenges to chemical synthesis and 
derivatisation during the lead optimisation process (Luzhetskyy et al., 2007). There is an urgent 
necessitates of a constant supply of new antibiotics for effective treatment of infections. 
In the development of new antibiotic agents from natural products, several issues need to 
be addressed, including the establishment and selection of primary screening assays, which are 
crucial to ensure a selection of extracts or molecules with relevant pharmacological action are 
worthy to follow up. The assay must be easy to perform, speedy, uncomplicated, produce quick 
results, and preferably at a low cost (Monteiro et al., 2012). In order to evaluate the plant 
constituents for biological activity, the plant material must firstly be subjected to a suitable 
extraction process. Extraction (as the term is pharmaceutically used) is the procedure used in 
separation of medicinally active molecules of natural product using selective solvents through 
standard processes. A wide range of technologies is available for the extraction of active 
components. The crude extract is screened to obtain an evaluation of the potential biological 
activities, the crude extracts are sequentially fractioned, and each fraction subjected to a further 
suitable bio-assay tests (Bobzin, Yang, & Kasten, 2000). 
There are various chromatographic techniques available to separate the bio-active 
components from the crude mixture, such as Column Chromatography (CC), Liquid 
Chromatography (LC), and Gas Chromatography (GC). Purification of the bio-active 
compounds from plants by chemical and chromatographic approaches usually followed by 
structural characterisation using spectroscopic methods including Ultra Violet (UV), Fourier 
Transform Infrared (FT-IR), Nuclear Magnetic Resonance (NMR), and Mass Spectrometry 
(MS). NMR and MS are the most powerful and widely used techniques for the structure 
determination of bio-active compounds (Amsath, 2013). 
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In the field of drug discovery, it is necessary to distinguish between the cause of the 
disease and its mechanism at the molecular level. Protein molecules that linked to a given 
disease are identified first. Alongside the determination of the target, we must understand the 
mechanism of action of the tested drug and its biological pathways in the cell. Currently, 
approaches to analyse how a drug works fall into these broad categories. First, includes several 
strategies that rely on model organisms that are compatible with the genetic manipulations. 
Second category involves affinity-based methods employed to identify proteins that stick to the 
drug. (Wacker et al., 2012). Modern drug discovery seeks to identify new small molecules that 
potently and selectively modulate the functions of target proteins (Monica et al., 2013). Good 
drugs must have significant effects on a specific biological pathway and minimal effects on all 
other pathways. Confirmation that a tested compound inhibits any intended target and the 
identification of mainly secondary effects are among the main challenges in the development of 
new drugs. Extensive methods that enable researchers to determine which genes or activities are 
affected by a given drug might improve the efficiency of the drug discovery process by quickly 
identifying potential protein targets (Marton et al., 1998). 
Proteomics may be defined as the genome-scale analysis of the structure, abundance, 
localisation, modification, and function of proteins present in a cell, organ, or organism at a 
given time. Currently, proteomics has gained comprehensive attention in the field of drug 
development and mechanism studies, since proteomic analysis provides a direct reflection of 
gene expression. Identifying protein targets of bio-active compounds are an efficacious 
approach to discover unknown protein functions, as well as dissect molecular mechanisms of 
drug effectiveness. It is really important to systemically characterise the drug and its reactive 
intermediate (Ji, 2015). Technically, proteomic analysis requires the combination of several 
technologies for protein separation and processing such as two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE), high-performance liquid chromatography (HPLC), and mass 
spectrometry (MS) which is the primary tool for protein identification and characterisation. 
There are many types of each technique and the researcher may choose the one useful for the 
intended work. Bioinformatics used in the analysis of qualitative and quantitative proteomic 
data, various search engines and software packages available for researchers, i.e. MaxQuant, 
MultiQuant, Progenesis QI, and much more (Hu, Paul Fawcett, & GU, 2012). 
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Most proteomic studies involve the high-resolution separation of proteins from a complex 
protein mixture isolated under certain experimental conditions. Particular proteins of interest 
are identified using MS data linked to a genome sequence database by specialised softwares. 
The ultimate goal of proteomics is the complete identification and quantification of a specific 
proteins, with aim of revealing proteins function and post-translational modifications (PTMs) 
as part of a complex associated system. It is crucial to include proteomic study in the field of 
drug discovery to reveal the mechanism of action and functional pathways of the drug under 
investigation (Cooper & Carucci, 2004). There are a number of ways to perform comparative 
analysis of proteins using MS techniques within samples, either using labeling techniques or 
label-free techniques. Labeling of samples for subsequent mass spectrometric analysis allows 
for direct comparison of individual protein abundance between two different conditions by 
comparison of the mass shift induced in labeled peptides with their unlabeled counterpart (Alan 
et al., 2005). Despite the success of labeling techniques in quantification of relative abundances 
of proteins between two samples, the labeling reagents are expensive, and data analysis of mixed 
samples is often complicated and time consuming. On the other hand, label-free techniques have 
the advantage of comparing two samples with different conditions. In addition, label-free 
approaches can offer the advantage of relatively uncomplicated data analysis and less costly 
(Tuli & Ressom, 2009). Current study employed the label-free proteomics approach to 
investigate the antibacterial mode of action of the compounds under investigation in 
Staphylococcus aureus (MSSA) as a drug discovery model. 
The noticeable developments in gene and protein sequence databases, provides a means 
to identify proteins expressed in organisms. Bioinformatics tools, such as Mascot, make it much 
easier to access these databases to search, match and identify a protein component. UniProt, 
trEMBL ExPASy, Swiss-Prot and NCBInr are the widely used protein sequence databases 
(Kambiz, Luc and Sylvia 2010). Identification of the cellular targets for the tested compounds 
is a crucial step in understanding their true mode of action (Wang et al., 2011).  
After a protein is synthesised, it can undergo posttranslational modifications (PTMs), the 
post-translational modification of proteins plays a critical role in the regulation of a broad range 
of cellular processes. The analysis of posttranslational modifications is particularly critical for 
the study of drug discovery, PTMs can occur at any step in the life cycle of a protein and can 
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influence their structure, stability, function, protein-protein interactions, and localisation within 
the cell. There are multiple assays available to measure post-translational modifications, 
including western blots, ELISAs, and mass spectrometry (Freiberg et al., 2004; Brötz-Oesterhelt 
et al., 2005). 
1.2 Aims and objectives of the present study  
The main aim of this PhD project was the identification and characterisation of natural 
products that can act as antibacterial agents. The objective of this research was to investigate 
the role and mechanism of action of compounds derived from four medicinal plants; Centella 
asiatica L., Imperata cylindrica L., Morinda citrifolia L., and Sauropus androgynous L. These 
plants have previously been implicated as having antibacterial properties and have previously 
raised a significant interest of many researchers. In order to evaluate these plants therapeutically, 
many lab techniques have been used and developed throughout this project. The outline 
strategies followed in this project, are: 
1. Extraction and purification of small molecules from Centella asiatica L., Imperata 
Cylindrical L., Morinda citrifolia L. and Sauropus androgynous L. by using various 
extraction and purification techniques. 
2. In-vitro evaluation of the antibacterial activity of these compounds against various 
known pathogens by utilising convenient biological assays in order to investigate their 
potential therapeutic activities, and determination of their Minimum Inhibitory 
Concentration (MICs) and Minimum Bactericidal Concentration (MBCs).  
3. Isolation and structure identification of the active compounds comprised in Centella 
asiatica L., Imperata Cylindrical L., Morinda citrifolia L., and Sauropus androgynous 
L. extracts that are responsible for inhibition of bacterial growth by standard 
spectroscopy techniques.  
4. Elucidation of the mechanism of action of selected compounds shown to have the potent 
antibacterial activities via liable-free proteomics analysis and MS fingerprinting.  
5. Identification of the targets on the bacteria that are bound to the active compounds 
contained in the medicinal plants under investigation using available software packages.  
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1.3 Significance of the study 
Bacteria, which cause diseases, react to the antibiotics used as treatment by becoming 
resistant to them, sooner or later, this natural process of adaptation and antimicrobial resistance 
affect the lifespan of antibiotics. The antimicrobial resistance has increased recently due to 
unnecessary use and inappropriate use of antibiotics especially. Accordingly, this lead to hyper 
mutation of many bacterial strains and spread of resistant bacteria (Chauhan et al., 2013). As 
resistance and virulence increases, the cost and burden on society increases as well, the 
damaging effects of the antimicrobial resistance are already manifesting themselves across the 
world. Antimicrobial resistant infections currently claim at least 50,000 lives each year across 
Europe and the US alone, with many hundreds of thousands more dying in other areas of the 
world. Latest figures suggest that drug resistant infections could kill an extra 10 million people 
across the world every year by 2050 if they are not tackled. World Health Organization (WHO) 
is calling on governments and the pharmaceutical industry to work together in taking 
comprehensive action against drug-resistant infections by increasing the investment in antibiotic 
researches to meet global public health needs (Suraj & Sapkal, 2015). 
New strategies have been implemented to combat this growing crisis and to help the 
healthcare sector coping with antimicrobial resistance. Investigation of the antimicrobial activity 
of the secondary metabolites from natural products represents a promising possible solution. 
Currently, there is an increasing interest in the isolation, screening and exploitation of 
antimicrobial activity of natural products of plants as an inexpensive and rich source of 
secondary metabolites. In this project, different strategies were implemented to evaluate the 
antibacterial activity of four medicinal plants, Centella asiatica L., Imperata cylindrica L., 
Morinda citrifolia L., and Sauropus androgynous L., in-vitro against various strains of 
pathogenic bacteria.  
Although the biological effects of Centella asiatica L., Imperata cylindrica L., Morinda 
citrifolia L., and Sauropus androgynous L. have been studied, there is no comprehensive study 
available to explain the actual role of active compounds from these plants and the mechanisms 
of their action. Accordingly, this project conducted a screening of the effects of various extracts 
of these plants to demonstrate their antibacterial activity. The extracts of interest were further 
explored to isolate and identify the compounds which were responsible for the observed 
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activities. The elucidation of possible mechanisms of action of the activity was also studied 
using LC-MS/MS proteomics approach. Success in combatting antimicrobial resistance 
requires sustainable commitment and partnership with the private sector, governments, and 
international aid organisations, no one can do this alone.   
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2.1 Antibiotics  
The word antibiotic is derived from the Greek words anti (against) and bios (life) and 
means, in principle, a substance, which kills any living organism. However, in medical practice, 
antibiotics are compounds produced by, or derived from, certain fungi, bacteria, and other 
organisms, which used to combat bacterial infections by either prevent the bacteria from 
growing (bacteriostatic agents) or to kill them outright (bactericidal agents) (Sommer & Dantas, 
2011). The term antibiotic is used to refer to a drug that cures infections caused by bacteria, 
while an antimicrobial agent is a general term mostly applied to substances working on bacteria 
(antibacterial), but can also be applied to agents working on viruses (antivirals), fungi 
(antifungals) and parasites (antiparasitic agents). Antimicrobials include antibiotics produced 
by other organisms (e.g. penicillin, tetracycline, and erythromycin), chemically modified 
antibiotics (e.g. doxycycline) as well as chemically produced substances (e.g. fluoroquinolones) 
(Davies, J, & Davies, D., 2010). 
There has been an ongoing conflict throughout history between humans and the 
uncountable numbers of microorganisms that cause infection and disease. Around the middle of 
the twentieth century, there was a major evolution in antibacterial drug development and other 
means of infection control, which helped turn the tide in favour of humans. This development 
was dramatically improved when penicillin became available for use in the early 1940s. 
However, the euphoria of this potential victory over infectious diseases last only for a limited 
time (Lynne, 2000). The first antibiotic, penicillin, was discovered by Alexander Fleming in 
1928 when he observed that a common mold (Penicillum) produced a substance that lysed 
colonies of Staphylococcus spp. The first major development after the introduction of penicillin 
was ampicillin, which offered a broader spectrum of activity than the original penicillin. 
Ampicillin has been used extensively to treat bacterial infections since 1961. In the following 
decades, many new antibiotics with novel properties were discovered, including streptomycin, 
chloramphenicol, and tetracycline. Modification of already known antibiotics has led to several 
derivatives having different antibacterial activities, pharmacokinetic properties, and resistance 
characteristics as compared to the older drugs (Sharma et al., 2013). 
The effectiveness of these compounds ‘against life’ stems from their ability to block or 
modify critical bacterial cellular processes. Different antibiotics inhibit certain process in the 
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pathogen, which are different from that found in the host. For instance, the antibiotics 
chloramphenicol and tetracycline inhibit the bacterial ribosome (serve as the site of mRNA 
translation and protein synthesis), but not the structurally-different eukaryotic ribosome, 
therefore it shows selective toxicity against bacteria only (Olgica et al., 2012). 
Almost as soon as antibiotic drugs were rolled out for general use in the world’s 
population, bacteria responded by developing various forms of resistance. As antibacterial usage 
increased, so did the level and complexity of the resistance mechanisms exhibited by bacterial 
pathogens (Nikaido, 2009). The struggle to control the infections continues to this day, and 
surprisingly the number of scientists who are developing new antibiotic agents has begun to fall 
back, even as bacteria evolve ever more advanced mechanisms of resistance. Nonetheless, 
recent lobbying of governments, worldwide, has brought a change in attitudes toward antibiotic 
research and more money is being made available to research centres to support this most urgent 
experimentation (Tenover, 2006).  
The number of new antibiotic agents coming on to the market is falling, for instance, 
sixteen agents were approved for use between “1983-87” but only seven were approved between 
“1998-2002” (Bush & Pucci 2011). Recently, only two new classes of antibiotics; daptomycin 
and oxazolidinones have been utilised to treat Gram-positive infections, whereas, innovation to 
address Gram-negative bacteria are still struggling. Furthermore, drugs with novel modes of 
action are even fewer in number. For instance, linezolid, which was approved in 2003, had a 
novel mechanism of action (protein synthesis inhibitor, which works by blocking the initiation 
of protein production, and not one of the later steps), while the remainder were solely modified 
structures of existing agents.  (Miller et al., 2014). 
A major problem of novel antibiotic development is that many drug companies see it as 
an unattractive financial risk. This is due to huge production costs for compounds which require 
relatively small doses and short treatment cycles to be effective and which may not have a long 
clinical shelf life. Many 'Big Pharma' are focusing their efforts on compounds used in long-term 
treatment plans, for chronic illnesses, obesity and quality of life drugs, all of which are more 
probable to yield a larger profit than antibiotics. Still, many governments and international 
authorities are aware of the situation and measures are being conducted to enhance awareness 
of prescribing and misuse of antibiotics (Kraus, 2008). 
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2.1.1 Antibiotic resistance of bacterial pathogens 
Antibiotics originally evolved within bacteria almost a billion years ago as organisms 
competed with each other, long before mankind had discovered antibiotics. It is fair to presume 
that resistance to antibiotics developed shortly afterwards, as susceptible bacteria developed 
means to defend themselves against antibiotic-producing bacteria (Bradley, 2014). Since the 
introduction of antibiotics into clinical use in the mid-1940s, microorganisms have shown a 
remarkable ability to protect themselves by developing and acquiring antibiotic resistance. By 
1942, penicillin resistance was reported after only a few months of limited clinical trials. With 
the development of resistance to tetracycline, streptomycin, chloramphenicol and erythromycin, 
other classes of antibiotics began to emerge (Mengiste, Hagos, & Moges, 2014). 
Many antibiotics from the days of Alexander Fleming were used for healing diseases. 
When microorganisms are exposed to antibiotics they adapt some alternative survival routes 
related to their metabolism, enzyme production and gene transfers. Microbes found adaptation 
to unfavourable environments and continuous doses of antibiotics. This phenomenon is 
frequently found throughout the world where organisms come into contact with antibiotics, and 
the occurrence of the resistance is more likely when patients being exposed to high dosages of 
antibiotic, such as during hospitalisation (Smitha et al., 2014). Figure (2.1) summaries the 
timeline of antibiotics deployment and their resistance development.  
The overwhelming use of antibiotics has played a significant role in the emergence of 
antibiotic resistant bacteria. Resistance of pathogenic organisms to approved antibiotics has 
become one of the medical world’s biggest concerns with serious consequences for the treatment 
of infectious diseases in patients. The main cause of this phenomenon is the increased use or 
misuse of antibiotics. There has been a terrifying increase of antibiotic resistance in bacteria that 
cause either community infections or hospital - acquired infections (Nosocomial infections). 
There is a particular interest in multidrug resistant pathogens (MDR), and one of these in 
particular is methicillin resistant staphylococcus aureus MRSA (Alekshun & Levy, 2007). 
Hospital infections with methicillin resistant staphylococcus aureus raised serious public health 
concerns recently, since the infection is resistant to numerous antibiotics, including methicillin, 
amoxicillin, penicillin and oxacillin, thus making it challenging to treat the infection 
successfully. (Goulet et al., 2009). 
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Figure 2.1: Timeline of antibiotics deployment (top) and the development of antibiotic 
resistance (bottom). Adapted from (Clatworthy et al., 2007) 
Pharmaceutical companies have ignored or dropped dramatically investments in the 
antibiotic research as mentioned earlier, and as a result the race to develop new classes of 
antibiotics with novel modes of action has been compromised in the last decades (Fox, 2006). 
In the absence of major new classes of antibiotics, we need to focus our efforts on new sources, 
such as natural products, as an alternative provider of antimicrobial agents in order to address 
this problem of mounting resistance. In addition, other strategies have to be considered to 
minimise the development of resistance, such as judicious antibiotic use, narrow spectrum 
antibiotics should also be used whenever possible, and antibiotics given for short courses and at 
appropriate times (Breu, Guggenbichler, & Wollmann, 2008). Accordingly, in search of a better 
drug, we have concentrated our search on natural product compounds derived from plants. 
Recently, natural product compounds have attracted attention of medical researchers towards 
their search for potential antibiotic. 
2.1.2 The Basic characteristics of antibiotics 
Nowadays, there are about 4000 compounds identified with antibiotic properties. 
Antibiotics are derived from three main sources: moulds or fungi, bacteria and synthetic or semi-
synthetic compounds. They can be used either topically or internally, and the results of their 
action are either inhibition of the growth of pathogens or their elimination. Therefore, antibiotics 
can be divided into two classes, bacteriostatic and bactericidal drugs. However, the distinction 
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is not absolute, and depends on the drug concentration, the bacterial species, and the phase of 
growth. (Shamnas, Arya, & Deepak, 2013). 
Antibiotics can be further classified on their ability to target Gram positive and Gram 
negative bacteria, these classifications are broad and narrow spectrum antibiotics. Broad 
spectrum antibiotics are active against both Gram-positive and Gram-negative organisms.  
Examples include: tetracyclines, phenicols, and fluoroquinolones. Narrow spectrum 
antibacterials have limited action and are mainly useful against particular species of 
microorganisms.  For instance, glycopeptides and bacitracin are only effective against Gram-
positive bacteria, whereas polymixins are usually only effective against Gram negative bacteria.  
Aminoglycosides and sulfonamides are only effective against aerobic organisms, while 
nitroimidazoles are generally only effective against anaerobes organisms (Shaikh et al., 2015). 
2.1.3 Mechanisms of antibiotic actions  
Antibiotics are used to treat bacterial infections by interrupting the physiological 
mechanisms inside the bacterial cell that allow normal cellular function. Antibiotics agents act 
selectively on vital bacterial functions with minimal effects, or without affecting host cell 
mechanisms. Different antimicrobial agents act in different ways, the understanding of these 
mechanisms as well as the chemical nature of the antimicrobial agents is crucial in the 
understanding of the ways in which resistance against them develops (Kohanski et al., 2010).  
As mentioned earlier, antibiotic agents may be described as either bacteriostatic or 
bactericidal. Bacteriostatic antibacterial agents only inhibit the growth or multiplication of the 
bacteria, giving the immune system the time to clear them. Complete elimination of the bacteria 
in this case therefore is dependent on the efficiency of the immune system. Bactericidal agents 
kill the bacteria with or without the assistance of the immune system of the host. However, the 
mechanism of action of antimicrobial agents can be categorised further based on the structure 
of the bacteria or the functions that are affected by the agents (Salih, Salimon, & Yousif, 2012). 
Accordingly, antibiotics can be classified into five distinct classes based upon their mechanism 
of action. Those classes are (1) inhibition of bacterial cell wall biosynthesis, (2) disruption of 
bacterial cell membrane, (3) inhibition of protein biosynthesis, (4) inhibition of 
deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) synthesis, and (5) inhibition of folate 
synthesis (Wright, 2012). These categories can be summarised in table (2.1.). 
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Mechanism of action Target Antibiotic families 
Inhibition of cell wall                           
synthesis 
Penicillin binding proteins, 
D-alanyl-D-alanine, 
Muropeptide transport 
β-lactam (Penicillins, 
Cephalosporins, Carbapenems, 
Monobactams); Glycopeptides; 
Cyclic lipopeptides (Daptomycin) 
Inhibition of protein 
synthesis 
30s and 50s subunits of the 
ribosome 
Tetracyclines; Aminoglycosides; 
Oxazolidonones (Linezolid); 
Streptogramins (Quinupristin-
dalfopristin); Ketolides; Macrolides; 
Lincosamides 
Inhibition of DNA 
synthesis 
DNA gyrase, DNA structure 
integrity 
Fluoroquinolones (Ciprofoxacin) 
Inhibition of RNA synthesis RNA polymerase Rifampin 
Inhibition of folic acid 
pathway 
Dihydrofolate reductase, 
Dihydropteroate synthetase 
Sulfonamides; Trimethoprim 
Disruption of 
bacterial membrane 
Phospholipid structure Polymyxins (Polymyxin-B, Colistin) 
Table2.1: Summary of mechanisms of action and their targets of selected classes of antibiotic. 
Adapted from (Brotz-Oesterhelt & Brunner, 2008). 
 
2.1.4 Mechanisms of antibiotic resistance 
After the discovery and commercial introduction of antibiotics, it was soon noticed that 
usually treatable infections were not affected by the treatment with antibiotics and had adapted 
mechanisms of resistance. Alexander Fleming predicted that too low frequent doses of penicillin 
would lead to the development of penicillin resistance. Surprisingly, bacterial resistance towards 
penicillin was actually noticed before it was made widely available to use, after a while, it was 
finally recognised that there should be some antibiotic control, as the use of penicillin and other 
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antibiotics were not restricted by any means (Hellen et al., 2015). Antibiotic resistance is a result 
of the evolutionary pressure that bacteria undergo, resistance occurs for all antibiotics after their 
clinical administration, and there is a limit to the number of antibiotic substances which fulfil 
all pharmacokinetics demands. Because of this, much of the antibiotic work done after the 1960s 
was focused on chemically modifying existing antibiotics to make them more potent to resistant 
pathogens and to improve pharmacokinetics properties. Recently, researchers have tried to find 
a new antibiotic candidate from natural products (e.g. medicinal plants) in a hope to meet the 
health sector demands (Davies & Dorothy, 2010). 
There are many methods by which bacteria can become resistant to antibiotics. The current 
scale of the problem and the number of resistances against drugs across different classes is 
unprecedented. Resistance can be caused by a variety of mechanisms and it can be summarised 
as: (i) the presence of an enzyme that inactivates the antibiotic agent, bacteria can produce 
enzymes that are capable of adding different chemical groups to antibiotics that prevents binding 
between the antibiotic and its target in the bacterial cell; (ii) the presence of an alternative 
enzyme for the enzyme that is inhibited by the antibiotic agent, for instance, Staphylococcus 
aureus can acquire the resistance gene mecA and produce a new penicillin-binding protein, the 
new penicillin-binding protein has low affinity to β-lactam antibiotics and results resistant to 
the drugs, (iii) a mutation in the antibiotic agent’s target which results changes in the 
composition or structure of the target in the bacterium and stop the antibiotic from interacting 
with the target. Alternatively, the bacteria can add different chemical groups to the target 
structure, in this way shielding it from the antibiotic; (iv) destroy the antibiotic through enzymes 
that can inactivate antibiotics. One obvious example is β-lactamase that destroys the active 
component (the β-lactam ring) of penicillin. Later, bacteria developed extended-spectrum β-
lactamases and become a major problem, due to the ability of destroying a wide spectrum of β-
lactam antibiotics; (v) reduced uptake of the antibiotic agent, bacteria achieve that by decrease 
the permeability of the membrane that surrounds the bacterial cell which make it more difficult 
to pass through; and (vi) efflux pumps, bacteria can produce pumps that are localised in their 
membrane or cell wall. In some cases, mutations in the bacterial DNA can make the bacteria 
produce more pumps to reduce the antibiotic concentration inside the bacterial cell (Fluit et al., 
2001; Chanda et al., 2010). Figure 2.2 summaries major resistance mechanisms. 
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Figure 2.2: Schematic diagram of major antibiotic mechanisms of resistance (Gullberg, 2014). 
At least seventeen different classes of antibiotics have been produced to date. 
Unfortunately, for each one of these classes at least one mechanism of resistance has developed 
over the years. In fact, in some cases these bacteria have been able to develop simultaneous 
resistance to two or more antibiotic classes, making the treatment of infections caused by these 
microorganisms extremely difficult, very costly and in many cases associated with high 
morbidity and mortality (Alanis, 2005).  
Antibiotic resistance can be divided into natural resistance and acquired resistance. 
Natural resistance means that the bacteria are intrinsically resistant, an example of this can be 
due to increased efflux activity, a mechanism responsible for moving out toxic substances and 
antibiotics outside the cell.  Acquired resistance refers to bacteria that are usually sensitive to 
antibiotics, but are liable to develop resistance. Acquired resistance is often caused by mutations 
in chromosomal genes, or by the acquisition of mobile genetic elements, such as plasmids or 
transposons, which carry the antibiotic resistance genes. (Katrijn and Arthur 2009). 
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It is important to have a good understanding of the molecular basis by which development 
of resistance occurs, because it allows us to develop new approaches to managing the infections 
caused by these bacteria and to create new strategies for the development of new treatments 
against these bacteria (Sefton, 2002). In most cases of bacterial resistance, changes in the genetic 
composition of the susceptible bacteria take place, either via a mutation or by the introduction 
of new genetic information. The expression of these genetic changes within the cell result in 
changes to one or more biological mechanism of the affected bacteria and ultimately determines 
the specific type of resistance that the bacteria develops, resulting in a myriad of possible 
biological forms of resistance (Figure 2.3). (Dzidic et al., 2008).  
 
 
 
 
 
 
 
 
 
Figure 2.3: Schematic diagram shows biochemical and genetic aspects of antibiotic resistance 
mechanisms in bacteria. Adapted from (Dzidic et al., 2008). 
The resistance among various microbial species (infectious agents; e.g., bacteria, fungi, 
virus, and parasite) to different antimicrobial drugs has emerged as a cause of public health 
threat all over the world, at a terrifying pace. One such bacterial pathogen is methicillin-resistant 
Staphylococcus aureus (MRSA), it has for several years been increasingly spreading at inpatient 
and outpatient health care facilities worldwide. This organism is capable of causing a range of 
infections from skin and soft tissue infections to more life threatening illnesses such as 
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pneumonia, bacteremia and surgical site infections (Landecker, 2015). The next section will 
focus on MRSA, as it comes a huge clinical burden that is causing great public and political 
concern, specially that the current treatments proved to be inactive.  
2.2 Methicillin-resistant staphylococcus aureus (MRSA) 
Staphylococcus aureus is a Gram-positive bacterium normally found as a commensal 
organism living on the human skin and mucosa. It is found in up to 30% of the population living 
harmlessly on the skin. Nevertheless, it is a versatile organism able to acquire entry to the 
physical structure and it is able to colonise in many situations, and often causing disease (Hardy, 
2004). The genus staphylococcus comprises of thirty-two species in which approximately 50 % 
are indigenous to man, and was first identified in 1880 by Alexander Ogston as the cause of 
many abscesses. The name is derived from the Greek words staphyle meaning "a bunch of 
grapes" and kokkos meaning "berry”. Staphylococcus aureus is a facultative anaerobic, non-
motile, non-spore forming cocci that have an average diameter of 1µm. They are arranged in 
grape-like clusters, in pairs and sometimes in short chains (Figure 2.4) (Stevens, 2006). 
 
 
 
 
 
 
Figure 2.4: Scanning Electron Micrograph of MRSA shows abundant clumps of MRSA. 
Magnification 4780x. Centers for Disease Control and Prevention (David, 2015). 
Of all the species of staphylococci, Staphylococcus aureus is by far the most important 
human pathogen, it causes a wide range of infections related to its ability to produce a variety 
of cellular and extracellular proteins associated with the virulence of the bacterium. When it 
finds the way to enter the body and bloodstream, it has become a major cause of nosocomial 
infection of surgical wounds and infections associated with some medical devices such as 
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catheters (Livermore, 2000). It also causes toxic shock syndrome (sudden high fever, low blood 
pressure (hypotension), vomiting or diarrhea, confusion, muscle aches, redness of eyes) by the 
release of super antigens into the bloodstream of the host. Most of the pathogenic effects of 
Staphylococcus aureus are associated with the amount of potential virulence factors. For 
instance, adherence, toxins, invasiveness and antibiotic resistance (Spaulding et al., 2013). 
Methicillin-resistant Staphylococcus aureus MRSA strains emerged soon after the 
introduction of methicillin into clinical practice, but were generally rare until the 1980. In the 
late 1970, however, MRSA emerged as a major pathogen of hospital infection worldwide and 
in addition it had also become a community pathogen. Clinical infections are most common in 
patients in hospital intensive care units, nursing homes, and other chronic care facilities. The 
increased frequency of community-associate MRSA infection has been associated with reports 
of increased morbidity and death rate. Specifically, a longer duration of fever, prolonged 
hospitalisation, a higher incidence of pulmonary complications along with bone and joint 
infections (Kazmierczak et al., 2014). 
MRSA infections are classified as either hospital-acquired or community-acquired MRSA 
infections (HA-MRSA or CA-MRSA). HA-MRSA is usually resistant not only to β-lactams, 
but also to other types of antibiotics. Because many hospitalised patients are weak and their 
immune systems compromised, to some degree HA-MRSA infections are often quite serious. 
CA-MRSA however, began to emerge in the 1990s in patients who do not have the risk factors 
usually associated with HA-MRSA. Such as recent hospitalisation, chronic diseases, kidney 
dialysis, human immunodeficiency virus infection, and intra-venous drug. CA-MRSA strains 
are usually resistant to β-lactams but susceptible to other antimicrobials like clindamycin and 
tetracycline. MRSA infections represent a burden for both patients and health care systems and 
these problems originate initially in large tertiary care hospitals with patients in burn, post-
operative, prolonged hospitalization and intensive care wards (Elliott et al., 2010). 
2.2.1 Pathogenesis of Methicillin-resistant Staphylococcus aureus 
Several factors are required to establish an infection. The pathogenicity of Staphylococcus 
aureus is dependent on production of more than forty different extra-cellular toxins, cell surface 
proteins and enzymes. Numerous surface proteins, mediate adherence to host tissues including 
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fibronectin binding protein, fibrinogen binding protein, collagen binding protein and clumping 
factor. Protein A, is an important virulence factor and may play a role in host defence evasion. 
Staphylococcus aureus produces numerous enzymes, such as proteases, lipases, hyaluronidase, 
and DNase, which enable it to invade and destroy host tissues and spread to other sites. The 
enzyme coagulase promotes the fibrin mesh development that contributes to abscess formation. 
Hemolysins and leucocidins cause leucocyte destruction by the formation of pores in the cell 
membrane, thereby altering their permeability and resulting in cell damage or death (Figure 2.5) 
(Collins et al., 2010). 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Pathogenic factors of Staphylococcus aureus, with structural and secreted products 
both playing roles as virulence factors (Gordon and Lowy, 2008). 
Staphylococcus aureus virulence factors include the production of a wide range of 
extracellular toxins which released by the bacterium either by secretion or cell lysis. When 
released act upon the host, causing localised damage or systemic infection. Staph. aureus is also 
capable of producing septic shock, it does this by interacting with and activating the host 
immune system and coagulation pathways. Peptidoglycan, lipoteichoic acid, and α- toxin may 
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all play a function during the invasion. Other virulence mechanisms include biofilm formation 
(slime), which allows Staphylococcus aureus to resist host defences or certain antibiotics. 
Moreover, the majority of strains produce extracellular proteins, described as fatty acid 
modifying enzymes (FAME) that detoxify fatty acids, increasing the invasiveness of 
Staphylococcus aureus (Gordon and Lowy, 2008). 
The key determinant of methicillin resistance is the mecA gene, which encodes in a novel 
penicillin-binding protein (PBP2/PBP2a) that reduces the binding of all β-lactam drugs to the 
cell wall and therefore, mediates cross-resistance to all these compounds. The mecA gene is 
carried on a mobile genetic element assigned the staphylococcal cassette chromosome mec 
(SCCmec), SCCmec is inserted into the chromosome at a unique site (attBscc) located near the 
Staphylococcus aureus origin of replication. SCCmec is composed of the mec gene complex, 
which gives resistance to methicillin, and the ccr gene complex, which encodes recombinases 
responsible for its mobility (Figure 2.6) (Deurenberg & Stobberingh, 2008).   
 
 
 
 
 
 
 
 
Figure 2.6: Structure of the staphylococcal cassette chromosome mec (SCCmec), with the 
recombinase genes complex upstream of the mec complex (Rybak & La Plante, 2005). 
Apart from the inability of an antibiotic to bind to the target site due to structural defect 
of such site, other mechanisms that may usually play significant roles in the development of 
resistance in MRSA include efflux phenomenon resulting in continuous pumping of 
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antibacterial drugs out of the bacterial cell. Others alter membrane proteins, which limit the 
access of drugs to the cell. Resistance can also occur from high level production of β lactamase. 
MRSA is produced when Staphylococcus aureus acquires a genetic element called SCCmec. 
SCC is a basic mobile genetic element that serves as the vehicle for gene exchange among 
staphylococcal species (Luong et al., 2002). 
2.3 Proteomics 
2.3.1 Origin, definition and significance 
The first proteomics studies were reported nearly 40 years ago with the introduction of 
two dimensional gel electrophoresis (2D-GE) by O'Farrel who attempted to characterise the 
proteins expressed by Escherichia coli. Although many proteins could be separated and 
visualised, they could not be identified (O'Farrel, 1975). This ground breaking work was 
followed by attempts to map the proteins of mouse (Klose, 1975), guinea pig (Scheele, 1975) 
and human (Graves & Haystead, 2002). The term proteomics was first used in 1995, and it was 
defined as a large-scale characterisation of all proteins that are expressed by an organism at a 
certain time under a certain condition. Proteomics studies involve characterisation of protein 
mixtures in order to help understanding biological systems and determine the relationships 
among proteins, the diverse structural characteristics, functionality and interactions of proteins, 
and to determine post-translational modified sites (Thelen, 2007). 
Currently, there are two definitions of the term proteomics. The first is the more classical 
definition, restricting proteomics to large scale analysis of proteins only. The second, more 
inclusive definition, combining protein expression studies with mRNA studies, genomics and 
studies of the 3D structures of the proteins. However, the goals of proteomics remain the same. 
The most important goal is to obtain a more global and integrated view of biology by studying 
all proteins in a cell rather than each one individually (Pandey & Mann 2000). 
The field of proteomics covering the analysis of whole proteins. Proteome study would 
provide the absolute quantitative measurement of every protein, its isoforms, modifications and 
complexes within a given sample. Typically, there are multiple proteins associated with each 
gene, the average number of protein formed per gene was predicted to be one or two in bacteria, 
three in yeast and three or more in human (Daniel, 2002). Comprehensive cellular information 
cannot be obtained from the study of genes alone. For instance, proteins, not genes, are 
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responsible for the phenotypes of cells. Furthermore, it is impossible to demonstrate 
mechanisms of disease, senility, and effects of the environment just by studying the genome. 
Only through the study of proteins, can protein modifications be characterised and the targets 
of drugs identified. Thus, the focus of research is now moving to intensify the task of identifying 
the structure, function, and interactions of the proteins produced by individual genes (Bradshaw 
& Burlingame, 2005).    Many different areas of study are now grouped under the name of 
proteomics. These include protein expression, protein modifications, protein-protein interaction, 
protein localisation, and protein function studies (Figure 2.7). 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Type of proteomics and their applications to biology. 
The development of proteomics is a direct consequence of advances made in large-scale 
nucleotide sequencing and in the sensitivity of protein identification methods. Without this 
information, proteins could not be identified even with the improvements made in mass 
spectrometry. Protein identification relies on the presence of databases for the given organism. 
The majority of DNA and protein sequence information has been accumulated within the last 
twenty years. One of the first applications of proteomics is to identify the total number of genes 
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in a given genome. This is necessary because it is difficult to predict gene function accurately 
from genomic data (Eisenberg et al., 2000). 
The other application of proteomics includes providing the means for studying protein 
expression which cannot be achieved by mRNA analysis alone. Transcriptomic studies have 
become increasingly popular and includes DNA arrays and serial analysis of gene expression 
(SAGE). However, many studies have shown that mRNA is not a direct reflection of the protein 
content of the cell; in fact, there is a very poor correlation between mRNA levels and protein 
expression levels. The reason for this is that the formation of mRNA is only the first step in a 
series of events leading to the synthesis of a protein (Figure 2.8). After a protein is synthesised 
it can undergo posttranslational modifications (PTMs) and it has been estimated that up to 200 
different posttranslational modifications may exist. Proteins are also regulated by proteolysis 
and compartmentalisation (Gygi et al., 2000; Venkateshwar et al., 2008). Proteomics also 
include the study of protein function. The complete function of genes in a genome will aid the 
scope of structural genomics, and the ultimate goal is to obtain 3D structures of the products of 
all genes in a genome to conclude the function of many proteins (David, 2000). 
 
 
 
 
Figure 2.8: Schematic diagram showing the mechanisms of how a single gene can lead to 
multiple gene products. 
Other important applications of proteomics are the characterisation of the posttranslational 
modifications (PTMs), compartmentalisation of the proteins and protein-protein interactions. 
Cell growth, life span, and the decision to proceed through the cell cycle are all regulated by 
signal transduction through protein complexes. Therefore, there are different subjects of 
proteomics, such as protein expression proteomics, structural proteomics, and functional 
proteomics. The quantitative studies of protein expression among samples that differ by some 
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variables is known as expression proteomics. In this way proteins specific for a disease state, 
cell line or specific growth condition can be identified (Graves & Haystead, 2002).  
When the goal of proteomic studies is to map out the structure of a protein complex, or 
proteins present in a specific organelle, then it known as "cell mapping" or structural proteomics. 
Structural proteomics attempts to identify all proteins within a complex, determining their 
location and illustrate the protein-protein interaction. Isolation of specific subcellular organelles 
or protein complexes by purification can greatly simplify the proteomic analysis. Functional 
proteomics could include isolation of protein complexes and also the study of their 3D structure 
which mainly provide important information of protein signaling, disease mechanisms and 
protein-drug interaction (Au et al., 2007; Csermely et al., 2013). In what is termed comparative 
proteomics, comparing two protein extracts of the same isolate under two different conditions, 
or treatment, will result two lists of proteins. The differentially expressed proteins may be related 
to the condition that induced their expression (e.g. high osmolality) and ultimately allowing the 
elucidation of which proteins are important or required for the condition (e.g. outer membrane 
porins) and the characterisation of the physiological response (Kaake, Wang, & Huang, 2010).  
2.3.2 Proteomics in Microbiology 
Before the universal accessibility of methods for protein identification, two-dimensional 
polyacrylamide gel electrophoresis 2D-PAGE was widely applied to distinguish between related 
isolates of various bacterial species, like (Jackson et al., 1985) did with Neisseria spp., and 
(Dunn et al., 1987) did with Campylobacter spp., and many more studies in this context. Early 
application of 2D-PAGE used the method simply as a sensitive technique for the differentiation 
of closely related microbial isolates on the basis of protein charge and molecular weight. When 
interpreting the results, it is broadly assumed that co-migrating protein spots are functionally 
identical proteins with amino acid homology. However, it has to be considered that even a single 
charged amino acid substitution can alter the position of a protein to what may seem a unique 
protein spot on a 2D-PAGE. In fact, bacterial strains can sometimes indicate a bigger level of 
variability when compared on 2D-PAGE in comparison to DNA-DNA hybridisation. (Jungblut, 
2001). 
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The improvements made in the area of mass spectrometry, for identification of 
electrophoretically separated proteins, allowed the technique of 2D-PAGE to grow further. 
Nowadays, 2D-PAGE is infrequently utilised as a tool for epidemiological studies, and instead, 
it is used for elucidating the mechanism of bacterial pathogenicity, antibiotic resistant, 
physiology and vaccine development (Vesela & Robert, 2010). Many studies have been 
conducted to analyse the global bacterial proteome. A few examples are the reference maps of 
the cytosolic proteins created for Staphylococcus aureus (Cordwell et al., 2002), Bacillus 
licheniformis (Voigt et al., 2004), Bacillus subtilis (Eymann et al., 2004) and many others. The 
protein expression patterns obtained are typical of growing cells containing glycolytic enzymes, 
elongation factors and chaperones among the most abundant proteins. Therefore, for several 
microorganisms, with extensively characterised proteins such as Escherichia coli, Bacillus 
subtilis and the Cyanobacterium synechocystiss, databases are now available which are freely 
accessible via the Internet (Cash, 2003).  
The publication of the first complete genome sequence of a living organism, the 
bacterium Haemophilus influenzae in 1995 (Fleischmann et al., 1995), opened up a new era in 
biology. The exponential increase in genome sequence information that followed after this 
imprint has posed a challenge for bioinformatics and for researchers to design new “global” 
experiments to attempt to understanding the functions of all of these new genes (Hecker et al., 
2003). Today, as the genomes of various bacteria have been sequenced, new technologies for 
genome wide approaches for analysis of bacterial protein regulation are being explored. These 
include transcriptional profiling using whole genome DNA microarrays to analyse bacterial 
gene expression profiles and quantitative protein profiling. Although transcriptional profiling is 
relatively quick and easy, mRNA abundance is not always a reliable indicator of corresponding 
protein abundance. In addition, bacterial RNA is relatively unstable and difficult to purify, 
which might limit the detection of rare transcripts.  A large number of genes encoding for 
proteins with unknown functions have been derived from genome sequencing, among them new 
global regulators such as alternative sigma factors, (σ factor, is a protein needed only for 
initiation of RNA synthesis), response regulators or other activators. It appears that even for 
model organisms, many sections of their cell physiology or molecular biology remain 
unexplained for the time being (Guina et al., 2003; Zhou et al., 2013). 
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Quantitative proteomics have become an indispensable analytical tool for microbial 
research nowadays. Modern microbial proteomics covers a wide range of areas in basic and 
applied research from in vitro characterisation of individual organisms to unravel the 
physiological implications of stress, to the characterisation of the protein content of a cells at a 
given time. With the wide range of techniques available, ranging from classical gel-based 
procedures to modern MS-based quantitative techniques, including metabolic and chemical 
labeling, as well as label-free techniques, quantitative proteomics today is highly successful in 
sophisticated settings of high complexity, such as host-pathogen interactions, mixed microbial 
communities, and microbial metaproteomics (genes and / or proteins most abundantly expressed 
in environmental samples) (Andreas et al., 2014).  
A proteomics study can be conducted in a top down method where the proteins are studied 
directly, enabling post translational modifications and splice variants to be determined, key 
amino acid sequence can also be determined, although specialised MS analysis needed. A 
bottom up (shotgun) method can also be used where the protein identity is conferred through 
the study of peptides generated through enzymatic proteolysis of the total proteins from the cell 
and is the preferred method for complex samples, even though it increases sample complexity 
through the generation of many peptides for each protein. The optimal methodology depends on 
the overall complexity of the sample and the information required from the analysis (Wu et al., 
2010). Bottom up quantitative proteomics was performed in this research due to the complexity 
of our sample. 
2.3.3 Proteomics as a tool in drug discovery  
Drug discovery is a lengthy and highly expensive procedure. To speed up the procedure, 
a number of biotechnologies, including genomics, proteomics and cellular/organismic 
methodologies, have been produced and developed over the years (Veenstra, 2007). Proteomics 
development faces many multidisciplinary challenges, including both the traditional 
technologies (Biology and Chemistry) and the emerging of high-throughput automation 
technologies and Bioinformatics. Emergent technologies include two-dimensional 
ployacrylamide gel electrophoresis 2D-PAGE, mass spectrometry MS, protein arrays, isotope-
encoding, two-hybrid systems, bioinformatics technology and activity-based assays. These 
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technologies are promoting the utility of proteomics in the drug discovery process (Burbanm & 
Tobal, 2002). Some commonly used technologies are shown in figure (2.9). 
 
 
 
 
 
 
 
 
 
Figure 2.9: A partial view of various proteomic technologies important in drug discovery.  
The decisive point of the drug discovery process is getting the best drug for the most 
appropriate target with minimal side effects to the host. Proteins are the fundamental targets of 
drug discovery, it represents more than 90 % of druggable targets and will most likely remain 
the single most important class of molecules targeted by pharmacological agents (Natural or 
synthesised) as more novel targets are identified. However, the huge excellence of potential drug 
targets and the hype about target validation has led to a confusion over how to determine the 
optimal molecular targets for pharmacological intervention. Functional proteomics represent a 
powerful approach providing valuable information on target druggability (term used in drug 
discovery to describe a biological target, such as a protein, that is known to or is predicted to 
bind with high affinity to a drug), and facilitate rapid access to relevant therapeutic leads 
(Walgren & Thompson, 2004). 
The drug discovery process involves many phases, and the proteomics investigation is the 
important one. Common applications of proteomics in the drug industry include target 
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identification and validation, identification of efficacy and toxicity biomarkers from readily 
accessible biological fluids, investigations into mechanisms of drug action or toxicity, exploring 
protein-protein interactions, and pre-clinical/clinical development. Effectiveness of this 
procedures relies on timely knowledge of biological cause-and-effect in the course of disease 
and treatment, which in the end rests on knowledge of protein function and regulation (Jhanker 
et al., 2012). 
Target identification and validation are the first key stages in the drug discovery, which 
involves identifying proteins whose expression levels or activities change in disease states. Drug 
target is the specific binding site of a drug in vivo through which the drug exerts its action. The 
drug target is a biomolecule(s), normally a protein, the biomolecules have special sites that 
match other molecules, and these molecules could be endogenous or extraneous substances such 
as drug. The biomolecule structure might change when it binds to small molecules (drug) and 
the changes in structure normally are reversible (Chen & Du, 2007). Following the change in 
the biomolecule’s structure, various physiological responses occur and induce regulation of the 
cell, organ, tissue, or body status. The expression, activity, and structure of the biomolecule 
might change over the duration of the pathological process. This application provides a protein 
profile of a cell or tissue that can be used to compare a healthy with a diseased state for protein 
differences in the search for new drug targets. This is one of the most important applications for 
proteomics (Latterich et al., 2008). 
Proteomics technologies may also help identify protein-protein interactions that influence 
either the diseased state or the proposed therapy. Protein-protein interactions have been 
identified through the use of the latest proteomics technology, including a method known as 
stable isotopic amino acids in culture (SILAC). Other methods used to study protein interaction 
include surface plasmon resonance (SPR) technology, the more recent techniques of reverse 
transfection and tandem affinity purification. Advances in mass spectrometry have also 
facilitated the study of protein-protein complexes. Fourier transform ion cyclotron resonance 
mass spectrometry (FTICR-MS) provides a high mass resolution and accuracy of whole proteins 
and protein-protein complexes via the circulation of ions in a superconducting magnet (Walgren 
& Thompson, 2004). 
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Efficacy biomarkers are used to assess whether target modification has taken place. They 
are used for the characterisation of disease models and to assess the effects and mechanism of 
action of lead candidates in animal models. Toxicity biomarkers are used to screen compounds 
in pre-clinical studies for target organ toxicities as well as later on in development during clinical 
trials. Complementary approaches such as metabolomics and genomics can be utilised in 
conjunction with proteomics throughout the drug development process to create more of a 
unified systems biology approach (Hewick, Lu, & Wang, 2003). 
Post-translational processes such as protein modifications or protein degradation remain 
unaccounted for in genomic analysis. Because both cell function and its biochemical regulation 
depend on protein activity, and because the correlation between message level and protein 
activity is low, the measurement of expression has proven to be inadequate. Consequently, the 
development of drug discovery technologies has begun to shift from genomics to proteomics. 
The data from recent proteomics studies have demonstrated the potential value that proteomics 
has to offer in drug development. Proteomics techniques provide precise and fairly rapid 
methods to screen both target proteins and potential therapeutic compounds (Elangovan, 2013). 
2.3.4 Proteomic Analysis Techniques 
The rapid growth in the field of proteomics is a direct result of the advances made in the 
technologies for protein extraction, solubilisation, separation, and the sensitivity of the methods 
used for protein identification. Attempts to overcome the challenges of heterogeneity, instability 
and the dynamic range of proteins lead to two main requirements of any techniques apply to 
proteomic analysis. The first, is the ability to reduce sample complexity to manageable levels, 
the second is the ability to identify proteins once they are separated. The most popular methods 
for separating proteins are gels and chromatography columns, and in both cases, the principle 
of their action is to split a complex mixture of proteins into multiple lower complexity fractions. 
The most effective tool for protein identification has become the mass spectrometer and 
bioinformatics (Michael and John, 2000). The ultimate goal of technologies applies in 
proteomics studies is the characterisation of protein mixtures in order to understand biological 
systems and determine relationships between proteins, the diverse structural characteristics, 
functionality and interactions of proteins, and to determine post-translational modified sites. 
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2.3.4.1 Protein separation using gel based techniques 
The modern approach of proteomics consists of two basic elements: the separation of the 
complex mixture of proteins, and identification of the individual proteins. High resolution 
separations are the most important feature in separation sciences, in order to be able to analyse 
complex samples especially in the biological samples. Electrophoretic separations of proteins 
are no exception to this rule, with the additional difficulty that proteins are very complex 
substances that have a strong tendency to precipitate (Graves & Haystead, 2002). Two high-
performance electrophoretic separations of proteins were available at the very beginning of the 
70s, the first one is electrophoresis of proteins in the presence of SDS, as described by (Laemmli, 
1970), a technique that instantly became very popular, and the second one is denaturing 
isoelectric focusing, as described by (Gronow & Griffith, 1971). As these two techniques used 
completely independent separation parameters (molecular mass and isoelectric point, 
respectively) it is not surprising that it was soon tried to couple them. The first successful, 
detailed study, utilising these two different parameters was reported by (O'Faffel, 1975). 
Subsequently, this technique got its famous name the two-dimensional polyacrylamide gel 
electrophoresis 2D-PAGE (Rabilloud & Lelong, 2011). 
Some complex biological sample may contain too many proteins or peptides for the mass 
spectrometer to detect them all at once, so separation techniques can be utilised to reduce the 
complexity of an analyte proteome. By far, the most common technique for the analysis of either 
a subset of proteins or all resolvable proteins in a cell is gel electrophoresis including either 1D 
sodium dodecyl sulfate polyacrylamide gel electrophoresis SDS-PAGE or two-dimensional 
polyacrylamide gel electrophoresis 2D-PAGE. When using SDS-PAGE, the proteins are both 
solubilised and given a charge by the detergent SDS and further separated according to their 
molecular weight. Negatively charged proteins traps in the polyacrylamide matrix (gel) as they 
travel towards a positive electrode (anode), facilitated by an electric field applied across the gel. 
The ionic detergent SDS is added to the proteins where it binds and denatures the proteins, 
distributing a negative charge evenly across the whole protein. SDS-PAGE is simple to perform, 
reproducible and can separate proteins with molecular weights between 10 and 300 kDa. For 
many applications SDS-PAGE is the method of choice, but due to its limited resolving power it 
is only suitable for separation of mixtures after some form of purification (John, 2002). 
Reducing SDS-PAGE is usually performed, which includes the addition of dithiothreitol (DTT) 
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to the sample, this denatures the proteins further by breaking any disulphide bonds and 
disrupting any tertiary protein folding and quaternary structure, giving an improved protein 
separation (Claudia et al., 2012). 
When separation of more complex samples is required, such as total cell lysates, 2D-
PAGE is the method of choice. 2D-PAGE is an extension step of the 1D separation with the 
addition of isoelectric focusing (IEF) before SDS-PAGE separation. IEF of proteins is 
performed along an acrylamide gel strip with an immobilised pH gradient, where proteins are 
separated based on their charge in a specific buffer and their differing isoelectric points, which 
is the point on the pH gradient where each protein has no net charge. Proteins migrate along the 
gel with the electric field to their isoelectric point. This immobilised pH gel is then added to the 
top of a large polyacrylamide gel and SDS-PAGE is performed (Figure 2.10). The combination 
of these two methods achieves resolution far exceeding that of SDS-PAGE alone (Rogowska et 
al., 2013).   
 
 
 
 
 
 
 
 
 
 
Figure 2.10: 2D Electrophoresis. Protein spot result from two separations: first by pI (IEF) and 
then by size (SDS-PAGE). (Bio-Rad, 2014). 
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Isoelectric focusing became more reproducible with the development of immobilised pH 
gradients (IPG) and Immobiline™, eliminating the possibility of the pH gradient drift and 
brought superior resolution and reproducibility to first dimension IEF. The primary application 
of 2D-PAGE is expression the profile of complex protein mixtures extracted from cells, tissues, 
or other biological samples, when the comparison of the resulting images of two samples is 
possible, and that gives both quantitative and qualitative information. Another application of 
2D-PAGE is monitoring post-translational modifications, which is possible because most of the 
modifications would alter the charge and the molecular weight of the protein. Currently there 
are many software packages designed to detect, match and calculate the volumes of spots 
between gels, this enables quantitative and statistical analyses. For instance, BioNumerics 2D, 
Delta 2D, ImageMaster 2D, and many others. Protein spots of interest can be excised from the 
2D-PAGE, digested, and the peptides subjected to mass spectrometry (MS) to identify the parent 
protein (Yerlekar & Dudhe, 2014). 
With all advantages and features of 2D-PAGE based proteomics, there are still a number 
of limitations when using this approach. Major shortcomings of 2D-PAGE include the poor 
representation of basic and membrane proteins (Due to poor solubility in non-ionic lysis buffers 
and inefficient transfer from the isoelectric focusing strip to the SDS-PAGE gel), limited 
dynamic range and the potential for “hidden” proteins, 2D-PAGE spots may be made up of more 
than one protein (two or more may have similar isoelectric point and molecular weights), as 
well as tendency towards high abundance proteins (isoelectric point of 4-7), and finally the 2D-
PAGE is time consuming to run and manually intensive. These disadvantages of 2D-PAGE 
demonstrate that the choice of method depends largely on the type of sample and its complexity 
(Wittmann-Liebold, Graack, & Pohl, 2006). 
2.3.4.2 Methods of protein quantitation and identification 
Although electrophoretic separation of proteins can effectively separate all the component 
proteins of a proteome, and provide quantitative data, protein identification and function remain 
unknown. The methods for the identification of proteins present in single gel spots/bands have 
been improved significantly with the development of mass spectrometry techniques. After 
performing gel electrophoresis, the protein of interest can be excised from the gel and digested 
into small peptides by proteases in preparation for MS analysis. Trypsin is the most widely used 
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protease, which cleaves proteins at the position C-terminal to lysine and arginine residues 
(Rappsilber & Mann, 2002). 
Until recently, the identification of a protein mostly relied on antibody recognition using 
western blot through transference of proteins from the SDS-PAGE gel, or Edman sequencing 
(A method of sequencing amino acids in a peptide developed by Pehr Edman). Antibodies are 
a very useful tool, however, their binding to a given protein is not necessarily proof that it is the 
product of a specific gene, as cross-reactivity can result in the antibody binding unrelated 
proteins. Edman sequencing depends on the stepwise cleavage of amino acids from the N-
terminus of a protein. Often no peptides that were sufficiently long enough to provide protein-
specific identification could be sequenced, or the N-terminus was acetylated or otherwise 
blocked, preventing the Edman reaction (Smith, 2001). 
Nowadays, mass spectrometry has played an important role in proteomics as it is a 
powerful tool for the structural characterisation of proteins, and it allows the analysis of proteins 
separated by electrophoretic technique with great accuracy, rapidly and sensitively. MS is an 
analytical technique that measures an intrinsic property of a molecule based upon the motion of 
a charged particle in an electric or magnetic field. MS enables protein structural information, 
such as peptide masses or amino acid sequences, to be obtained. The sample molecules are 
converted into ions in the gas phase and separated according to their mass to charge (m/z) ratio. 
In order to form a multiple-charge ion, an analyte molecule must have more than one site which 
can be ionised. In electrospray analyses, these charge loci may be any of the functional groups 
that normally associate with protonation (positive charge) or deprotonation (negative charge). 
Amines are excellent proton acceptors and a very common site for positive charges, while 
carboxylic acids are common site to form a negative ion (Guerrera & Kleiner, 2005). 
 A typical mass spectrometer is composed of (i) Ionisation source, to produce ions from 
sample (ii) Mass analyser, to separate the ions based on their mass-to-charge ratio (m/z) (iii) A 
detector system, to detect the ions, (iv) Computer, to record and analyse data. Electrospray 
ionisation (ESI) and matrix-assisted laser desorption ionisation (MALDI) are the most 
commonly used ion source techniques. Samples ionised by MALDI are dry and co-crystallised 
with a matrix, it is primarily used to analyse simple peptide mixtures. Samples ionised by ESI 
are transferred into gaseous ions at atmospheric pressure and delivered to the mass analyser 
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through a capillary tube which experiences an electric field. ESI combined with LC-MS is used 
to analyse more complex samples. Accuracy and precision are two important standards for any 
mass analyser. Ion trap, time-of-flight (TOF), quadrupole and Fourier transform ion cyclotron 
resonance (FT-ICR) are the common types of mass analyser. Proteins from gels can be 
characterised using mass spectrometry via peptide mass fingerprinting (PMF) (Lane, 2005). 
The use of peptide mass fingerprinting (PMF) in combination with the use of software 
algorithms was first described for the identification of proteins in 1993 by a number of research 
groups (Henzel et al., 1993; Mann et al., 1993; Pappin et al., 1993). The approach utilised 
peptide masses, in the absence of tandem MS information, to identify a protein from a database 
containing many thousands of sequences. This approach is rapid and most effective when the 
sample under investigation was relatively simple, either purified or pre-fractionated. For more 
complex samples, many protein sequences in the database could lead to the PMF observed by 
ESI or MALDI, with an incorrect identification. If a protein cannot be identified by its PMF 
alone, primary sequence information on the peptides is required. This can be obtained by tandem 
MS. In 1994, McCormack and coworkers published an approach that utilised both peptide mass 
and tandem MS data, using a computer algorithm to identify proteins from Escherichia coli and 
Saccharomyces cerevisiae cell lysates (McCormack et al. 1994).  
This method couples two stages of MS, it utilises collision-induced dissociation, the 
process breaks proteins within the peptide backbone and because of this fragmentation, 
comparisons between the observed fragment sizes and the database of predicted masses is 
possible. A very similar method to the tandem MS approach is peptide fragmentation 
fingerprinting (PFF), Instead of utilising collision-induced dissociation, this method uses 
enzymatic digestion of a single peptide to generate a fragmentation pattern. These fragments are 
analysed and compared to a database of observed fragments for the particular enzyme in a 
method similar to the Tandem MS approach. Tandem MS and peptide fragmentation 
fingerprinting PFF can also be used for protein sequencing (Nilsson et al., 2010). 
Mass spectrometry has become a powerful tool in quantitative proteomics, it gives a list 
of identified proteins and profiling global protein abundances in biological matrices, which can 
provide important information for the study of cellular response to disturbance and diseases, as 
well as the drug targets. Quantitative proteomics provides quantitative information of the 
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analysed sample proteins, as a major advance in proteomics, which allows researchers to 
quantitatively compare the samples (Rodriguez and Whetton, 2013). Relative and absolute 
quantification represents two forms of quantitative data. In relative quantification, the protein 
amount is calculated relatively for the same protein present in a reference sample, whereas 
absolute quantification determines exactly how many copies or amount of a protein there are 
per cell. Compared to the classic methods of differential protein gel or blot staining by dyes and 
fluorophores, mass spectrometry-based approaches enable us to identify and quantify many 
proteins in parallel, which has been hugely successful in the large-scale proteomics research 
field (Al Feteisi et al., 2015).  
There are two quantitative strategies in proteomics, the top-down protein profiling 
approach, which often involves the use of 2D-PAGE, followed by MS analysis. Top-down 
proteomics is capable of identifying and quantitating unique proteoforms through the analysis 
of intact proteins. this method served as the main proteomics method of choice in the past and 
has been utilised in many bacterial pathogen studies, e.g. (Kohler et al., 2005; Becher et al., 
2009). This approach has some disadvantages including lack of resolution and sensitivity, 
especially with low abundance proteins, proteins with extremely high /low molecular weights 
and it is inefficient for the analysis of insoluble proteins. The inherent limitations associated 
with 2D-PAGE/MS lead to the development of gel-free MS-based approaches, better known as 
the bottom-up “shotgun” proteomics approach, the method demonstrated better sensitivity and 
reproducibility over the 2D-PAGE based method, it involves protein digestion of a complex 
mixture followed by peptide separation and mapping by UHPLC-MS. For the shotgun protein 
quantification by mass spectrometry, there are two kinds of strategies involved, isotope-labelled 
and label-free methods (Soufi & Boumediene, 2016). 
Label free and isotope labeling are two basic strategies with a different basis. Isotope 
labeling approaches introduce a differential mass tag to the samples that can be recognised by a 
mass spectrometer and at the same time provide the basis for quantification. However, this 
approach has potential limitations such as high cost of reagents, time consuming, complicated 
sample preparation, incomplete labeling, requirement of larger sample amounts, and 
sophisticated software required for data analysis. Label free quantification approach, however, 
represents a strategy which avoids the isotope labeling step limitations. It became a popular 
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technique very recently. There are two categories under label-free based measurements: peak 
area (or ion intensity) and the number of peptide sequencing events (spectral counting). These 
two categories are mostly used to achieve the relative or absolute quantification. Label-free 
method has become the preferred method of choice for quantification of global protein 
expressions as an alternative to isotope labelling. The label free technique is simple and 
relatively cost effective. One of the main advantages of label free quantitation is that there is no 
limit to the number of samples analysed, whereas isotope labelling methods will always be 
limited by the number of labels available to the researcher (Bantscheff et al., 2007).  
A typical workflow for a label free quantitation experiment is the digestion of protein 
extracts from different samples, normally using trypsin, so generating complex peptide 
mixtures. An aliquot of this, for each sample, is analysed with the LC-MS system for the initial 
data acquisition. Typically, for initial acquisition, only MS1 data is collected, as a high frequency 
of MS spectra is required to obtain the required chromatographic resolution for peak detection 
and integration. Following the label free analysis and identification of features of interest, the 
sample aliquot is re-analysed, and MS-MS (MS2) data is selectively acquired in a targeted 
manner (Griffiths et al., 2014).  
The fast development of gene and protein sequence databases provides a means to identify 
proteins expressed in organisms. Sequencing of bacterial genome is now a standard procedure, 
by using third-generation DNA sequencing (TGS) (sequencing single DNA molecules without 
the need to halt between read steps), it is possible to completely sequence a bacterial genome in 
a few hours. This has enabled MS-based proteomics technologies to rapidly advance in order to 
study microbial models and their communities in a robust and systematic pattern. Bioinformatics 
tools make it easier to access these databases to search, match and identify a protein component. 
There are number of an online database search engines which facilitate the matching and 
identification, Mascot is a search engine used widely in this field. UniProt, trEMBL and NCBInr 
are the widely used protein sequence databases (Ribeiro et al., 2012). 
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2.4 Natural Products 
2.4.1 General Introduction  
Nature has been a source of therapeutic agents for thousands of years, and an impressive 
number of modern drugs have been derived from natural sources, many based on their use in 
traditional medicine (Murugan & Mohan, 2011). Products came from natural origins can be 
called “natural products”. Natural products come from four major sources: (i) An entire 
organism (e.g., a plant, an animal, or a microorganism) that has not been subjected to any kind 
of processing or treatment other than a simple process of preservation, (ii) Part of an organism 
(e.g., leaves or flowers of a plant, or an isolated animal organ), (iii) An extract of an organism 
or part of an organism, and (iv) Pure compounds isolated from plants, animals, or 
microorganisms , (e.g., alkaloids, flavonoids, glycosides, steroids, sugars, terpenoids, etc.) 
Nevertheless, in most cases the term natural products refer to secondary metabolites (small 
molecules produced by an organism that are not strictly necessary for the living of the organism). 
Natural products can be from any terrestrial or marine source: plants, animals, or 
microorganisms. The databases of natural products have recorded more than two hundred 
thousand compounds from almost all part of the world (Satyajit, Zahid & Gray, 2006). 
Research into the chemical and biological properties of natural products over the past two 
centuries has not only yielded drugs for the treatment of human illnesses, but have provided the 
motivation for the development of modern synthetic organic chemistry and the emergence of 
medicinal chemistry as a major field for the discovery of novel and more effective therapeutic 
agents. Natural products not only served as the main source of medicine for mankind, but played 
a vital role in the history of medicine, with the plants represented a rich source among them in 
the ancient time. The structure determination and biological activity screening of natural 
products, particularly those with a history of medicinal use, taking clues from folklore medicines 
(Gordon & David, 2005). Plant preparations have a very special characteristic that distinguish 
them from chemical drugs and any other natural sources, a single plant may contain a 
considerable number of bio-active compounds and a combination of plants even more. This 
complexity is one of the most important challenges to phytoscientists attempting to identify a 
single bio-active phytocompound or chemical group in the enormous molecules that comprises 
a single crude extract (Mendonca-Filho, 2006). 
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The natural product drug discovery process in general includes the testing of extracts of 
plant, marine or microbial origin in adequate in vitro assays target based, followed by bioassay-
guided fractionation of the active extracts and isolation and purification of active constituents. 
Those constituents showing significant in-vivo activity in appropriate animal models are 
considered as lead molecules, which may be chosen as candidates for preclinical development. 
Initially, such leads may be structurally modified through use of medicinal or combinatorial 
chemistry techniques to provide agents having prevailing activity or decreased toxicity. The 
development of natural product-derived drugs poses significant challenges in several areas 
(Cragg & Newman, 2005). Figure (2.11) summaries the natural product drug discovery process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: Steps of natural products discovery. Modified from (Katiyar et al., 2012). 
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2.4.2 Importance of Medicinal Plants 
There has been an increasing concern, in the health sector, due to the growing resistance 
of bacteria to the available antibiotics. As result, it is very important to develop new strategies 
that could discover new therapeutic agents by exploring a new agents derived from plants 
(Monteiro et al., 2012). Bio-active compounds in plants are compounds produced by them that 
have pharmacological or toxicological effects in any other organism. Although nutrients can 
show pharmacological or toxicological effects when consumed at high dosages (e.g. vitamins 
and minerals), nutrients in plants are generally not included in the term bio-active plant 
compound. The typical bio-active compounds in plants are produced as secondary metabolites. 
Thus, a definition of bio-active compounds in plants could be the secondary plant metabolites 
showing pharmacological or toxicological effects in man and animals (Aksel, 2010). 
The use of plants as traditional medicines has been known for a long time by the ancient 
people from Egypt, India, Africa and Asia. There are large numbers of written herbal 
manuscripts that explain how the plants were prepared and applied as traditional medicine, 
although some of the traditional prescriptions have only been transmitted by word of mouth 
through the generations. One of the ancient scripts from Egypt (2600 BC), which mentioned the 
uses of plants as the major ingredient of their traditional remedies, another ancient scripts from 
Chinese scientists (100 BC) and Greek physicians (100 AD) documented the prescription of 
herbal medications to their patients. In general, parts of the plants used as medicines were only 
treated with simple galenical preparations to obtain impure crude extracts in the form of liquid, 
semi-solid or powder prior to oral or external use (Rates, 2001).  
Even today, according to the World Health Organization (WHO), about 80% of the 
population in many third world countries still use traditional medicine (e.g., medicinal plants) 
for their primary health care, due to poverty and lack of access to modern medicine. About 25% 
of all prescription drugs in industrialised countries also contain active compounds that are still 
extracted or derived from higher plants and this situation has continued over the last few 
decades. Studies on a significant number of novel plant derived substances have entered into 
western drug markets and clinical plant based research has made great progress in important 
fields, such as in anti-cancer and anti-malarial therapies (Paulsen, 2010). 
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The search for useful drug molecules from plants began right after the discovery of 
morphine in 1804. Since then many thousands of novel structures have been discovered. In spite 
of this considerable research activity the number of plant-based drugs on the market is still less 
than two hundred. This is partly because of the poor pharmacological/toxicological profile of 
many plants (Harvey, 2008). There are presently no scientific methods applicable for the 
selection of plants that can be anticipated to contain novel biologically active substances. The 
provision for plant based drug development programs must utilise approaches that are 
considered to be "nonscientific" to save the time and money spend on these tasks. Historically, 
scientists claiming to have an interest in drug discovery from natural products have used 
approaches like, phytochemical screening, followed by bioassay and pharmacological 
screenings. The last and best approach however is selection based on "folklore" use. A 
considerable number of drugs based on higher plants came to the attention of pharmaceutical 
researchers because of their use in traditional medicine (Marderosian & Liberti, 1988). 
The WHO considers phytotherapy in its health programs and suggests basic procedures 
for the validation of drugs from plant origin in developing countries. Eastern countries, such as 
China and India have well established herbal medicines industries and ten Latin American 
countries have been investing in research programs in medicinal plants and the standardisation 
and regulation of phytomedicinal products following European countries, such as France and 
Germany. Despite all the activities described up to this point, it is still the case that of the 
estimated five million plant species, only a small percentage has been investigated 
phytochemically and even a smaller percentage has been properly studied in terms of their 
pharmacological properties. In most cases, only pharmacological screening or preliminary 
studies have been carried out (Phillipson, 2001; Bent & Richard2004)  
Over the last decade, exploration of active compounds contained in the traditionally-
known medicinal plants has become a significant interest in drug development research. Many 
sophisticated methods are currently available, especially in separation, spectroscopic and 
bioassay techniques, as a result of the growing demand of natural products research. For 
instance, GC-MS, LC-MS, LC-FTIR, LC-NMR, LC-NMR-MS and CE-MS have made possible 
the pre-isolation analyses of crude extracts or fractions from different natural sources. The 
emphasis on previous strategies has an impact on developing new methods based on 
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straightforward extraction and elucidation along with the new bioassay screening methods of 
the bioactive compounds (Sarker, Latif & Gray, 2006).  Figure (2.12) gives an example of 
natural product drug discovery process from plants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.12: An example of natural product drug discovery process (bio-assay guided 
approach). (Satyajit et al., 2006). 
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2.4.3 Extraction of plant-derived natural products  
The history of the extraction of natural products dates back to the Mesopotamia and 
Egyptian times, where production of perfumes, or pharmaceutically - active oils and waxes was 
a major business. Several Sumerian texts, found 400 km south of Baghdad (Iraq) from about 
2100 BC, also confirm that a sophisticated pharmaceutical and chemical technology existed at 
that time. In a papyrus of 1600 BC, beer and wine were used as alcoholic solvents, which give 
the distinguished advantages of achieving a higher solubility for a solute when producing 
perfumes. Otherwise up to forty repetitive extraction procedures were necessary to give a high 
yield. There was no more development until Middle Ages times, when pure ethanol became 
available as a solvent in about 900 AD (Bart, 2011). Medicinal plants are the richest bio-resource 
of drugs from traditional systems of medicine, modern medicines, nutraceuticals, food 
supplements, folk medicines, pharmaceutical intermediates and chemical entities for synthetic 
drugs. Extraction of the bio-active plant constituents has always been a challenging task for the 
researchers (Tiwari et al., 2011).  
Extraction, as the term is used pharmaceutically, is the separation of medicinal active 
compounds from plants using selective solvents through standard procedures. The purpose of 
standardised extraction procedures for crude drugs (medicinal plant parts) is to achieve the 
therapeutically desired compounds and to eliminate unwanted material by treatment with a 
selective solvent. The solvent attracts the soluble molecules and leave the insoluble material 
behind (Das, 2010). There are many protocols available to extract bio-active molecules from 
medicinal plants such as maceration, infusion, percolation, digestion, hot continuous extraction 
(Soxhlet), microwave-assisted extraction, boiling, and ultrasonic extraction (sonication). 
Selection of procedures and solvents for extraction of the particular components of the plants 
depends on the nature of the desired molecules. Variation in extraction methods usually depends 
on some factors such as: length of the extraction period, solvent used, Temperature, particle size 
of the plant tissues, the solvent-to-sample ratio (Mendonça-Filho, 2006) 
Successful Identification of biologically active compounds from plant material is 
significantly dependent on the type of solvent used in the extraction procedure (Table 2.2). 
Solvent characteristics need to be carefully considered when deciding on the extraction protocol 
to follow. Solvents have to be easily removed from the extract; therefore, the highly volatile 
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solvents are preferred. Other factors such as physical and chemical properties of the compounds 
of interest have to be taken into consideration as they may affect the extraction procedure. 
Standardisation of extraction procedures contributes significantly to the final quality of the 
herbal drug (Handa, 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2: Typical solvents used to extract active components from medicinal plants. Adapted 
from (Handa, 2008). 
Standard steps in the extraction of plant material start with size reduction of dried plant 
material, the purpose of this step is to break the cell wall in order to increase the surface are 
exposed to the solvent. The next step is the treatment with the desired solvent followed by the 
filtration of the extract. The final step is the concentration and drying process to remove the 
solvent and obtain the dried crude extract. This step can be achieved by evaporating the solvent 
under reduced pressure followed by a freeze dried or the use of a low temperature oven (Tiwari 
et al., 2011).   
                                                                                                                                      Chapter 2 
48 
 
2.4.4 Isolation and purification of natural products  
Bio-active compounds in plants can be classified according to different criteria. It could 
be based on clinical function, their pharmacological or toxicological effects, and that relevant 
to the clinician, pharmacist or toxicologist. It might be a botanical categorisation based on 
families and genera of the plants producing the bio-active compounds. It could be useful to 
categories them according to biochemical pathways and chemical classes. The main chemical 
groups of bio-active compounds in plants are: Flavonoids, Glycosides, Tannins, Resins, 
Lignans, and Alkaloids (Ramawat, Dass, & Mathur, 2009). 
Plant extracts are mixtures of complex molecules that have different physical, chemical 
and biological properties. It is not easy to obtain pure bio-active compounds with only one 
isolation procedure; more than one protocol is usually applied to isolate them to homogeneity. 
The initial step is the separation of the extracted components into various fractions of similar 
properties, these fractions can be obtained by elution with a particular solvent in various 
chromatography techniques. These techniques based on separation of substances between a 
stationary and a mobile phase. The mobile phase moves close to the stationary phase and the 
mixture to be separated move together with the mobile phase, the isolation occurs due to the 
different interactions of the mixture with both phases (Czaplicki, 2013). 
Chromatography is one of the most important techniques in the isolation and purification 
of natural products. The older techniques comprised of thin layer chromatography (TLC), 
column chromatography (CC) and flash chromatography. The latest techniques include high 
performance thin layer chromatography (HPTLC) and high performance liquid chromatography 
(HPLC). Selection of isolation protocols of the known molecules can be carried out based on 
the general features of the molecules itself such as, size, stability, charge and solubility. 
However, it is more difficult to design an isolation protocol for unknown components. In this 
case, the nature of the crude extracts is an important factor to be considered. It is also worthwhile 
carrying out qualitative tests for the presence of various types of compounds, such as, phenolics, 
steroids, alkaloids, flavonoids, as well as analytical thin-layer chromatography (TLC), or HPLC 
profiling in order to determine the general profile of the extracts (Sarker, Latif and Gray, 
2006). Figure (2.13) Illustrates analytical methodology used for isolation and identification of 
natural bio-active compounds. 
                                                                                                                                      Chapter 2 
49 
 
In the most cases, it is not easy to apply a single separation technique to isolate individual 
compounds from a crude mixture due to its complexity. Hence, the crude extract is initially 
separated into various detached fractions containing compounds of similar polarities or 
molecular sizes. For initial fractionation of any crude extract, it is advisable not to generate too 
many fractions, because it may spread the target compound over several fractions and might 
avoid detection. Modern preparative, or semi preparative high-performance liquid 
chromatography (HPLC) can be used for finer fractionation and often guided by an on-line 
detection technique (Sarker, Latif & Gray, 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13: Schematic diagram illustrates analytical methodology used for isolation and 
purification of natural bio-active compounds 
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2.4.4.1 High-performance liquid chromatography (HPLC) 
As mentioned earlier, prior to the 1970's, few reliable chromatographic technologies were 
commercially available for routine laboratory work. Before that, most chemical separations 
were carried out using a variety of techniques including open-column chromatography, paper 
chromatography, and thin-layer chromatography. Later, high pressure liquid chromatography 
(HPLC) began to emerge in the industries, it was developed in the mid-1970's and quickly 
improved with the development of column packing materials and the improvement of the on-
line detectors. In the late 1970's, new methods including reverse phase liquid chromatography 
allowed for improved separation between very similar compounds (Charles et al., 2001). HPLC 
is a chromatographic technique that can separate a mixture of compounds and is used in 
biochemistry and analytical chemistry to identify, quantify and purify the individual 
components of the mixture. By the 1980's HPLC was commonly used for the separation of 
chemical compounds. New techniques improved separation, identification, purification and 
quantification of HPLC, computers and automation was added, improvements in type of 
columns such as micro-column, affinity columns, all that lead to improve the reproducibility 
and reliability, and finally fast HPLC began to emerge (Sailaja et al., 2014).  
HPLC system consists of a computer, solvent reservoirs, pumps, injector, column, 
detector, and fraction collector. The main part of the system is the column where separation 
occurs. Separation of components occurs as the analytes and mobile phase are pumped through 
the column (stationary phase) (Kupiec, 2004). Types of HPLC generally depend on the phase 
system used in the process, these types including; normal phase HPLC (NP-HPLC), this method 
uses a polar stationary phase and a non-polar mobile phase; Reversed phase HPLC (RP-HPLC) 
has a non-polar stationary phase and an aqueous, moderately polar mobile phase; Size exclusion 
chromatography (SEC), also called as gel permeation chromatography mainly separates 
particles on the basis of size, this technique is widely used for the molecular weight 
determination of polysaccharides; In ion-exchange chromatography, retention is based on the 
attraction between solute ions and charged sites bound to the stationary phase. Ions of the same 
charge are excluded; Bio-affinity chromatography based on specific reversible interaction of 
proteins with ligands, because of specificity of the interaction, this type can result in very high 
purification in a single step (Verma, 2014; Malviya et al., 2010). 
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Among all available techniques, reversed-phase chromatography is the most commonly 
used separation modes due to its broad application range, especially with the separation of 
natural products from plant material. The reasons for this include the simplicity, versatility, and 
range of the reversed-phase method as it is able to handle compounds in a wide range of polarity 
and molecular mass. The separation mechanism in reverse phase chromatography depends on 
the hydrophobic binding interaction between the solute molecule in the mobile phase and the 
immobilised hydrophobic material in the stationary phase (Prathapa et al., 2013). 
2.4.5 Structure elucidation of natural products  
The final step of natural product extraction is to identify, unequivocally, the molecule that 
is responsible for a given pharmacological effect. It is possible to determine the chemical 
composition through advanced spectroscopic techniques including Mass Spectrometry (MS), 
Nuclear Magnetic Resonance (NMR), MS-MS, and LC-NMR-MS (Bobzin et al., 2000). The 
purified extracts are subjected to NMR and MS methods to characterise and identify the 
components. The characterisation and identification of the components requires to know the 
most appropriate technique for the sample to suggest a reasonable structure. It would also 
require knowledge of the available literature and databases which the suggested structure can 
be compared with them (Queiroz et al., 2002). 
As a spectroscopic method, nuclear magnetic resonance (NMR) has seen spectacular 
growth, both as a technique and in its applications. Today's applications of NMR span a wide 
range of scientific disciplines, from physics to biology to medicine. Since the development of 
higher resolution NMR spectrometers, NMR spectra have been a major tool for the study of 
both newly synthesised and natural products isolated from plants, bacteria, etc. The introduction 
of reliable superconducting magnets combined with newly developed, highly sophisticated 
pulse techniques provided the chemist with methods suitable to determine the 3-dimensional 
structure of very large molecules in solution. For the last decade, NMR methods have been 
introduced for quantitative analysis in order to determine the impurity profile of a drug, to 
characterise the composition of drug products, and to investigate metabolites of drugs in body 
fluids (Holzgrabe, Diehl, & Wawer, 1998). 
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NMR spectroscopy is routinely used by chemists to study the chemical structure of simple 
molecules using simple one dimensional techniques (1D-NMR). Two-dimensional techniques 
(2D-NMR) are used to determine the structure of more complicated molecules. (Krystyna et al., 
2010). The nuclei of many elemental isotopes have a characteristic spin, the common isotopes 
used in organic chemistry is ¹H and ¹³C. The NMR behaviour of ¹H and ¹³C nuclei has been 
exploited by organic chemist since they provide valuable information that can be used to 
conclude the structure of organic compounds. 1D proton spectra (¹H NMR) are far too complex 
for interpretation when analysing plant products, as most of the signals overlap heavily. By the 
introduction of additional spectral dimensions these spectra are simplified and extra information 
is obtained, the invention of 2D NMR was the major leap in NMR spectroscopy. Types of 2D 
NMR experiments include Correlation Spectroscopy (COSY), Total Correlation Spectroscopy 
(TOCSY), Nuclear Overhauser Effect Spectroscopy (NOESY), Rotating Frame Nuclear 
Overhauser Effect Spectroscopy (ROESY), Heteronuclear Single-quantum Correlation 
Spectroscopy (HSQC) and Heteronuclear Multiple-bond Correlation Spectroscopy (HMBC) 
(Timothy, 2009). 
In phytochemical and small molecules research work, mass spectrometry plays a very 
important role. Generally, MS provides information related to molecular mass, molecular 
formula, and fragmentation pattern. While NMR gives useful data to identify the molecular 
structure of target compounds such as the number and types of protons in the molecule of 
interest. The protons in a molecule appear as an NMR signal and this provides information about 
the proton environment and coupling partners. Nonetheless, this information needs an accurate 
interpretation before the final structure can be concluded that can be achieved through various 
automated structure elucidation software, which have been developed to simplify the structure 
interpretation process (Stevenson, 2004; Queiroz et al., 2002).   
2.5 Medicinal plants used in the study  
2.5.1 Centella asiatica (L.) 
2.5.1.1 Description of the plant 
Centella asiatica L. (Synonym: Hydrocotyle asiatica L.), is a plant belonging to 
Mackinlayaceae family. It grows well in both tropical and sub-tropical countries including India, 
Sri Lanka, Northern Australia, Indonesia, Iran, Malaysia, China, and other parts of Asia. Being 
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herbaceous, it contains thin long stems, creeping stolons, green to reddish green in colour, 
interconnecting one plant to another. It has 1-5 small fan-shaped green leaves per node with 
long stalks (Figure 2.14). Each plant has 3-6 small flowers which are purple to white-green in 
colour and arranged in umbels (flower cluster) arising from the axils of the leaves. The plant is 
a popular herb, it has been exploited for several hundred years by traditional medicine dealers, 
and it consumed fresh, or processed into tea or juice (Rahman, Sayeed, & Haque, 2012). 
 
 
 
 
 
 
 
 
Figure 2.14: Aerial parts of Centella asiatica (L.) (Harry, 2005) 
2.5.1.2 Pharmacological properties of Centella asiatica (L.) 
There have been a number of studies exploring the pharmacological properties of Centella 
asiatica L. and to exploit its effects. The results from these studies confirmed the medicinal 
effects of this plant, and determined that this plant is a rich source of potentially active 
compounds. C. asiatica possesses a wide range of pharmacological properties; the plant has a 
good effect in ulcer prevention, it has also been used for improvement of wound healing, mental 
disorders, antibacterial, antioxidant and anticancer purposes. The plant is found to improve the 
power of concentration, general ability and behaviour of mentally retardation in children, and 
to treat rheumatic disorders. asiaticoside is one of the prime triterpene saponins found in leaves 
in large amount and is utilised commercially as a wound healing agent due to its potent anti-
inflammatory effect and showed the potential use as an anti -gastric ulcers drugs (Seevaratnam 
et al., 2012). A very recent study carried out by Rishikesh (2013) demonstrated thrombolytic 
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activity of C. asiatica leaves. In addition to above mentioned activities, C. asiatica were also 
claimed to be effectively applied for anti bilharzial, antifertility, immunomodulatory and 
antagonizing liver fibrosis. 
Within antimicrobial studies, C. asiatica showed a significant effect as an antibacterial 
agent.  Rahman, Sayeed, & Haque, (2012) reported that the methanolic extract of the plant 
showed good activity against a wide range of microorganism. Arumugam et al., (2011) have 
found that the methanol, acetone, chloroform and water extracts of leaf have a significant 
antibacterial activity against Bacillus cereus, Escherichia coli, Staphylococcus aureus and 
Pseudomonas aeruginosa. However, methanol extracts of leaf and callus showed maximum 
inhibitory effects. In addition, there are many studies carried out by a number of researchers 
(College & Naka, 2009; Dash et al., 2011; Vadlapudi, 2012; Udoh et al., 2012) which confirmed 
the significant antibacterial activity of the aqueous and alcoholic extracts of the plant. However, 
these studies were completed on crude extracts only. Despite a large number of studies reported 
over the past decades on the evaluation of biologically active components and their mechanisms 
of action, the outcome of these studies is still unsatisfactory, more scientific investigation is 
needed to explore the active compounds responsible for this activity, and their mechanism of 
actions inside the microorganism.  
2.5.1.3 Chemical constituents isolated from Centella asiatica (L.) 
According to a number of studies exploring C. asiatica, it has been reported to contain a 
vast number of compounds belonging to different chemical classes, chemical constituents of 
C.asiatica have a very important role in medical and pharmaceutical applications (Table 2.3). 
The triterpenes are a major component of C.asiatica, and are composed of many compounds 
including acetic acid, madecassic acid, asiaticosside, madecassoside, brahmoside, brahmic acid, 
brahminoside, thankiniside, isothankunisode, centelloside, madasiatic acid, centicacid, and 
cenellicacid. Among these triterpenes, the most important biologically active compounds are 
asiatic acid, madecassic acid, asiaticosside and madecassoside. In addition to terpenoids, C. 
asiatica also contains phenolics flavonoid components, such as quercetin, kaempherol, catechin, 
rutin, apigenin and naringin. It also has volatile oils such as caryophyllene, farnesol and 
elemene. C.asiatica is also a rich source of vitamin C, vitamin B1, vitamin B2, niacin, carotene 
and vitamin A. (Seevaratinam et al., 2012).  
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Table 2.3: Chemical constituents of C. asiatica. Modified from (Roy, Barman &Shaik, 2013) 
 
2.5.2 Imperata cylindrica (L.) 
2.5.2.1 Description of the plant 
Imperata cylindrica L. is popular weed worldwide, the common name is cogon grass in 
English, the plant belongs to the Poaceae (Gramineae) grass family. It is a perennial grass that 
thrives around areas, it is distributed primarily in Southeast Asia and throughout the tropical and 
subtropical regions including Africa, Australia, and the Pacific Islands. Imperata cylindrica L. 
vary considerably in appearance, the leaves appear light green, with older leaves becoming 
orange-brown in colour. The leaves originate directly from ground level and range from one to 
four feet in length with 1/2 to 3/4 of an inch width (Figure 2.15). (MacDonald, 2004). Imperata 
cylindrica L. has been classified as one of the ten worst weeds in the world. This aggressive, 
rhizomatous plant is considered a very harmful plant due to its ability to spread and colonise 
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successfully, which leads it to compete with desirable vegetation and disturb ecosystems. It has 
also been found that even with its disappearance from certain place; other plants cannot grow 
where it has previously been grown (Omezine and Skiri-Harzalla, 2009).  
 
 
 
 
 
 
 
 
 
Figure 2.15: Aerial parts of Imperata cylindrica L. in two different life stages. (John, 2013).   
 
2.5.2.2 Pharmacological properties of Imperata cylindrica (L.) 
The leaves and rhizome of I. cylindrica have traditionally been used for treating a wide 
range of illnesses, or as herbal supplements for health promotion. It has some wound healing 
properties and it is used for the treatment of nose bleeds. It is also an important drug in folk 
medicine for the treatment of urinary stones, retention of urine, diabetes, cardiac disorders, gout, 
common cough and anaemia. I.cylindrica reported to has an antibacterial effect against different 
bacterial species. It also has some activity in conditions like, arthritis, diarrhea and anthelmintic 
(used to treat parasitic worms). (Parvathy et al., 2012). Previous studies have clearly revealed 
that a crude extract of I. cylindrica has a wide range of pharmacological effects; one of the most 
important benefit is the potential antimicrobial activity. A recent study conducted by Balangcod 
et al. (2012) demonstrated good activity of a methanolic extract of I. cylindrica against four 
different pathogenic bacteria, these were Escherichia coli, Staphylococcus aureus, 
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Pseudomonas aeruginosa and Salmonella typhimurium. Another study carried out by Voukeng 
et al., (2012) showed that the methanol extract of I. cylindrica has a significant effect against 
Gram-negative multi-drug resistant bacteria. A further recent study conducted by Parkavi et al., 
(2012) revealed a good inhibition effect of aqueous and ethanolic extracts against Escherichia 
coli and Staphylococcus aureus. 
2.5.2.3 Chemical constituents isolated from Imperata cylindrica (L.) 
Imperata cylindrica is a rich source of medicinal bio-active compounds. The preliminary 
phytochemical screening study, which was carried out by Parvathy and his co-worker (2012) 
confirmed the presence of Alkaloids, Carbohydrates, Flavonoids, Glycosides, Saponins, 
Steroids and Tannins. It has been suggested that phenolic compounds are the major constituents 
of I. cylindrica. A very recent study about the phenolic compounds from I. cylindrica revealed 
the presence of 7-hydroxy-4-methoxy-5-methylcoumarin, 5,7 dihydroxy-8- methoxyflavone, 4-
hydroxybenzaldehyde, 4-hydroxy-cinnamic acid, 3,4-dimethoxyphenyl-O-α-L-
rhamnopyranosyl-(1→6)-β-D-glucopyranoside, graminone A, 7-O-β-D-glucopyranosyl- 4-
methoxy-5-methylcoumarin, 6-hydroxy-5-methoxyflavone, 5-methoxyflavone, 4-hydroxy-
cinnamic acid and impecyloside. The last four compounds were isolated from this plant for the 
first time in 2013 (Rong-hua et al., 2013). 
The presence of jaceidin, quercetagetin-3,5,6,3`-tetramethyl ether, tricin, 3,5-di-omethyl- 
kaempferol and b-sitosterol-3-O-b-D-glucopyranosy l-6´- tetradecanoate have been confirmed 
for the first time in the study conducted by Mohamed et al., (2009). In addition, six new 
compounds, 1-(3, 4, 5-trimethoxyphenyl)-1, 2, 3-propanetriol, arundoin, impecylone, 
deacetylimpecyloside, seguinoside K 4-methylether and impecylenolide were isolated for the 
first time from Imperata cylindrica by a group of researcher in two separate studies (Liu et al., 
2012, Liu et al., 2014). 
2.5.3 Morinda Citrifolia (L.) 
2.5.3.1 Description of the plant 
Morinda citrifolia L. belongs to the Rubiaceae family, and commonly known as “noni” 
which is the Hawaiian and Tahitian island's name for its fruit. M. citrifolia is deemed to be the 
second most important herb plant in the Hawaiian Island. It is also known in different 
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communities with different names such mengkudu in Indonesia and Malaysia, apatot in 
Philippines and Indian Mulberry in India. The plant is a small evergreen tree or bush found in 
the Southeast Asian region and believed to have spread across Australia and Indo-Pacific region. 
Usually it grows in open coastal regions at sea level and in forest areas, up to about 1300 feet 
above sea level (Singh et al., 2006). M. citrifolia usually less than 10 feet height but occasionally 
rise up to 20 feet. The leaves are large with a shiny green colour and generally occur in pairs. 
Leaves are deep veined, short stemmed and 8 inches or longer. The flower heads grow to become 
mature fruit, 3 to 4 inches in diameter. The fruit is initially green in colour, turns to yellowish-
white, normally 4 to 6 inches in length with a surface covered in polygonal-shaped sections 
(Figure 2.16) (Elizabeth and Murugesan, 2012). 
 
 
 
 
 
 
 
 
 
 
Figure 2.16: Aerial parts of Morinda citrifolia (L.) and its fruit (Arthur, 2011). 
2.5.3.2 Pharmacological properties of Morinda Citrifolia (L.) 
Morinda Citrifolia L. has a long history of use as a medicinal plant and is reported to have 
a broad range of therapeutic effects. Its root, leaves, stem, bark, flowers and fruits have all been 
used to treat a wide range of illness such as diabetes, diarrhea, hypertension, malaria, pain, and 
topical infections. The fruits are also eaten as a food in times of famine. There are a number of 
in vitro studies about the biological activities of crude extracts or fractions of M. citrifolia, such 
as antibacterial, antiviral, antifungal, analgesic, antioxidant and immune enhancing effects (Su 
et al., 2005). 
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There are some studies carried out to determine the antimicrobial effect of crude extracts 
of M. citrifolia, Kumar and co-workers, (2010) have evaluated the petroleum ether and alcoholic 
extracts of M. citrifolia leaves for their antimicrobial activities. The alcoholic extract exhibited 
significant antibacterial and antifungal activity, comparable to the standard drug tetracycline. 
Rivera and co-workers (2011) have revealed that the M. citrifolia fruit juice has a noticeable 
effect on mycoplasmas clinical isolates and type strain. Previous studies have shown clearly that 
M. citrifolia contains some useful compounds, which may lead to develop a new antibacterial 
agent, and potentially with a new mechanism of action. More research has to be done to achieve 
that. 
2.5.3.3 Chemical constituents isolated from Morinda Citrifolia (L.)  
Morinda Citrifolia L. is considered a very rich source of chemical compounds with many 
biological activities. To date, approximately 200 phytochemicals have been identified and 
isolated from different parts of the plant. However, chemical composition differs broadly 
according to the part of the plant used in the studies.  M.citrifolia contained a broad spectrum of 
secondary metabolites (Table 2.4), which include acids, alcohols, phenols, flavonoids, 
anthraquinone, glycosides, carotenoids, esters, iridoids, ketones, lactones, lignans, nucleosides, 
triterpenoids, sterols and several minor compounds. Anthraquinones considered the major 
phenolic compounds that have been identified and isolated from different parts of M. citrifolia 
(Singh, 2012). 
Researches are trying to explore M. citrifolia unknown compounds and evaluate its 
potential activities. Deng et al., (2007) have revealed for the first time two unknown compounds 
from this plant, (+)-3,4,3’,4’-tetrahydroxy-9,7’α-epoxylignano-7α,9’-lactone and (+)-3,3’-
bisdemethyltanegool along with seven known compounds. The structures of the new 
compounds were determined by spectroscopic techniques. While Takashima et al., (2007) has 
isolated a new iridoid glycoside, citrifoside, and a new anthraquinone, 1, 5, 15-
trimethylmorindol from the leaves of this plant, along with 24 other known compounds. The 
new isolated anthraquinone in this study has shown a significant cytotoxicity against selected 
pathogenic microorganisms. 
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Classes Compounds Occurrence 
Anthraquinones Morindine, rubiadine, lucidin-3-prineresal Roots & fruit 
Glycosides 
Glycoside of coumarin, flavone and 
anthraquinones 
Fruit 
Essential oils Volatile oil Ripe fruit 
Coumarone Scopoletin Fruit 
Flavonol Vomifoliol Ripe fruit 
Monoterpenes Iridoid Leaves 
Sterol 
Stigmpesterol, Stigmasterol, Sitosteryl 
palmitate, Isofucosteryl palmitate 
Cell suspension 
culture 
vitamins Vitamin C Dried fruit 
Table 2.4: Examples of compounds isolated from Morinda citrifolia (L.). 
 
2.5.4 Sauropus androgynus (L.) 
2.5.4.1 Description of the plant 
Sauropus androgynus L., also known as star gooseberry, katuk, or sweet leaf, is one of 
the most popular leafy vegetables. It is a small shrub belonging to Euphorbiaceous family 
(Figure 2.19). This plant is spread mostly in tropical regions, such as India, Sri Lanka, Thailand, 
Laos, Malaysia, and Indonesia, and almost in all countries of Southeast Asia. S. androgynus has 
upright, multiple stems and can grow up to three meter in height. The leaves are simple, 5-6 cm 
long, alternately arranged and lanceolate or oblong in shape. The upper surface of the leaf is 
dark green in colour while the lower surface is light green. The flowers are orange to red in 
colour, unisexual and arranged in axillary clusters. The fruits are rounded capsules with six 
distinct partitions (Figure 2.17) (Kaushik & Dhiman, 1999). 
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Figure 2.17: Aerial part of Sauropus androgynus (L.) and its fruit (Phuong, 2010) 
2.5.4.2 Pharmacological properties of Sauropus androgynus (L.) 
Sauropus androgynus L. has high nutritional and medicinal value; it is widely used in 
cooking and as a medicinal herb for curing of illnesses. S. androgynus claimed to be effective 
in the treatment of diabetics, cancer, inflammation, microbial infection, cholesterol and allergy. 
Different parts of this plant have different benefits, for instance, leaves and roots can be used to 
relieve fever and urinary problems, whereas the juice of S. androgynus leaves can serve as a 
remedy for earache. The overconsumption of this plant has been reported to cause drowsiness 
and constipation. The young tips and leaves are a common nutritious vegetable for cooking due 
to its high content of protein (Wei et al., 2011; Senthamarai & Basker, 2012).   
There have been a number of studies carried out by researchers to study the potential 
antimicrobial activity of S. androgynus. A study conducted by Ariharan et al., (2013) showed 
that the methanol extract of S. androgynus leaves exhibited significant antibacterial activity 
against all bacterial strains in their study. Another experiment conducted by Gayathramma, 
Pavanik and Raji (2012) to evaluate the antibacterial activity of S. androgynus leaves, they tested 
the petroleum ether, methanol, ethanol, and water extracts on selected bacterial species like 
Klebsiella pneumoniae, Bacillus cereus, Staphylococcus aureus, Escherichia coli and 
Pseudomonas aeruginosa. The in vitro antibacterial activity revealed that the methanol and 
ethanol leaf extracts have a significant effect against pathogenic organisms tested.  
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2.5.4.3 Chemical constituents isolated from Sauropus androgynus (L.) 
Sauropus androgynus L. is commonly used in folk medicine in different regions of the 
world due to its effectiveness in treating some diseases. There are few studies that have 
documented the chemical properties of this plant. S. androgynus claimed to have a high level of 
vitamin A, especially in freshly picked leaves, as well as high levels of vitamins B and C, protein 
and minerals. Nutrient content of the leaves is usually higher in more maturing leaves. A lignin 
diglycoside, (−) - isolariciresinol 3α-O-β- apifuranosyl- (1→2) – O - β-glucopyranoside, and a 
megastigmane glucoside, sauroposide and papaverine have isolated as well. This plant has also 
been reported to have resins, steroids, tannins, glycosides, reducing sugar, carbohydrates, 
saponins, sterols, terpenoids, acidic compounds, cardiac glycosides, phenols, flavonoids and 
considerable amount of alkaloids (Gayathramma, Pavanik and Raji, 2012). Senthamarai and 
Basker (2012), isolated 2(1H) naphthalenone,3,5,6,7,8,8a-hexahydro-4, 8a-dimethyl-6-(1-
methylethenyl), azulene, pyrene hexadecahydro, squalene and phytol from S. androgynus leaves 
extract.   
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                       Chapter 3  
64 
 
3.1 Materials  
3.1.1 Plant Materials 
This study used four medicinal plants, which are believed to have important antibacterial 
activities according to previous studies. There are Centella asiatica L., Imperata cylindrica L., 
Morinda citrifolia L. and Sauropus androgynus L. The dried leaves were obtained as a powder 
from PT Haldin Pacific Semesta, Jakarta, Indonesia. Product specification for each plant are 
shown in Appendices. 
3.1.2 Chemicals 
Unless otherwise stated, all chemicals used for the present study were of molecular 
biology grade, or spectroscopic grade. All chemicals were purchased from local suppliers, 
unless otherwise stated, such as Sigma-Aldrich, UK Ltd. (Gillingham, Dorset, UK), Fisher 
Scientific UK Ltd. (Loughborough, UK), GE Healthcare (Buckinghamshire, UK) and Oxoid 
Ltd. (Basingstoke, Hampshire, UK). 
3.1.3 Equipments 
All procedures were performed using the equipment available in the Kidscan laboratories 
of the Centre for Biochemistry, Drug Design and Cancer Research, University of Salford, unless 
otherwise stated, such as HPLC, NMR, 1D/2D-PAGE. For the biological screening, the 
equipment available in the Hygiene and Disinfection Centre, University of Huddersfield, were 
used, such as the Bioscreen-C Automated Growth Curve Analysis System for routine 
microbiology work, Whitley Automated Spiral Plater (WASP) for culturing bacteria on plates 
and Automated Colony Counting Methods (ACCM) for counting bacterial colonies. 
3.1.4 Culture media 
 The following microbiological media were used throughout this study: 
 Tryptone Soy Agar (TSA, Oxoid Ltd.), prepared by dissolving 40g in 1L of ddH2O. 
 Tryptone Soy Broth (TSB, Oxoid Ltd.), Prepared by dissolving 30g in 1L of ddH2O. 
 Maximum Recovery Diluent (Peptone Saline Diluent) (MRD, Oxoid Ltd.), prepared 
by dissolving 9.5g in 1L of ddH2O.  
 DE neutraliser broth (DE, LabM Ltd.), prepared by dissolving 9.5g in 1L of ddH2O. 
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All microbiology investigations were carried out via a set of standard microbiological 
techniques. All cultures were incubated at 37oC for 24 hours under aerobic conditions. MRD 
was used as an isotonic diluent for maximum recovery of microorganisms. The low 
concentration of peptone does not cause multiplication of the organisms within 1-2 hours of 
dilution of the sample. DE broth was used to neutralise the inhibitory action of our tested 
compounds and determine the Minimum Bactericidal Concentration (MBC). All media were 
sterilised by autoclaving (Portable Prestige Medical Autoclave 2100) at 121°C, with a pressure 
of 15 psi for 20 mins, heat labile components were sterilised via filtration through sterile Millex-
GP syringe filter 0.22 μm (Sigma-Aldrich, UK Ltd.). 
3.1.5 Bacterial strains  
A wide range of bacterial strains were utilised in this study, these strains are outlined in 
table (3.1). All isolates were preserved on Microbank beads (Prolab Diagnostics Ltd.) in TSB 
media with 15 % glycerol and stored at -80°C until they were needed. These beads were revived 
on TSA media under standard conditions. Bacterial strains were kindly provided by Professor 
Howard Foster (School of Environment & Life Sciences, University of Salford), and Dr. Paul 
Humphries (Hygiene and Disinfection Centre, School of Applied Science, University of 
Huddersfield). These organisms are often used as a model for antibacterial susceptibility testing 
studies.  
NO. Strains Reference 
1 Escherichia coli ATCC 25922 
3 Staphylococcus aureus  (MSSA) ATCC 6538 
4 Staphylococcus aureus  (MRSA) NCTC 13142 
5 Pseudomonas aeruginosa ATCC 15442 
6 Klebsiella pneumoniae NCTC 13438 
8 Enterococcus hirae ATCC 10541 
Table 3.1: Bacterial strains used throughout this project. 
 (NCTC) National Collection of Type Cultures  
 (ATCC) American Type Culture Collection 
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3.2 Methods 
3.2.1 Bacterial culture conditions and preparation of inoculums 
Fresh cultures were prepared from frozen stocks every two weeks. Bacterial cultures were 
maintained in an appropriate medium and incubated aerobically at 37°C. A single colony of 
working microorganisms, grown overnight on TSA media, was inoculated into a 50 ml TSB 
media in Corning tubes (SANYO MIR-262 Incubator). The liquid cultures were then incubated 
in a desktop shaking incubator set at 37°C/200 rpm (NB-205L, N-BIOTEK Co., Ltd.) for 24 h. 
The optical density (OD) of the culture can be used to measure the concentration of 
bacterial cells. Accordingly, the concentration of the cells in broth media was measured using 
plastic, disposable cuvettes at a wavelength of 600 nm with (Biochrom WPA Lightwave II 
UV/Visible Spectrophotometer). Stock suspensions were prepared by taking cultures from TSA 
stock plates and dispersing them in a sterile universal tube containing 10 ml of MRD and 5 g of 
glass beads by vortex mixer. The OD of the suspension was adjusted to be equivalent to a 0.5 
McFarland standard at 600 nm in a spectrophotometer. This OD approximated to a 1-1.5 x 108 
cfu/ml suspension. For monitoring the cells concentration throughout the work, several dilutions 
were made: 1-1.5 x 107, 106, 105 and 104 cfu/ml. Culture dilutions 1 x 105 and 104 were plated 
out on TSA Petri dishes via Whitley Automated Spiral Plater (WASP II Spiral Plater, Don 
Whitley, Scientific Ltd.), figure (3.1/1), the plates incubated overnight at 37ºC and cells count 
was done via Automatic Colony Counter (aCOLyte3, Synbiosis Ltd.) Figure (3.1/2). 
 
 
 
 
 
 
Figure 3.1: (1) Whitley Automated Spiral Plater (WASP II Spiral Plater, Don Whitley, 
Scientific Ltd.), (2) Automatic Colony Counter (aCOLyte3 Colony Counter, Synbiosis Ltd.). 
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3.2.2 In-vitro, Antibacterial activity assays 
The testing of potential antibiotic compounds carried out via two different techniques, the 
disc diffusion assay and the bioscreening technique. The disc diffusion assay is designed for 
rapid determination of antibacterial activity and as such is not particularly useful to generate an 
accurate research data. Nowadays, more sophisticated approaches for evaluating the 
antibacterial activity are available, on top of them, the revolutionary machine, the Bioscreen-C 
Automated Growth Curve Analysis System (Growth Curves Ltd., USA), (Figure 3.2). 
 
 
 
 
 
 
 
Figure 3.2: Automated microbial growth curve analysis system (Bioscreen-C systems). 
3.2.2.1 Disc diffusion assay 
In the disc diffusion assay, Tryptone Soya agar (TSA) plates were incubated with freshly 
grown bacterial cultures of approximately 1 x 104 cfu/ml. Crude extracts were dissolved 
separately in 10 % DMSO, and all extracts were filtered through 0.22 µm syringe filter (Millex-
GP). Then, 50 μl of each plant crude extract was applied to 6 mm sterile filter paper discs 
(Whatman No.1, Sigma Aldrich, UK) at a concentration of 500, 250, 125 μg/ml, and dried in 
sterilised conditions to evaporate the residual solvent and were later placed on the TSA plate. 
Discs with 10 % DMSO only used as a negative control, while chloramphenicol 30 μg/ml discs 
were used as a positive control for antibacterial activity assay. The experiment was done in 
triplicate and plates were incubated for 24 h at 37°C. The inhibitory activity of the compounds 
was determined by comparing the average sizes of inhibition zones (mm), including disc 
diameter, of the different extracts with those of the controls.  
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3.2.2.2 MIC Calculation using Bioscreen-C system 
The Bioscreen system provides a tightly controlled environment for monitoring the 
growth of bacteria by measuring turbidity of the liquid growth medium in the 100 well honey 
comb microtiter plates at specific temperature with or without shaking. These measurements 
were done by a real-time recording of the optical density (OD) of the cultures under 
investigation. The measurement interval can be set from minutes to hours. The filter chosen was 
a wide band filter 420-580 nm. The Bioscreen technology is highly efficient, which can create 
up to 200 growth curves from 200 samples in one run, a number of modelling approaches have 
been developed to transform Bioscreen-C data into a key results, such as minimum inhibitory 
concentration (MIC) and minimum biocidal concentration (MBC) (Dalgaard & Koutsoumanis, 
2001; Lambert & Lambert, 2003). The MIC may be defined as the lowest concentration of tested 
compound, which is required to inhibit the growth of a microbe in vitro. Bioscreen-C technology 
employs a 100 well microtiter plate, with two plates being utilised per run (Figure 3.3), allowing 
up to 200 samples to run simultaneously. To determine the MIC of our compounds, eight serial 
dilutions were created vertically (500-3.9 μg/ml), down the plate, using drugs dissolved in 10 
% DMSO, TSB media was used throughout this procedure. 50 μl of a 1 x 104 cfu/ml suspension 
of the tested bacteria were added to all wells. The plates were incubated for 24 h at 37°C with a 
continuous shaking, and optical density measurements were carried out every 60 minutes at a 
wavelength of 420-580 nm. Data obtained is in the form of an array of OD readings per well per 
60-minute intervals.  Data was transferred to Microsoft Excel to convert it to growth curves.  
 
 
 
 
 
 
Figure 3.3: Schematic diagram of a 100 well microtiter plate used in Bioscreen-C machine.  
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The data obtained from the Bioscreen-C machine used to calculate the MIC of our 
compounds, an adapted approach described by Lambert (2001) was employed. Firstly, the area 
under the growth curve (Figure 3.4) was determined using the trapezoidal formula rule in 
Microsoft Excel. Comparison of the test curve with that of the positive and negative controls 
allows the calculation of a fractional area (fa) (Equation 3.1). Once a range of fractional areas 
have been calculated, data can be plotted against the log concentration (Figure 3.5) to allow 
analysis via a modification of the Gompertz function in Excel (Equation 3.2). This function was 
fitted to the data using the solver function in Excel which allowed the MIC values to be 
calculated with the best fit to the experimental data from the constants M and B (Equation 3.3).  
 
 
 
 
 
 
 
 
Figure 3.4: A typical Bioscreen growth curve (OD vs. Time). 
 
 
 
 
Equation 3.1:      
 
Areat = Area under the test curve 
Areanc = Area under the negative control  
Areapc = Area under the positive control 
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Figure 3.5: A typical profile of fractional area fa vs. drug concentration 
 
 
 
Equation 3.2:  
A= Lower asymptote of y 
C = distance between upper and lower asymptote 
B= Slope parameter 
X= Biocides concentration 
M= Log Concentration of the inflexion point 
 
 
Equation 3.3:   
B= Slope function 
M= the log concentration at the inflexion point 
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3.2.2.3 MBC Calculation of tested molecules 
The minimum biocidal concentration (MBC) test determines the lowest concentration at 
which an antimicrobial agent will kill a particular microorganism. The MBC was determined 
via a series of steps undertaken after the end of the Bioscreen-C run. To determine the MBC, 
the dilutions representing the MIC and at least two of the more concentrated tested product were 
plated on TSA plate and incubated to determine if there were any viable cells. Briefly, 100 μl 
of the cells suspension were transferred from each well to another Bioscreen-C plate containing 
100 μl of DE neutralising broth (LabM Ltd.), after 30 min, 100 μl from each well was removed 
and plated out on a solidified TSA plate. Inoculums were spread out using disposable L-Shaped 
sterile spreader. After 24 h incubation under standard conditions, the colonies were counted, and 
the lowest concentration with no grown cells considered the MBC for that product.  
3.2.3 Natural products techniques 
3.2.3.1 Plant material extraction  
Crude extracts of the dried powder of medicinal plants Centella asiatica (L.), Imperata 
cylindrica (L.), Morinda citrifolia (L.) and Sauropus androgynus (L.) were obtained by 
maceration and Soxhlet extraction techniques. Successive extractions were carried out using a 
modified procedure described by Kisangau et al., (2007). Briefly, Soxhlet extraction was carried 
out by placing plant material in a thimble which was then inserted inside the Soxhlet apparatus 
and exposed to four different absolute solvents of different polarities (Methanol, Ethanol, 
Chloroform and Hexane), the ratio of sample to solvent was 1:10 (w/v). The extraction 
continued until the solvent appeared clear in the upper extraction chamber (Figure 3.6). For 
maceration, plant material macerated with four different solvents (methanol, ethanol, acetone 
and chloroform), solvents were changed daily and the collected solvent stored in closed 
containers in the fridge, this process continued until the solvent appeared clear. Extracts 
obtained from both procedures were then filtered twice through a Whatman No.1 under vacuum 
pressure. Extracts were concentrated by vacuum rotary evaporator (IKA RV 10 digital rotary 
evaporator, Germany), and then extracts freeze dried to completely eradicate solvents. The crude 
extracts were stored in glass containers and kept in the freezer at -20°C until further analyses. 
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Figure 3.6: Schematic diagram of Soxhlet extraction apparatus 
 
3.2.3.2 Isolation and purification of natural products  
Isolation and purification of the active compounds were conducted according to the 
guidance of the bioassay-guided isolation protocol. Briefly, the active extracts were separated 
by high performance liquid chromatography (HPLC), followed by bioassay test to determine 
which fractions were most likely to contain the active substances. Finally, active fractions were 
analysed by spectrometry techniques to identify their molecular structures. All crude extracts 
obtained from the previous processes were separated further by (HPLC). High performance 
liquid chromatography is an efficient technique for the isolation and purification of natural 
products, due to its ability to separate complex mixtures of compounds in a short time with a 
high purity. In our study, the reverse phase high performance liquid chromatography (RP-
HPLC) was applied. For the preparative reverse phase RP-HPLC analysis, an ACE reverse 
phase column (5 µm, C18, 100Å, 250 x 21.2 mm, Hichrom Ltd., UK) was used. Analytical RP-
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HPLC work was carried out with Kinetex reverse phase column (5µm, C18, 100Å, LC Column 
250 x 4.6 mm, Phenomenex, UK).  
Analyses were performed using a Gilson 307 HPLC pump with Varian Prostar 320 UV-
VIS HPLC Detector. Rheodyne 7725i injection valve was used to deliver the sample to the 
system, and was fitted with a 20 µl and 500 µl sample loop for analytical and preparative HPLC 
respectively. The sample concentration was 10 mg/ml for analytical and 100 mg/ml for 
preparative HPLC. The output signal was monitored and processed using PicoLog data 
acquisition software (Pico technology Ltd., Cambridge, UK). Both analytical and preparative 
RP-HPLC methods were optimised for each extract. Analytical HPLC provides a general 
indication of the compounds in the crude extracts and monitors the purity of the compounds. 
Whilst preparative HPLC is used to separate large amounts of crude extracts. The peaks eluted 
from the preparative column were collected manually. 
More than one approach was employed in order to develop a mobile phase system for each 
plant extract, and to achieve that, isocratic solvent systems were used. The mobile phase which 
gave a consistent good separation, at room temperature conditions (25 ±2ºC), consisted of 15 % 
(v/v) HPLC grade methanol with 0.1 % (v/v) trifluoroacetic acid (TFA) in water. Solvents were 
filtered through a 0.45μm filter (Millipore, Bedford, MA, USA) and degassed in an ultrasonic 
bath prior to use. Samples were dissolved in the mobile phase solvent and filtered with a 0.22μm 
syringe filter, and then injected to the column. The flow rate was set at 1.0 ml/min for analytical 
column and 10 ml/min for the preparative column, and 260nm was the best wavelength that 
showed a good detection. 
3.2.3.3 Structure elucidation of active compounds 
Structure elucidation and identification is a crucial part of natural products discovery. 
Spectroscopic methods, such as nuclear magnetic resonance NMR (tell us about the 
environments of the various elements in a molecule) and mass spectrometry MS (gives the 
molecular weight and formula, both of the molecule itself and various structural units within it), 
have become indispensable tools in in this field. Development of computerised techniques has 
permitted utilisation of these methods for acquisition of spectra and greatly increased the 
capabilities of these methods (Kind & Fiehn, 2010). 
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3.2.3.3.1 Nuclear magnetic resonance (NMR) spectroscopy 
The measurement of 1D/2D NMR spectra was carried out at Salford Analytical Services 
centre (SAS), (University of Salford, Manchester, UK). Proton (1H) and carbon (13C) NMR 
spectra were recorded on Bruker Ultra-shield Avance AMX 400 MHz spectrometer. Samples 
were dissolved in deuterated DMSO (DMSO-d6) for NMR measurement. Samples were filtered 
through a cotton wool plugged into Pasteur pipette and then placed in Wilmad NMR tubes (5 
mm diam., precision, 500 MHz, Sigma-Aldrich, UK). More sophisticated NMR tube was used 
as well (Shigemi 5mm Symmetrical NMR Microtube assembly matched with DMSO-d6, 
Shigemi INC., USA).  Solvent peaks were used as an internal standard and all resonance 
assigned were relative to them. Spectra of pure compounds were processed using TopSpin 
software (v 3.5) under automation controlled by “iconnmr”. Structural assignment was based on 
spectra resulting from The 1D 1H and 13C NMR experiments. In addition, homo and 
heteronuclear 2D NMR experiments were also acquired. 
3.2.3.3.2 Purity check of the active compounds 
Nowadays, softwares specifically created for analysing primarily 1D quantitative NMR 
spectra (1H and 13C) have emerged, in addition to analysis software provided by the respective 
NMR instrument manufacturers. For the purity determination of the bio-active compounds 
isolated in this study, q1H NMR was employed by using Mnova NMR software (v 10.0.2) for 
windows, (Mestrelab Research, Santiago de Compostela, Spain). This software has been 
developed in the last few years, and it is a multivendor, multiplatform software for visualisation, 
processing, analysing and reporting of 1D and 2D-NMR data, it has designed to support the 
specific needs of researchers (Mestrelab, 2015). qNMR plugin has been used, which can interact 
with other Mnova plugins to offer the user access to a very advanced functionality with an 
accuracy, which is needed for the purity check of natural products. The qNMR process was done 
by using the automatic functions available in the software, (phase and baseline correction), 
whilst the solvent peaks were used as an internal reference. The raw data is preserved in the 
background to allow more detailed processing. 
3.2.3.3.3 Mass Spectroscopy (MS) of the active compounds  
Samples of the active small molecules were sent to the Intertek pharmaceutical services 
laboratories (Manchester, UK) for accurate mass analysis. Waters ZQ detector integrated with 
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Waters 2695 Alliance HPLC system (Waters Corp, Milford, MA) was used for the experiment. 
Prior to the injection into the HPLC system, the sample was dissolved in 50 % (v/v) acetonitrile 
in water, and the volume injected was 10 μl of approximately 1 mg/ml. The eluent was 9:1 
ACN/water at 0.15 ml/min and 2 second scans were acquired over the range 100 to 1500 m/z in 
positive and negative ion modes. Subsequently, samples were introduced into an electrospray 
(ES) ionization source to ionize the molecules at atmospheric pressure. The ions were separated 
according to their mass-to-charge ratio. The separated ions were detected and then the signals 
were amplified. Collected spectra sent to the Waters Empower software for further MS analysis. 
3.2.4 Proteomics analysis 
3.2.4.1 Bacterial total protein extraction  
A starter culture of 10 ml TSB media was inoculated with a single colony from TSA plate 
and grown overnight under standard conditions. 50 μl of a 1 x 104 cfu/ml suspension of the tested 
bacteria were used to inoculate 10 ml of TSB media, after 8 hours of standard incubation 
conditions (log phase), the tubes were inoculated with sub-inhibitory dose of our tested 
compounds for 2.5 h, to give the cells a chance to respond to the stress of the compound and 
continue to grow (Yun et al., 2011). This allows the proteome profiling to pick up perturbations 
owing to compound response in the context of relatively normal cellular processes. A higher 
dose would have triggered massive disruptions in the cellular processes as the cells struggle to 
survive, which can potentially masked proteome changes directly related to antibiotic response. 
Protein extraction was done by using MinuteTM Bacterial Total Protein Extraction Kit MBTPE, 
(Invent Biotechnologies, Inc. USA). The MBTPE kit is designed to rapidly extract denatured 
total proteins from cultured bacterial cells for different assays, such as SDS-PAGE, 
immunoblotting, ELISA and other applications.  
Briefly, the protein extraction filter cartridge, with collection tube, was pre-chilled on ice 
for 30 min. Bacterial cells were harvested by centrifugation in a 2.0 ml microcentrifuge tube 
with a table-top microcentrifuge (Microcentrifuge Labnet Spectrafuge, 24D) at 13000 
rpm/16000 x g for 2 min. The supernatant was removed and discarded. Then, the cell pellet 
washed in cold 1X Phosphate-buffered saline (PBS). The supernatant was again removed 
leaving a small amount of PBS (about equivalent volume of packed cells) in the tube. The cell 
pellet with the PBS was vortexed briefly to resuspend the cells, and 250 µl of bacterial lysis 
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buffer A added to the cell suspension then vortexed vigorously for 10 seconds, at room 
temperature.  25 µl of buffer B (1/10 of buffer A) was then added to the lysate and vortexed 
vigorously for 10 seconds. The suspensions were transferred into the pre-chilled filter cartridge, 
which was then centrifuged, in a microcentrifuge at 13,000 rpm/16,000 x g, for 1 min. The clear 
cell lysate in collection tube was ready to use and the total bacterial protein yielded with this 
method was about 2.0-2.5 mg/ml. 
3.2.4.2 Protein concentration assay 
PierceTM BCA Protein Assay Kit (Thermo Fisher Scientific, UK) was used to determine 
the protein concentration of bacterial lysates. Briefly, a protein standard curve was created using 
Bovine Serum Albumin Standard (BSA) in the range of 25-2000 μg/ml. A working dye reagent 
was prepared by mixing 50 parts of BCA Reagent A (sodium carbonate, sodium bicarbonate, 
bicinchoninic acid and sodium tartrate in 0.1 M sodium hydroxide) with 1 part of BCA Reagent 
B (4 % cupric sulfate) (50/1, Reagent A/B). 25 µl of each standard or unknown sample was 
added into a 96 microtiter plate wells (working range = 20-2000 µg/ml). 200 μl of the working 
dye reagent was added to each well and the plate agitated thoroughly on a plate shaker for 30 
seconds followed by incubation at 37°C for 30 min. Samples and standards were measured in 
three replicates. Plates were read at 562 nm using a Multiskan™ FC Microplate Reader 
(Thermo, UK). The absorbance values of each extract was converted into protein concentrations 
using the gradient of the BSA standard curve (Figure 3.7). All replicates values were averaged 
and a final concentration was recorded. 
 
 
 
 
 
 
 
Figure 3.7: Standard curve for Bovine Serum Albumin (BSA) using the microtiter plate 
Protocol (37°C/30 minute incubation). Diluted BSA standards (25–2,000 µg/mL) were added to 
Pierce BCA Protein Assay working reagent, and absorbance (562nm) was measured. Data 
points and standard deviations were calculated from three replicates. 
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3.2.4.3 Two-dimensional gel electrophoresis (2D-PAGE) 
Isoelectric focusing (IEF) (first dimension) was conducted using PROTEAN® IEF 
System (Bio-Rad, Hertfordshire, UK) with the Bio-Rad Focusing Tray which holds 1-12 Ready 
IPG strips for flexibility and streamline handling. The second dimension was performed on the 
Hoefer SE600 Standard Dual Cooled Vertical Unit (GE Healthcare). 
3.2.4.3.1 Rehydration 
Immobiline Dry Strip gels (IPG strips) with a linear separation range of pH 3-11(11 cm, 
GE Healthcare) was rehydrated overnight at room temperature in the Immobiline dry strip 
reswelling tray (Bio-Rad). 125 μl of the rehydration solution (Table 3.2) containing 150 μg 
protein was applied along the reservoir channel of the reswelling tray, then followed by the 
application of the IPG strip onto the sample. Strips were prevented from dehydration and 
oxidation by overlaying with a covering fluid (Immobiline DryStrip Cover Fluid, GE 
Healthcare). 
Components Final concentration Volumes 
Urea (M.W 60.06) 7 M 8.40 mg 
Thiourea (M.W 76.12) 2 M 3.04 mg 
CHAPS 2 % 400 mg 
DDT 0.4 % 80 mg 
IPG Buffer 3-10  0.5 % 100 μl 
Bromophenol blue 0.002 % 50 μl of 1 % solution 
Milli-Q water 
 
add to final volume 20 ml 
Table 3.2: Components of the rehydration solution (recipe for 20 ml final volume) 
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3.2.4.3.2 Isoelectric focusing (IEF) 
The rehydrated IPG strips were placed in the PROTEAN® IEF strip holder. 8 μl of 
nanopure water was pipetted to the electrode wicks, to act as receptacles for salts and other non-
amphoteric constituents of the sample. IPG strips were then covered with 2 ml of covering fluid 
and proteins were separated on the basis of their isoelectric point (pI). The IEF was carried out 
at 20°C with the PROTEAN® IEF system. The isoelectric focusing conditions were 150 V for 
40 min, 300 V for 1 h, 450 V for 2 h, 750 V for 15 min, 2000 V for 15 min, reaching a total of 
8000 V in 2 h (max 0.125 mA and 0.125 W per strip). After focusing, the second dimension was 
run immediately or the strips were stored at -80°C until required. 
3.2.4.3.3 Preparation of SDS- polyacrylamide gels 
Prior to preparation of the polyacrylamide gel solutions, the SE600 Standard Dual Cooled 
Vertical Unit (GE Healthcare) was assembled. The polyacrylamide gels used for the second 
dimension of 2D-PAGE contained 12 % acrylamide (1 mm thick). To make six gels, 187 ml 
Milli-Q water was added to 140 ml 40 % acrylamide/bis solution 37.5:1 (Bio-Rad) and 112.5 
ml of 1.5 M Tris-HCl (pH 8.8) and stirred. To this mixture, 4.5 ml of 10 % SDS solution was 
added, with 5 ml of 10 % ammonium persulphate (APS), and 125 μl of N,N,N,N'- 
tetramethylethane-l,2-diamine (TEMED) to catalyse polymerisation. Each gel was overlaid with 
4 ml of a Butanol- Milli-Q water mix solution (10:1) to obtain a uniform gel surface. The 
overlaid solution was removed after gels were polymerised at the room temperature (≃1 h). Gels 
were either used immediately or kept in the fridge for short-term storage (1-4 days) after 
wrapping it with wet paper towels.  
3.2.4.3.4 IPG strips Equilibration 
Frozen strips were allowed to thaw at room temperature for roughly 30 min. Prior to the 
separation in the second dimension, the IEF gels (IPGs) were equilibrated twice under mild 
shaking for 20 min in 10 ml equilibration buffer. First equilibration buffer consisted of 6 M urea, 
75 mM Tris-HCl, pH 8.8, 30 % (v/v) glycerol, 2 % (w/v) SDS, 0.5 % (w/v) of DTT to reduce 
the side chains of cysteine amino acids, and a trace of bromophenol blue. Strips were then 
equilibrated in 10 ml of the same buffer for 20 minutes with 2.5 % (w/v) iodoacetamide 
(replacing the DTT) to alkylate the reduced cysteine side chains. This reduction and alkylation 
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prevented re-oxidation of the reduced proteins during electrophoresis. Excess of equilibration 
solution was removed by briefly dipping the IPG gels into deionised water.   
3.2.4.3.5 Second Dimension gel electrophoresis  
SE600 Standard Dual Cooled Vertical Unit (GE Healthcare) was filled with 1 x 
electrophoresis buffer (Prepared from 10 x electrophoresis buffer: Table 3.3). The casting 
cassettes (containing the polymerised gels) were washed with deionised water and put into the 
separation chamber of the apparatus. Equilibrated IPG strips were placed directly on top of 12 
% polyacrylamide gel surface. 10 μl of protein marker (Molecular Weight Marker Rainbow, 
Sigma) dropped on a piece of filter paper (marker pad) and a dried marker pad were also placed 
onto the acrylamide gel surface next to the strips. Strips and marker pad were covered with an 
air bubble free heated agarose sealing solution (Table 3.4). Finally, the 2D gels were immersed 
in 1 x running buffer in the lower buffer chamber while the upper buffer chamber contained 2 x 
running buffer. Proteins were separated for 30 min at 25°C with 50 W per gel (PowerPac™ HC 
High-Current Power Supply, Bio-Rad), and afterwards with 200 W per gel until the 
bromophenol blue dye reached the bottom of the gel (usually 4-5 h). 
 
 
 
 
Table 3.3: Components of (10x) electrophoresis buffer 
 
 
 
 
 
Table 3.4: Components of agarose-sealing solution 
Components Amount 
Tris 60.4 g 
Glycine 288.4 g 
SDS 20 g 
Milli-Q water up to 2 L 
Components Amount 
Agarose molecular  grade 125 g 
Electrophoresis buffer (1x) 25 ml 
Bromophenol blue trace 
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3.2.4.3.6 Protein staining and Gel imaging 
After proteins were separated, the gels were gently removed from the glass slab, 
transferred into a suitable container, and washed briefly with distilled water to remove the 
remaining buffer. Subsequently, gels were fixed in fixing solution (50:40:10, ddH2O, methanol, 
acetic acid) for 1 h and then stained overnight with Coomassie Brilliant Blue R-250 stain (Sigma 
Aldrich). The staining steps were performed under mild agitation on an IKA® KS 260 orbital 
shaker (IKA®-WERKE, Germany). The gels were rinsed twice with distilled water and de-
stained with 10 % (v/v) methanol for one hour before imaging. Gels stained with Coomassie 
blue were scanned using GS-800 calibrated densitometer (Bio-Rad) and analysed using a 
Quantity One® image analyser software. 
3.2.4.4 Separation of proteins by 1D SDS-PAGE 
Protein samples were solubilised using 2 x sample buffer (0.125 M Tris-HCl (pH 6.8), 4 
% (w/v) SDS, 20 % (v/v) glycerol, 2 % (v/v) 2-mercaptoethanol, 0.05 % (w/v) bromophenol 
blue). Samples were heated at 95ºC for 10 min and allowed to cool to room temperature prior 
to loading. 10 μl of protein marker (Molecular Weight Marker Rainbow, Sigma) was used. 
Separation was performed using 12 % polyacrylamide resolving gels and 4 % stacking gel. 
SE600 Standard Dual Cooled Vertical Unit (GE Healthcare) was used at 200 v for 
approximately 5 hours. Gels were stained with 100 ml of Coomassie Brilliant Blue R-250 
(BioRad) overnight, at room temperature, with continuous shaking. Then, gels were destained 
with destining solution overnight, at room temperature, again with continuous shaking. Finally, 
gels were scanned using GS-800 calibrated densitometer (Bio-Rad) and Quantity One image 
analyser software was used. After scanning, gels either used immediately for the Label-free 
protein quantitation, or stored in the fridge for a short term use. 
3.2.4.5 Label-free protein quantitation and proteomics analysis 
Label-free quantitative proteomics analysis is a proteomics platform based on the 
observation that the intensity of the MS spectrum is linearly proportional to the concentration 
of the ion being detected. Quantitative and qualitative proteomics analysis of the total bacterial 
protein of Staphylococcus aureus (MSSA) was performed in this study according to the protocol 
described by Liu et al. (2014), at the Biological Mass Spectrometry Facility (BioMicS), based 
in the Faculty of Science, University of Sheffield, UK. The isolated protein samples (section 
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3.2.4.1) were quantified and the concentrations were adjusted to obtain an equal amount of 
protein between all samples. After 1D SDS-PAGE being performed, bands were excised into a 
fresh siliconised Eppendorf tubes, with a fresh clean scalpel blade, inside the fume cabinet. Gel 
slices then covered with 200 μl of solution 1 (200 mM ammonium bicarbonate (ABC), 40 % 
acetonitrile (ACN)), and incubated at 37°C for 30 min. Solution then discarded, and the washing 
step repeated twice with a fresh solution. The last step was drying down gel slices in a vacuum 
concentrator (Vacufuge® plus Eppendorf, UK) for 30 min.  
Subsequently, the samples were reduced using 200 μl of reduction buffer (100 mM 
dithiothreitol (DTT) and 50 mM ammonium bicarbonate ABC). Then, gel slices incubated at 
56°C for 1 h. Later, gel slices were centrifuged in Eppendorf tube centrifuge at 13000 x g for 
10 min and the supernatants were discarded. Next step was the alkylation, where 200 μl of 
alkylation buffer (55 mM iodoacetamide (IAA) and 50 mM ABC) was added to the gel slices 
and then incubated at 20°C for 30 min in dark. Gel slices later washed with 200 μl of Solution 
2 (50 mM ammonium bicarbonate ABC) for 15 min at room temperature. Washing step repeated 
twice with a fresh solution. The last step was washing gel slices with 200 μl of Solution 3 (50 
mM ammonium bicarbonate ABC, 50 % acetonitrile ACN) and incubate them for 15 min at 
37°C. Then, gel slices centrifuged at 13000 x g for 10 min, the supernatants then discarded and 
the gel slices dried down in the vacuum concentrator for 1 h. 
Proteolytic digestion was performed after trypsin solution was made, the solution consists 
of one vial of proteomics grade trypsin (TPCK 20 μg, Sigma, UK), 100 μl of 1 mM HCl, 900 μl 
of 40 mM ammonium bicarbonate (ABC), and 9 % acetonitrile (ACN). After ensuring the gel 
slices were covered by fluid at the bottom of the Eppendorf tube, it was Incubated overnight at 
37°C. Following the trypsin digestion, gel slices were centrifuged at 13000 x g for 10 min, and 
the supernatant was recovered to a fresh siliconised Eppendorf tube. Then, gel slices incubated 
at 37°C for 15 min in 20 μl of 100 % acetonitrile (ACN). Subsequently, 50 μl of 5 % (v/v) 
formic Acid (FA) was added to the gel slices and incubated again at 37°C for 15 min. The last 
step was centrifuging the tube at 13000 x g for 10 min and the supernatant then collected. The 
gel slices were discarded then. The recovered supernatants were placed in a vacuum 
concentrator and the extracted peptides dried down overnight at 20°C. Tubes were stored at -
20°C and it was ready for MS analysis. 
                                                                                                                                       Chapter 3  
82 
 
3.2.4.6 LC-MS/MS Analysis of digested portions 
Nanoscale LC separation was performed using a Dionex Ultimate 3000 uHPLC. Peptide 
mixtures were first injected onto a pre-column (PepMap 100, C18 2 cm x 75 µm I.D trap 
column, Thermo Fisher Scientific, UK), where the flow rate was 10 µl/min, and the mobile 
phase consisted of 0.1 % (v/v) Formic Acid (FA) and 2 % (v/v) Acetonitrile (ACN). Peptides 
were eluted from the pre-column to the analytical column (EasySpray 15 cm PepMap 100 C18, 
2µm particle size, 100Å pore size 75µm I.D, Thermo Fisher Scientific, UK). Sample was 
separated over a 64 minutes using uHPLC run of increasing acetonitrile (ACN) 2.4-72 % and 
0.1 % Formic Acid (FA). The flow rate set to 250 nl/min with a constant temperature of 35°C. 
Mass spectrometry analysis of the complex peptide mixtures was performed using 
electron transfer dissociation (ETD) enabled Thermo Fisher-Scientific Orbitrap Elite, equipped 
with an Easyspray (ESI) source. Nanospray ionization was carried out at 1.8 KV, with the ion 
transfer capillary at 250 (C, and S-lens setting of 60 %.  MS1 spectra were acquired at a resolving 
power of 60,000 with an automatic gain control (AGC) target value of 1 x 106 ions by the 
Orbitrap detector, with a range of 350-2000 m/z. Following MS1 analysis, the top 20 most 
abundant precursors were selected for MS2 data dependent analysis (DDA) using collision 
induced dissociation (CID). Charge state screening and monoisotopic precursor selection were 
enabled with precursor ions of single charge rejected, and a 30 second dynamic exclusion 
window setting was used after a single occurrence of an ion with a +/- 10 ppm tolerance. 
The resulting spectra were searched, for protein identification, using Mascot (Matrix 
Science, UK) against the Swissprot database (Eubacteria taxonomic filter) and a decoy database. 
Progenesis QI for proteomics (Nonlinear Dynamics, Water, UK) software package (v 4.1) was 
used as proteomics data analysis search engine. Proteins required a minimum of two peptides 
with a 95 % confidence or above in order to be reported. Proteins were investigated to assess 
their cellular localisation, as well as their biological and molecular functions by the aid of 
PANTHER classification system (Huaiyu et al.,2015). Finally, a comprehensive Gene Ontology 
(G.O.) and enriched pathways analysis of the proteins functions was conducted by the aid of 
DAVID pathway analysis tool (Database for Annotation, Visualization and Integrated 
Discovery, v 6.7) (Huang et al., 2009), given the set of differentially expressed proteins in 
treated and untreated bacterial groups. The data analysis workflow is summarised in figure (3.8). 
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Figure 3.8: Experimental workflow for the sample preparation and data analysis. 
 
3.2.5 statistical analysis 
All statistics were performed using Minitab Statistical Software, version 17 (Minitab Inc., 
USA). Data were expressed as standard error of mean ± (SEM). Statistical analysis was 
performed by one-way analyses of variance (ANOVA) test with Duncan test. A p-value of <0.05 
was considered statistically significant. 
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4.1 Crude extracts 
4.1.1 Introduction  
A thorough review of the current literature led us to choose the four plant species that 
were used in this study.  However, critically, little is known regarding the actual structure and 
mechanism of action of the antibacterial compounds derived from these plants. Extraction, as 
the term is pharmaceutically used, can be defined as the technique used for separation of 
therapeutically active natural compounds and elimination of unwanted insoluble material by 
treatment with selective solvents. Screening the crude plant extracts for the desired bioactivity 
is among the most important operations in medicinal plant research, and extraction is the first 
crucial step of the process. Several approaches can be employed to extract (or release) the 
compounds from the biomass. Although water is used as an extractant in many traditional 
protocols, organic solvents of varying polarities are generally selected in modern methods of 
extraction to exploit the various solubilities of the plant constituents. This can be referred to as 
the solvents' ability to increase cell wall permeability, facilitating the efficient extraction of large 
amounts or polar and medium-to-low polarity constituents. The use of less-polar solvents 
(hexane and chloroform) is beneficial for the extraction of a group of relatively non-polar 
substances, i.e., lipids and terpenoids (Seidel, 2006). 
There are several methods that have been used to extract potential antibacterial 
compounds from natural products. The conventional way of testing an antibacterial compound 
from natural products is to prepare the crude extract, which is thereafter purified, analysed and 
tested against bacterial strains. Solvent extraction procedures applied to plant natural products 
including maceration, percolation, Soxhlet apparatus, ultrasound assisted solvent extraction, 
microwave assisted extraction, and steam distillation. Soxhlet extraction is used widely in the 
extraction of plant metabolites, this method is adequate for both initial and bulk extraction. The 
main advantage of Soxhlet extraction is that it is a continuous process, as the solvent (saturated 
in solubilised metabolites) empties into the flask, the solvent is re-condensed again and extract 
more material. This makes Soxhlet extraction less time and solvent consuming than other 
methods. In addition, heating during the process induce the small molecules to be extracted from 
the biomass by disrupting the cell wall of the plant, diffuse into the cells, solubilise the 
intracellular metabolites, and diffuse out into the enriched extractant (Sarker et al., 2006). 
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Many comparative studies have been carried out in order to assess the best method to be 
followed in the extraction of plant natural products and then use as antibacterial agents. Berka-
Zougali et al., (2012), and Kothari et al., (2012) suggested in their comparative studies that the 
Soxhlet extraction method was the best amongst the other extraction techniques, in terms of 
high extraction efficiency and extraction of many phytochemical groups compared to other 
techniques. Soxhlet extracts from different medicinal plants have demonstrated the highest 
antibacterial activity against Gram positive and Gram negative bacteria. Current study employed 
two different extraction techniques to compare their efficiency in term of antibacterial activities. 
Soxhlet and maceration were the methods of choice. 
4.1.2 Results 
4.1.2.1 Plant material  
The starting materials of Centella asiatica L., Imperata cylindrica L., Morinda citrifolia 
L., and Sauropus androgynus L. were obtained from air-dried healthy leaves, after grinding 
them into a fine powder. It is crucial in herbal medicine to pulverise plant materials to a fine 
powder in order to increase the surface area of the biomass to be exposed to the extraction 
solvents. The products were packed in an airtight container to maintain optimal conditions 
during shipping. The physical characteristics of the products were dry yellowish-brown to pale 
brown powders with different consistencies, and an approximate 6 % moisture was recorded 
before packing. Dried plant material can be used as a source for secondary plant components 
for several reasons. Differences in water content may affect the solubility of subsequent 
separation, and the secondary metabolic plant components should be relatively stable, especially 
if it is to be used as an antibacterial agent and that would not be achieved with the presences of 
water (Ncube et al., 2008). 
 In compliance with the standard requirement for the production of herbal preparations, 
plant materials had been previously screened by the manufacturer for the presence of 
contaminants such as toxic metals and non-metals impurities and biological contaminants, 
which might affect the purity of the product or serve as hazardous contaminants. All the 
screening results were within the acceptable limits of herbal medicine products guidelines of the 
world health organisation (WHO, 2007). Comprehensive information of the plant material is 
available in Appendix 1. 
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4.1.2.2 Preliminary Plant extraction 
In the preliminary plant extraction, solvents with different polarities were used; methanol, 
ethanol, chloroform and hexane in both maceration and Soxhlet extraction techniques and the 
protocol adapted from Kisangau et al. (2007) has been followed. These two techniques were 
used for obtaining the crude extracts of medicinal plants under investigation as described in 
section (3.2.3.1). The yields of crude extract % (w/w), from medicinal plant materials are 
illustrated in table (4.1) for Soxhlet extraction, and table (4.2) for maceration. 
Solvents Methanol Ethanol Chloroform Hexane 
Source of material % Of extracts yield out of 50 grams from plant materials 
Cantella asiatica L. 8.7 % 8.1 % 3.4 % 1.1 % 
Imperata cylindrica  L. 9.3 % 7.2 % 2.7 % 0.9 % 
Morinda citrifolia L. 10.1 % 9.8 % 2.4 % 0.7 % 
Sauropus androgynus L. 10.2 % 9.6 % 3.1 % 1.3 % 
Table 4.1:  Total extracts produced by maceration extraction technique (w/w) %, yield = 
(weight of the extract / weight of plant material) × 100. 
 
Solvents Methanol Ethanol Chloroform Hexane 
Source of material % Of extracts yield out of 50 grams from plant materials 
Cantella asiatica L. 14.1 % 12.9 % 3.1 % 1.6 % 
Imperata cylindrica  L. 11.3 % 10.7 % 3.2 % 1.4 % 
Morinda citrifolia L. 12.1 % 11.1 % 2.9 % 0.9 % 
Sauropus androgynus L. 11.9 % 8.3 % 2.4 % 1.5 % 
Table 4.2:  Total extracts produced by Soxhlet extraction technique (w/w) %, yield = (weight 
of the extract / weight of plant material) × 100. 
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In maceration extraction technique, methanolic extract of Sauropus androgynus L. 
recorded the highest yield amongst all extracts with 5.05 g, while hexane extract of Morinda 
citrifolia L. recorded the lowest yield amongst all extracts with 0.35 g. The highest yield from 
Soxhlet technique was recorded in methanolic extracts, while the lowest yield recorded in 
hexane extracts. Methanolic extract of Cantella asiatica L. recorded the highest yield amongst 
all extracts with 7.05 g, whilst hexane extract of Morinda citrifolia L. recorded the lowest yield 
amongst all Soxhlet extracts with 0.45 g. The highest yield in both techniques was recorded in 
methanolic extracts and the lowest yield was recorded in hexane extracts. The appearance of 
plant residues left after extraction were relatively similar to the starting materials in colour. The 
appearance of methanolic and ethanolic extracts were flaky, while the consistency of chloroform 
and hexane extracts were thicker and tend to be oily.  
4.2 Antibacterial screening of crude extracts 
4.2.1 Introduction  
The first step towards validating the effectiveness of natural products as a potential 
antibacterial is the in-vitro antibacterial activity assay, in which many methods for susceptibility 
testing of bacteria have been used in the past. However, published susceptibility assessment 
reviews have shown that the findings could be slightly different if two methods being followed 
for the same sample (Seidel, 2006). The Minimum Inhibitory Concentration (MIC) test, is an 
important tool in the field of microbiology, it gives an idea of the microbial activity assessment. 
The MIC test tells us about the efficiency of the natural products under investigation, it helps to 
identify the most effective drug candidate from a number of natural product extracts. Thus, the 
results obtained from the MIC test can be used to monitor the preparation of a new antibacterial 
agent which has greater efficiency (Sarker et al., 2006).  
 Disk diffusion assays followed by MIC determination by broth macro/micro dilution is 
widely used. The agar dilution method has also been proven and accepted to be an equally good 
technique as compared to broth dilution, and has been recommended as an alternative to broth 
macro/micro dilution. However, these methods are tedious and time consuming to implement 
as routine tests in many microbial laboratories. Therefore, this study utilised the Bioscreen-C 
system to evaluate the antibacterial activities, and to determine the MICs, of tested extracts 
following the disc diffusion assay. The Bioscreen-C system is an in-vitro machine for 
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quantitative antimicrobial susceptibility and MIC testing, and it has been validated for its high 
accuracy and ease of performance for routine microbiological use (Weiss et al., 2004).  
In this study, four medicinal plants (Centella asiatica L., Imperata cylindrica L., Morinda 
citrifolia L., and Sauropus androgynus L.) that have been reported in many studies for their 
antibacterial activities were investigated. These plants are widely distributed in tropical areas 
and have been used as natural remedies in folk medicine. As a result, they have drawn the 
attention of many scientists who interested in exploring the pharmacological properties of them. 
This section focuses on the screening of the activities of the crude extracts from these medicinal 
plants towards two Gram negative bacteria, Escherichia coli (ATCC 25922) and Pseudomonas 
aeruginosa (ATCC 15442), and two Gram positive bacteria, Staphylococcus aureus (ATCC 
6538) and Enterococcus hirae (ATCC 10541). 
4.2.2 Results 
4.2.2.1 Antibacterial activity of crude extracts (Disc Diffusion Assay) 
The potential antibacterial activity of the crude extracts was initially determined by the 
disc diffusion approach, then MICs were calculated from bioscreening results as described in 
chapter 3(section 3.2.2.1). Results are given in table (4.3) for Centella asiatica L., table (4.4) 
for Imperata cylindrica L., table (4.5) for Morinda citrifolia L., and table (4.6) for Sauropus 
androgynus L.  
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Microorganisms E. coli S.aureus P. aeruginosa E.hirae 
Conc. (µg/ml) 500  250 125 500  250 125 500  250 125 500  250 125 
M
a
ce
ra
ti
o
n
 E
x
tr
a
ct
io
n
 
C
en
te
ll
a
 a
si
a
ti
ca
 (
L
.)
 
Methanol 
21.3b 
0.57 
19.6c 
0.57 
17d 
1 
22.6b 
0.57 
20c 
1 
18.3d 
0.57 
19b 
0 
17.6c 
1.15 
13e 
1 
21b 
0 
18c 
0 
12e 
1 
Ethanol 
19.6b 
0.57 
18c 
1 
13d 
0 
21.3b 
1.15 
17.3c 
0.57 
14d 
0 
18.3b 
1.52 
16c 
1 
14.3d 
0.57 
19.6b 
0.57 
15.3c 
1.15 
12e 
0 
Chloroform 
14b 
1 
13c 
1.73 
11.3d 
0.57 
16.3b 
1.52 
14.6c 
0 
9.6d 
1.15 
14.3b 
0.57 
12c 
0 
9.6d 
0 
12.6b 
1.15 
9.6c 
0.57 
7e 
1.7
3 
Hexane 
9.6c 
1.52 
8.6d 
0.57 
0e 
0 
10c 
1 
8d 
0.57 
0e 
0 
9c 
1 
0d 
0 
0d 
0 
10.3c 
0.57 
7d 
0 
0e 
0 
Microorganisms E. coli S.aureus P. aeruginosa E.hirae 
Conc. (µg/ml) 500  250 125 500  250 125 500  250 125 500  250 125 
S
o
x
h
le
t 
E
x
tr
a
ct
io
n
 
C
en
te
ll
a
 a
si
a
ti
ca
 (
L
.)
 
Methanol 
23.3b 
0.57 
21.6c 
0.57 
16.3d 
1.15 
24a 
1.73 
21 b 
1 
19.3c 
1.52 
22 b 
0 
20.6c 
1.15 
17d 
1 
20.6b 
0.57 
18.6c 
1.15 
15.3d 
0.5
7 
Ethanol 
22.6b 
0.57 
18c 
1 
14.3d 
0.57 
22.6b 
1.15 
19c 
0 
15d 
1 
20b 
0 
17.3c 
1.53 
13.6d 
1.15 
21b 
0 
18.3c 
0.57 
13.6d 
0.5
7 
Chloroform 
16b 
0 
14.6c 
1.15 
12.6d 
0.57 
18 b 
1.73 
16.6c 
0.57 
11e 
0 
14b 
0 
11.3c 
1.15 
8.3e 
0.57 
15 b 
1 
12.3c 
0.57 
9.3e 
0.5
7 
Hexane 
10c 
0 
7.3d 
0.57 
0e 
0 
9.3c 
1.52 
0d 
0 
0d 
0 
9c 
0 
0d 
0 
0d 
0 
12.6b 
0.57 
9c 
1 
0d 
0 
-Ve Control No inhibition No inhibition No inhibition No inhibition 
+Ve Control  27.30.57 24.30.57 250 221 
Table 4.3: Antibacterial activity (zone of inhibition) of methanol, ethanol, chloroform, and 
hexane crude extracts (maceration and Soxhlet) of Centella asiatica (L.) leaves against E. coli, 
S. aureus, P. aeruginosa, and E. hirae bacteria. 
 Negative Control = 10 % DMSO and Positive control = Chloramphenicol 30 μg/ml. 
 Values expressed as Mean  standard error (SEM); n=3 in each group. 
 Inhibition zones were measured in mm and disc diameter was included. 
 Means in the same raw within groups not followed by the same superscript are 
significantly different; one-way ANOVA and Duncan's test were conducted (P<0.05). 
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Microorganisms E. coli S.aureus P. aeruginosa E.hirae 
Conc. (µg/ml) 500  250 125 500  250 125 500  250 125 500  250 125 
M
a
ce
ra
ti
o
n
 E
x
tr
a
ct
io
n
 
Im
p
er
a
ta
 c
yl
in
d
ri
ca
 (
L
.)
 
Methanol 
16.3b 
0.57 
15.3c 
0.57 
11.6d 
0.57 
17.6b 
0.57 
17c 
0 
13.6d 
1.15 
17.6b 
1.15 
16.6c 
0.57 
15.3d 
0.57 
13b 
1.73 
12.6c 
0.57 
8e 
1 
Ethanol 
16b 
0.57 
14.6c 
1.52 
8.3d 
0 
16.3b 
1.15 
13c 
0 
9.3d 
2.08 
13.3b 
0.57 
12c 
1 
8.6d 
0.57 
12.6b 
0.57 
11.3c 
0.57 
10d 
1 
Chloroform 
11.6c 
0.57 
10.3d 
0.57 
8e 
1.73 
10.3c 
0.57 
10d 
0 
0e 
0 
11.3c 
0.57 
9.3d 
1.15 
7.6e 
0.57 
0b 
0 
0b 
00 
0b 
0 
Hexane 
8.3c 
1.15 
0d 
0 
0d 
0 
0b 
0 
0b 
0 
0b 
0 
9.6d 
0.57 
0e 
0 
0e 
0 
0b 
0 
0b 
0 
0b 
0 
Microorganisms E. coli S.aureus P. aeruginosa E.hirae 
Conc. (µg/ml) 500  250 125 500  250 125 500  250 125 500  250 125 
S
o
x
h
le
t 
E
x
tr
a
ct
io
n
 
Im
p
er
a
ta
 c
yl
in
d
ri
ca
 (
L
.)
 
Methanol 
18.3b 
0.57 
15.6c 
0.57 
13.6d 
0.57 
19b 
0 
17.6c 
0.57 
13d 
1 
19 b 
0 
17c 
1.73 
14.3d 
0.57 
15.6b 
1.15 
13c 
0 
9.3d 
1.52 
Ethanol 
16.3b 
0.57 
13.6c 
0.57 
10e 
0 
19.3b 
0.57 
17c 
1 
13.6d 
1.15 
16b 
0 
13.3c 
0.57 
9.6e 
1.15 
13b 
1 
10c 
1 
7.3e 
0.57 
Chloroform 
11.3c 
1.15 
9.3d 
0.57 
7.6e 
0.57 
11 c 
0 
9.6d 
0.57 
0f 
0 
14b 
0 
11.6c 
0.57 
8.6e 
1.52 
8.6 c 
0.57 
0d 
0 
0d 
0 
Hexane 
0b 
0 
0b 
0 
0b 
0 
0b 
0 
0b 
0 
0b 
0 
0c 
0 
0c 
0 
0c 
0 
0b 
0 
0b 
1 
0b 
0 
-Ve Control No inhibition No inhibition No inhibition No inhibition 
+Ve Control  27.30.57 24.30.57 250 221 
Table 4.4: Antibacterial activity (zone of inhibition) of methanol, ethanol, chloroform, and 
hexane crude extracts (maceration and Soxhlet) of Imperata cylindrica (L.) leaves against E. 
coli, S. aureus, P. aeruginosa, and E. hirae bacteria. 
 Negative Control = 10 % DMSO and Positive control = Chloramphenicol 30 μg/ml. 
 Values expressed as Mean  standard error (SEM); n=3 in each group. 
 Inhibition zones were measured in mm and disc diameter was included. 
 Means in the same raw within groups not followed by the same superscript are 
significantly different; one-way ANOVA and Duncan's test were conducted (P<0.05). 
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Microorganisms E. coli S.aureus P. aeruginosa E.hirae 
Conc. (µg/ml) 500  250 125 500  250 125 500  250 125 500  250 125 
M
a
ce
ra
ti
o
n
 E
x
tr
a
ct
io
n
 
M
o
ri
n
d
a
 C
it
ri
fo
li
a
 (
L
.)
 
Methanol 
24.6b 
0.57 
22.3c 
0.57 
20.6d 
1.52 
25.3a 
0.57 
23.6b 
1.15 
21c 
1 
21b 
0 
19c 
1.15 
14.6d 
0.57 
20b 
0 
16.3c 
0.57 
13d 
1.73 
Ethanol 
22.6b 
0.57 
20.3c 
0.57 
16.6d 
0.57 
23.3b 
1.15 
22.3c 
0.57 
21.6d 
1.15 
19b 
1 
16.3c 
0.57 
13.3d 
0.57 
18b 
0 
11.6c 
2.08 
9.3e 
0.57 
Chloroform 
17.3b 
0.57 
15c 
1 
11d 
1 
16.3b 
1.15 
11c 
0 
0e 
0 
9.3b 
0.57 
0d 
0 
0d 
0 
16.3b 
0.57 
13c 
0 
10.3d 
0.57 
Hexane 
10.6c 
1.15 
8.3d 
1.15 
0e 
0 
10c 
0 
7.6d 
0.57 
0e 
0 
0b 
0 
0b 
0 
0b 
0 
8.6c 
0.57 
0d 
0 
0d 
0 
Microorganisms E. coli S.aureus P. aeruginosa E.hirae 
Conc. (µg/ml) 500  250 125 500  250 125 500  250 125 500  250 125 
S
o
x
h
le
t 
E
x
tr
a
ct
io
n
 
M
o
ri
n
d
a
 C
it
ri
fo
li
a
 (
L
.)
 
Methanol 
26b 
0 
24c 
0 
21.3d 
0.57 
26.6a 
0.57 
25.3 b 
1.15 
23c 
1 
24.3 b 
1.15 
21.6c 
1.15 
19.6d 
0.57 
24 a 
1 
22.6b 
0.57 
19.3c 
0.57 
Ethanol 
24.6b 
0.57 
22c 
1 
18.6d 
0.57 
23.6b 
0.57 
20.6c 
0.57 
18d 
0 
22.6b 
1.15 
22.3c 
0.57 
19d 
1 
21.6a 
0.57 
17b 
0 
12c 
1 
Chloroform 
14.3b 
1.15 
12c 
0.57 
10d 
0.57 
16.3 b 
1.52 
13.6c 
0.57 
10d 
1 
9.6c 
0.57 
0d 
0 
0d 
0 
12.6 b 
1.15 
8.6c 
0.57 
0d 
0 
Hexane 
9c 
1 
0d 
0 
0d 
0 
11c 
1.73 
8.3d 
2.08 
0e 
0 
8.6c 
1.52 
0d 
0 
0d 
0 
7.6c 
0.57 
0d 
1 
0d 
0 
-Ve Control No inhibition No inhibition No inhibition No inhibition 
+Ve Control  27.30.57 24.30.57 250 221 
Table 4.5: Antibacterial activity (zone of inhibition) of methanol, ethanol, chloroform, and 
hexane crude extracts (maceration and Soxhlet) of Morinda Citrifolia (L.) leaves against E. coli, 
S. aureus, P. aeruginosa, and E. hirae bacteria. 
 Negative Control = 10 % DMSO and Positive control = Chloramphenicol 30 μg/ml. 
 Values expressed as Mean  standard error (SEM); n=3 in each group. 
 Inhibition zones were measured in mm and disc diameter was included. 
 Means in the same raw within groups not followed by the same superscript are 
significantly different; one-way ANOVA and Duncan's test were conducted (P<0.05). 
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Microorganisms E. coli S.aureus P. aeruginosa E.hirae 
Conc. (µg/ml) 500  250 125 500  250 125 500  250 125 500  250 125 
M
a
ce
ra
ti
o
n
 E
x
tr
a
ct
io
n
 
S
a
u
ro
p
u
s 
a
n
d
ro
g
yn
u
s 
(L
.)
 Methanol 
19.3b 
0.57 
17.6c 
0.57 
14.6d 
1.15 
20b 
0 
18.3c 
0.57 
16.6d 
1.15 
20.6b 
0.57 
18.6c 
0.57 
16.3d 
1.52 
18b 
1.73 
16.3c 
1 
13.6d 
0.57 
Ethanol 
18b 
0 
16.3c 
0.57 
14d 
1 
18.3b 
0.57 
16c 
0 
12.6d 
0.57 
17b 
0.57 
14c 
0 
11.6d 
0.57 
15.6b 
1.15 
12.6c 
0.57 
9d 
1 
Chloroform 
13.6b 
1.73 
11.6c 
2.08 
10d 
1.15 
13.3b 
0.57 
10.3c 
0.57 
8d 
1 
8.3c 
0.57 
0d 
0 
0d 
0 
11.6b 
0.57 
9.3c 
1.52 
7.6e 
0.57 
Hexane 
11.6c 
1.15 
10d 
0 
8.3e 
0.57 
13.3b 
0.57 
10.6c 
0.57 
8d 
1 
0b 
0 
0b 
0 
0b 
0 
8.6c 
0.57 
0d 
0 
0d 
0 
Microorganisms E. coli E. coli S.aureus P. aeruginosa 
Conc. (µg/ml) 500  250 125 500  250 125 500  250 125 500  250 125 
S
o
x
h
le
t 
E
x
tr
a
ct
io
n
 
S
a
u
ro
p
u
s 
a
n
d
ro
g
yn
u
s 
(L
.)
 Methanol 
21.3b 
0.57 
18.6c 
1.15 
15d 
1 
22b 
0 
19.3c 
0.57 
16.3d 
0.57 
21 b 
1 
19.6c 
0.57 
17d 
1.73 
20b 
0 
18c 
0 
15.6d 
0.57 
Ethanol 
19.3b 
0.57 
17c 
1.52 
13d 
1 
19.3b 
0.57 
15.3c 
0.57 
12.6d 
0.57 
22.3b 
0.57 
20c 
1 
16.6d 
0.57 
18.3b 
2.08 
17c 
0 
14.3d 
0.57 
Chloroform 
15b 
0.57 
12.6c 
0.57 
9d 
1.73 
8.6c 
0.57 
0d 
0 
0d 
0 
12c 
0 
10.3d 
0.57 
8e 
0 
10.6 c 
1.15 
0d 
0 
0d 
0 
Hexane 
10.3c 
1.15 
7.3d 
0.57 
0e 
0 
9.6c 
1.52 
7d 
1 
0e 
0 
11c 
1 
10d 
0 
8.6e 
0.57 
0b 
0 
0b 
1 
0b 
0 
-Ve Control No inhibition No inhibition No inhibition No inhibition 
+Ve Control  27.30.57 24.30.57 250 221 
Table 4.6: Antibacterial activity (zone of inhibition) of methanol, ethanol, chloroform, and 
hexane crude extracts (maceration and Soxhlet) of Sauropus androgynus (L.) leaves against E. 
coli, S. aureus, P. aeruginosa, and E. hirae bacteria. 
 Negative Control = 10 % DMSO and Positive control = Chloramphenicol 30 μg/ml. 
 Values expressed as Mean  standard error (SEM); n=3 in each group. 
 Inhibition zones were measured in mm and disc diameter was included. 
 Means in the same raw within groups not followed by the same superscript are 
significantly different; one-way ANOVA and Duncan's test were conducted (P<0.05). 
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The results obtained from the disc diffusion assay showed that there has been a significant 
increasing effect on bacterial growth inhibition (P<0.05), with the increasing concentration of 
the extracts (Figure 4.1). Staphylococcus aureus showed the highest sensitivity in maceration 
extracts when treated with 500 μg/ml of Morinda citrifolia L extracts, and the inhibition zones 
recorded were, 25.3, 23.3, 16.3, and 10 mm in methanol, ethanol, chloroform, and hexane 
extracts, respectively. However, the recorded inhibition zones of Staphylococcus aureus when 
treated with 125 μg/ml of the same extract were 21mm in methanolic extract and 21.6 mm in 
ethanolic extract, while no inhibition zones were recorded in chloroform and hexane extracts. 
Soxhlet methanolic extracts exhibited stronger activity compering to the maceration methanolic 
extracts. The highest inhibition zones among Soxhlet methanolic extracts were recorded in 
Morinda citrifolia L., and the inhibition zones were 26, 26.6, 24.3 and 24 mm in Escherichia 
coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus hirae respectively. 
The lowest recorded in Imperata cylindrica L. with inhibition zones of 18.3, 19, 19, and 15.6 
mm in Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus 
hirae respectively. The maximum inhibitory zones were recorded in methanolic maceration 
extracts from Morinda citrifolia L., and ranged from 24.6, 25.3, 21, and 20 mm in Escherichia 
coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus hirae respectively. 
The lowest recorded was in Imperata cylindrica L. with activity zones ranged from 16.3, 17.6, 
17.6, and 13 mm in Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and 
Enterococcus hirae respectively. 
 
 
 
 
 
 
Figure 4.1: Disc diffusion assay of Imperata cylindrica L. ethanolic extract in S. aureus (left) 
and E. coli (right). 1=10 % DMSO, 2=125 μg/ml, 3=250 μg/ml, 4= 500 μg/ml. 
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Ethanolic extracts were slightly less active than the methanolic extracts in both extraction 
techniques (P<0.05), however, all tested bacteria were susceptible to ethanolic extracts. The 
highest activity recorded in Soxhlet ethanolic extracts were in Morinda citrifolia L. with activity 
ranging from 24.6, 23.6, 22.6, and 21.6 mm in Escherichia coli, Staphylococcus aureus, 
Pseudomonas aeruginosa, and Enterococcus hirae respectively, and the lowest were recorded 
in Imperata cylindrica L. with inhibition zones ranged from 18.3, 19, 19, and 15.6 mm in 
Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus hirae 
respectively. The maximum inhibitory zones recorded in maceration ethanolic extracts were in 
Morinda citrifolia L. and ranged from 22.6, 23.3, 19, and 18 mm of Escherichia coli, 
Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus hirae respectively, while 
the lowest recorded in Imperata cylindrica L. with activity zones ranged from 17.6, 15.3, 13.3, 
and 12.6 mm in Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and 
Enterococcus hirae respectively.  
Chloroform extracts were less active than methanolic and ethanolic extracts, and in some 
cases there were no activity recorded even with the higher concentrations. Enterococcus hirae 
did not record any inhibition zone when tested with maceration chloroform extract of Imperata 
cylindrica L., however, Soxhlet extract of the same plant recorded a very weak activity of 8.6 
mm at 500 μg/ml with the same microorganism. The highest inhibition zone recorded was in 
the chloroform Soxhlet extracts of Centella asiatica L. was 18 mm at 500 μg/ml in 
Staphylococcus aureus, while the lowest recorded was 7 mm in the same plant with maceration 
extract at 500 μg/ml. Chloroform extracts obtained by Soxhlet and maceration techniques of 
Centella asiatica L. demonstrated a varied range of activity against all tested strains even with 
the lower concentrations, unlike other plant extracts which did not record any activity in some 
lower doses, especially with maceration extracts. 
The least activity recorded was in the hexane extracts of all plants under investigation. In 
most cases, hexane extracts did not show any activity with lower concentrations, while higher 
concentrations showed a very weak activity comparing to the positive control at (P<0.05). The 
maximum inhibition zone was recorded in hexane maceration extract of Sauropus androgynus 
L. against Staphylococcus aureus, the inhibition zone was 13.3 mm at 500 μg/ml. While the 
lowest inhibition zone recorded at a concentration of 500 μg/ml was 7.6 mm in hexane Soxhlet 
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extract of Morinda citrifolia L. against Enterococcus hirae. Hexane extracts of Imperata 
cylindrica L. obtained by Soxhlet extraction method did not demonstrate any activity against all 
tested organisms, even with higher doses, however, maceration extract of Imperata cylindrica 
L. showed a very weak activity against Gram negative bacteria Escherichia coli and 
Pseudomonas aeruginosa at a concentration of 500 μg/ml, and the inhibition zones were 8.3 
mm and 9.6 mm respectively.  
4.2.2.2 Minimum inhibitory concentration (Bioscreening assay) 
In antibiotic drug discovery, MICs must not be analysed as an isolated data, it should be 
used for initial screening of natural products as well as for the selection of the material that 
continue in the following assays and target identification research. The MICs are the starting 
point in a bioprospecting program. For this reason, the protocols use must be implemented using 
international standards, because it takes into account the ability of the extract, fraction or 
compound to penetrate into the microorganism (Bueno, 2012). In order to provide a more 
developed understanding of the impact of the crude extracts on the growth of bacterial strains 
under investigation, the Bioscreen-C technology was employed to determine the relevant MICs. 
As described in section 3.2.2.2, MIC values were calculated from the Bioscreen-C system 
outputs using an adapted approach described by Lambert, (2001). 
The data obtained from the disc diffusion assay of the crude extracts suggested that 
methanolic and ethanolic Soxhlet extracts had potential antibacterial activity against Gram 
positive and Gram negative bacteria. Nonetheless, other solvent extracts showed antibacterial 
activity against tested bacteria to various degrees, but the inhibition zones were more eminent 
in the methanolic and ethanolic Soxhlet extracts. For this reason, these extracts were tested 
further on the same bacterial species to determine the minimum inhibitory concentrations 
(MICs) and the minimum bactericidal concentrations (MBCs). Figure 4.2 (methanolic Soxhlet 
extracts) and figure 4.3 (ethanolic Soxhlet extracts) represent the MIC values of Centella 
asiatica L., Imperata cylindrica L., Morinda citrifolia L., and Sauropus androgynus L., whilst, 
figure 4.4 (methanolic Soxhlet extracts) and figure 4.5 (ethanolic Soxhlet extracts) represent the 
MBC values of the same extracts. 
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Figure 4.2: Comparative analysis of all bacterial culture MICs of methanolic Soxhlet crude 
extracts for Centella asiatica (L.), Imperata cylindrica (L.), Morinda citrifolia (L.) and 
Sauropus androgynus (L.). All values represent a mean of three replicate tests and the standard 
error of the mean (SEM) has been calculated. 
 
 
 
 
 
 
 
 
Figure 4.3: Comparative analysis of all bacterial culture MICs of ethanolic Soxhlet crude 
extracts for Centella asiatica L., Imperata cylindrica L., Morinda citrifolia L., and Sauropus 
androgynus L. All values represent a mean of three replicate tests and the standard error of the 
mean (SEM) has been calculated. 
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Figure 4.4: MBC values of methanolic Soxhlet crude extracts of Centella asiatica L., Imperata 
cylindrica L., Morinda citrifolia L., and Sauropus androgynus L. Tested bacteria are 
Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus hirae. 
 
 
 
 
 
 
 
 
 
Figure 4.5 MBC values of ethanolic Soxhlet crude extracts of Centella asiatica L., Imperata 
cylindrica L., Morinda citrifolia L., and Sauropus androgynus L. Tested bacteria are 
Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus hirae. 
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The result of the minimum inhibitory concentration test indicated different levels of MICs 
depending on the bacterial strain being tested. In methanolic extracts of the four medicinal 
plants, MICs ranged from 83.3 μg/ml to 199.3 μg/ml, while the range was 89 μg/ml to 215.3 
μg/ml for the ethanolic extracts. Morinda citrifolia L. recorded the lowest MICs for all tested 
bacteria with methanolic and ethanolic extracts, the MICs in methanolic extracts were 92, 83.3, 
101, and 91μg/ml in Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and 
Enterococcus hirae, respectively. Morinda citrifolia L. ethanolic extract showed MICs of 98, 
89, 93.3, and 108 μg/ml in Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, 
and Enterococcus hirae respectively. Imperata cylindrica L. showed the weakest MICs among 
all tested extracts. Methanolic extract of Imperata cylindrica L. gave MIC values of 179, 168.3, 
175.6, and 199.3μg/ml in Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, 
and Enterococcus hirae, respectively, whilst ethanolic extract recorded 186, 196, 183.6, and 
215.3 μg/ml in Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and 
Enterococcus hirae, respectively. All tested bacteria showed different levels of MICs in 
Centella asiatica L. and Sauropus androgynus L. The lowest MIC observed in the methanolic 
extract of Centella asiatica L. was 110.6 μg/ml in Pseudomonas aeruginosa, whereas, the 
ethanolic extract of the same plant recorded the lowest MIC in Escherichia coli with a value of 
124 μg/ml. On the other hand, Sauropus androgynus L. recorded an MIC of 122 μg/ml in the 
ethanolic extract against Pseudomonas aeruginosa, whilst the lowest MIC in the methanolic 
extract of the same plant was 130 μg/ml with Staphylococcus aureus. 
The MBC is complementary to the MIC; whereas the MIC test demonstrates the lowest 
level of antibacterial agent that inhibits growth, the MBC demonstrates the lowest level of 
antimicrobial agent that results in microbial death. 125 μg/ml, is the lowest MBC value recorded 
in Morinda citrifolia L. against Staphylococcus aureus and Escherichia coli of, with the 
methanolic and ethanolic extracts, respectively. Whereas, MBC were ranged between 250 and 
500 μg/ml of all tested bacteria in other plant extracts.  
Figures 4.6, 4.7, 4.8, and 4.9 represents 1 x and ½ x MIC growth curve, in addition to the 
standard growth curve of particular strain of all tested bacteria with methanolic Soxhlet crude 
extract of Morinda citrifolia L., which demonstrated the highest activity against tested bacteria. 
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Figure 4.6: Standard Escherichia coli growth curve, of 1 x and ½ x MIC, activity of methanolic 
Soxhlet crude extract of Morinda citrifolia L. under standard conditions, 37ºC and 24 h 
incubation. All values represent a mean of three replicate tests. 
 
 
 
 
 
 
 
 
 
Figure 4.7: Standard Staphylococcus aureus growth curve, of 1 x and ½ x MIC, activity of 
methanolic Soxhlet crude extract of Morinda citrifolia L. under standard conditions, 37ºC and 
24 ho incubation. All values represent a mean of three replicate tests. 
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Figure 4.8: Standard Pseudomonas aeruginosa growth curve with, of 1 x and ½ x MIC, activity 
of methanolic Soxhlet crude extract of Morinda citrifolia L. under standard conditions, 37ºC 
and 24 h incubation. All values represent a mean of three replicate tests. 
 
 
 
 
 
 
 
 
 
Figure 4.9: Standard Enterococcus hirae growth curve with, of 1 x and ½ x MIC, activity of 
methanolic Soxhlet crude extract of Morinda citrifolia L. under standard conditions, 37ºC and 
24 h incubation. All values represent a mean of three replicate tests. 
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4.3 Discussion 
Natural resources are now being sought as a source of novel antimicrobial agents since 
conventional agents are increasingly ineffective due to the acquisition of resistance mechanisms. 
Complex plant based products contain various secondary metabolites with varying modes of 
action and complex interactions (Seidel, 2006). The presence of various secondary metabolites 
with different modes of action, reduces the likelihood that resistance to the products will develop 
in bacteria. Traditionally, the search for novel antibacterial agents, to tackle bacterial resistance, 
has focused around products which originate from microbial sources, though most of the 
antibiotics used clinically are produced by soil microorganisms (Aiyegoro & Okoh, 2009). Plant 
based antimicrobials have enormous therapeutic potential as they are effective in the treatment 
of infectious diseases while simultaneously reducing many of the side effects that are often 
associated with synthetic antimicrobials. The healing power of medicinal plants are in most 
instances not understood and their mechanism of action remains to be elucidated. With limited 
access to antibiotics in developing countries and with the upsurge in multi-resistant bacteria 
around the world, alternative therapies derived from plant extracts may be vital. However, 
validation of natural products is vital and often a challenging task (Pandey & Kumar, 2013). 
The initial stage in studying medicinal plants is the preparation of plant samples to 
preserve biomolecules in the biomass prior to the extraction. Plant samples such as leaves, barks, 
roots, fruits and flowers can be extracted from fresh or dried plant material. In most cases, dried 
sample is preferred as fresh samples are fragile and tend to deteriorate faster than dried samples. 
for this reason, pulverised dry leaves were used in this study of Centella asiatica (L.), Imperata 
cylindrica (L.), Morinda citrifolia (L.) and Sauropus androgynus (L.). Other pre-preparation of 
plant materials such as grinding and drying also influences the preservation of bioactive 
molecules in the final extracts. Lowering the particle size increases surface contact between 
samples and extraction solvents as powdered samples have a more homogenious and smaller 
particles, leading to better surface contact with extraction solvents (Azwanida, 2015). 
Conventional mortar and pestle or electric blenders and mills are commonly used to reduce 
particle size of the sample. This particular pre-preparation is important, as for efficient 
extraction to occur, the solvent must make contact with the target analytes. In a study conducted 
by Sulaiman (2011) and coworkers, they concluded that particle size smaller than 400 µm (0.4 
mm) or less is ideal for an efficient extraction. 
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Extraction is the second crucial step in the preparation of plant potential drug candidates 
in the field of natural product drug discovery. The extraction procedure determines both the 
quantity and quality of the crude extracts obtained from each extraction solvent. Modern 
methods of extraction are effective in advancing the development of potential antibacterial 
candidate. Considerable efforts have been made by researchers to find an efficient extraction 
method, for obtaining better quality and high efficiency of extraction of medicinal plants, 
methods have to be optimised. The need for selection of most appropriate extraction 
methodology is evident from the fact that when different methods are applied on the same plant 
material with same solvent, extraction efficiency can vary significantly. In addition, the method 
selected as the most appropriate one also needs to be standardised so as to achieve an acceptable 
degree of reproducibility (Jadhav et al., 2009). 
In this project, a comparative study between maceration and Soxhlet extraction techniques 
has been conducted to choose the most efficient method, in term of antibacterial activity and 
yield of the material, to follow with. Results obtained in this experiment suggested that Soxhlet 
extraction of four different solvents with different polarities gave a higher yield and bioactivity 
than that obtained by the maceration method. This result is in line with the work conducted by 
Selma et al. (2004), where they performed a comparative study in order to find a better technique 
for bioactive molecules extraction. Four extraction techniques were applied using organic and 
aqueous solvents to obtain various crude extracts: static maceration, dynamic maceration, 
extraction with the assistance of ultrasonic waves and Soxhlet extraction. Among all other 
extraction methods, Soxhlet extraction was the most efficient extraction technique, with the 
highest yield with the most antibacterial activity. However, researchers stated that Soxhlet 
extraction was time-consuming comparing with other techniques. They argued that its efficiency 
is due to the employment of a small volume of solvent, which is continually renovating contact 
with the plant material, promoting more interactions between them. The heat applied in Soxhlet 
extraction increases solvent’s transfer rate for the active site of the plant biomass. 
More recent studies conducted by Gothandam et al., (2010); Ismail et al., (2011); Rahman 
et al., (2013); and Nayak et al., (2015), to compare various extraction techniques for isolation 
and determination of phytochemical groups with their antibacterial activity in Sauropus 
androgynous L., Imperata cylindrica L., Centella asiatica L., and Morinda citrifolia L 
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respectively. Supercritical fluid extraction, pressurised fluid extraction, ultrasonic extraction, 
maceration, and Soxhlet apparatus are the extraction techniques being used for extracting active 
compounds from the four medicinal. They concluded that the Soxhlet extracts contained more 
active chemical groups, in the phytochemical assays, than other extraction techniques. Extracts 
of Soxhlet apparatus has demonstrated the greatest antibacterial activity, among other 
techniques, against Gram positive and Gram negative bacteria. Soxhlet extraction technique had 
more yield than other techniques, this finding agreed with the finding in our study, the highest 
was recorded in Centella asiatica L. with 14.1 % out of starting material, while the lowest was 
recorded in Imperata cylindrica L. with 11.3 % out of starting material. However, researchers 
stated that Soxhlet extraction was more solvent and time-consuming than other methods. Even 
though other extraction techniques had less active groups, they had some chemical groups which 
were not found in Soxhlet extraction. As a result, researchers suggested that more than one 
technique might be employed (to bring more active chemical groups) in the evaluation of the 
bioactive compounds of particular medicinal plant.  
According to Altıok et al. (2008), the choice of the solvent is another important factor 
affecting the efficiency of solid-liquid extraction. They stated that successful determination of 
biologically active compounds from plant material is largely dependent on the type of solvent 
used in the extraction procedure. Solvents to be used for medicinal plant extraction should be 
with a low toxicity, ease of evaporation at low heat, promotion of rapid physiologic absorption 
of the extract, preservative action and inability to cause the extract to complex or dissociate. 
Moreover, the choice of solvent is influenced by the intended use of the extract (Eloff, 1998).  
Solvents differ in their extraction capabilities depending on their own chemical properties 
and the solute’s chemical structures. Other factors affecting solvent selection are boiling point, 
density, surface tension, viscosity, stability, flammability, toxicity, compatibility with product, 
availability, and the cost (Cowan, 1999). Many types of solvents are available for extracting 
plant materials, including water, methanol, ethanol, acetone, chloroform, hexane, and petroleum 
ether. The most widely used solvents are water and methanol. Water is a universal solvent and 
for extracting compounds from medicinal plants. However, organic solvent extracts give more 
consistent reading of antimicrobial activity than water extracts. Surprisingly, most of the 
antimicrobial active components have been identified from organic solvent extracts (not water 
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soluble material) (Ncube et al., 2008). Water-soluble compounds, such as polysaccharides and 
polypeptides, are generally more effective as inhibitors of pathogen adsorption and have no real 
impact as antimicrobial agents. Moreover, water soluble flavonoids (mostly anthocyanins) have 
no antimicrobial significance and water soluble phenolics are only important as antioxidant 
compounds (Handa, 2008).  
The higher impact of the methanolic and ethanolic extracts as compared to the aqueous 
extract can be attributed to the presence of higher amounts of polyphenols as compared to 
aqueous extracts. This means that they are more efficient in cell walls degradation which have 
non-polar character and cause polyphenols to be released from cells. A more useful explanation 
for the decrease in activity of aqueous extracts can be ascribed to the enzyme polyphenol 
oxidase, which degrade polyphenols in water extracts, whereas in methanol and ethanol extracts 
they are inactive. Moreover, water is a better medium for the occurrence of the microorganisms 
as compared to alcoholic extracts (Tiwari, et al., 2011). Since nearly all of the identified active 
components from plants are aromatic or saturated organic compounds, they are most often 
obtained through initial ethanol or methanol extraction. The hydroxyl group in methanol and 
ethanol helps dissolve both polar molecules and ionic substances, Methanol is more polar than 
ethanol, but due to its cytotoxic nature, it is unsuitable for extraction in certain kind of studies 
as it may lead to incorrect results (Mandana et al., 2011). 
In our study, polar solvents, like methanol and ethanol, demonstrated stronger 
antibacterial activities than the less polar solvents, like chloroform and hexane. Many published 
studies came in line with the results obtained in this study, these studies have evaluated the 
ability of various solvents to solubilise antibacterial agents from plants. Arumugam et al., (2011) 
and Romika et al., (2015) examined a variety of solvents for their ability to solubilise 
antibacterials from Centella asiatica L. These studies used acetone, methanol, ethanol, and 
chloroform for the extraction. Results showed that methanol and ethanol extracts were active 
against the Gram positive and Gram negative bacteria, even with lower concentrations up to 50 
µg/ml. Antibacterial activities of acetone extracts were stronger on Gram negative bacteria than 
on Gram positive bacteria, while chloroform extract displayed very weak activity on all tested 
bacteria. Ismail (2011) and others, evaluated the antibacterial activity of Imperata cylindrica L., 
using methanol and chloroform as extraction solvents, they employed Soxhlet technique to 
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obtain crude extracts. The results suggested that methanolic extract was much more active than 
chloroform extract against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus 
aureus.   
Usha (2010) and coworkers, had subjected Morinda citrifolia L. to successive solvent 
extraction in the increasing order of polarity, from non-polar to highly polar.  The solvents used 
were petroleum ether, benzene, chloroform, ethyl acetate, ethanol, methanol and water. Extracts 
were tested against Escherichia coli and Staphylococcus aureus, their results revealed that the 
maximum activity recorded with the high polar organic solvents. Although water has a very 
strong polarity index (9), but aqueous extracts had a very weak activity against both tested 
strains. Sinica et al. (2015), evaluated phytochemical, antibacterial and antifungal activities of 
leaf extract of Morinda citrifolia L. using various solvents. The antibacterial activity was tested 
against gram positive bacteria Bacillus subtilis, Escherichia coli, Pseudomonas fluorescence 
and Salmonella typhi using disc diffusion method. The methanolic extract showed the highest 
zone of inhibition with more than 20 mm in diameter. 
Results by Ariharan and coworkers (2013), come in line with the results of our study. 
They carried out an antibacterial evaluation of the methanolic, ethanolic, and aqueous extracts 
of Sauropus androgynous L. leaves, against some Gram positive and Gram negative bacterial 
strains. Agar diffusion assay was used in their study, and Streptomycin was used as a reference 
antibiotic where all results were compared with it. Methanolic extract of Sauropus androgynous 
L. demonstrated significant antibacterial activity against all tested bacterial strains, while the 
aqueous and ethanolic extracts showed less activity against Salmonella typhimurium and 
Klebsiella pneumonia. 
Noticeable attention has been paid to antibacterial activity screening and evaluation 
methods. Several bioassays such as disk diffusion, well diffusion and broth dilution are well 
known and commonly used. Others, such as the time-kill test and flow cytofluorometry 
methods, provide information on the nature of the inhibitory effect (bactericidal or 
bacteriostatic; time-dependent or concentration-dependent) and the cell damage inflicted to the 
test microorganism. However, these methods require specified equipment and further evaluation 
for reproducibility and standardisation (Mayers et al., 2009). Bioscreen-C automated system has 
been utilised in this study, for its accuracy and ability to handle 200 sample at a time.  
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Automated systems are not without any limitations, particularly in laboratories with low 
resource settings. In a study conducted by Felmingham and Brown (2001), they argued that 
automated systems are considerably more expensive than other non-automated counterparts. 
They also stated that automated systems are generally broth-based analysis and cannot be used 
for all clinically important organisms, particularly those species that are more fastidious in 
nature. From the results given in this study, those disadvantages did not affect the reliability and 
accuracy of the experiments comparing to other methods. 
Samy and coworkers (2011), reported that in-vitro results of extracts taken from the leaves 
of Centella asiatica L. demonstrated an antibacterial action. Three solvents were used in their 
study; hexane, dichloromethane, and methanol, where dichloromethane extracts of C. asiatica 
showed significant and higher activity against various bacterial strains used in the study. While 
the hexane extract exhibited a weak activity, the methanolic extract had a moderate activity 
against all tested bacteria. The highest activity recorded with dichloromethane extract in 
Bacillus cereus and Escherichia coli with an inhibition zone of 26 mm. Results from our study 
contradict the results obtained in their study, as the Centella asiatica L. methanolic extract 
showed a significant activity against Escherichia coli, Staphylococcus aureus, Pseudomonas 
aeruginosa, and Enterococcus hirae. The difference in findings between our study and previous 
studies might be due to different extraction techniques being followed, tested microorganism, 
and choice of antibacterial test. In our study, the antibacterial susceptibility tests followed all 
the standards of the Clinical and Laboratory Standards Institute (2007). Other studies conducted 
by Harun et al., (2011); Thamyris et al., (2014); Paul et al., (2011) have previously reported that 
Imperata cylindrica L., Morinda citrifolia L., and Sauropus androgynus L. methanolic Soxhlet 
extracts had a potential antibacterial activity, in particular against Staphylococcus aureus, their 
results agreed with the findings of our study. 
Antibacterial compounds may affect bacterial cells in a variety of ways, many of them are 
poorly understood. At high concentrations, many agents are so destructive. Under certain 
conditions, some agents may specifically disrupt the cell membrane (Filomena et al., 2013). 
Many of the cell’s essential enzymes possess sulfhydryl (-SH) groups and can only function if 
they remain free and reduced, hence agents which oxidise or combine with sulfhydryl groups 
possess a strong inhibitory action. Many agents may act by interfering with one or specific 
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enzymatic reactions which is called chemical antagonism (Rakesh, 2012). There are few 
principle modes of action of antibacterial agents, such as the inhibition of the cell wall synthesis, 
inhibition of protein synthesis, inhibition of DNA replication, and disruption of the cell wall 
membrane function in intracellular metabolism. Some of the phytochemical groups of medicinal 
plants, such as flavonoids, appear to make the external structure of the cell wall permeable thus 
changing the physiology of bacteria increased leading to leakage of the cell contents (Kumar & 
Pandey, 2013). Most of methanolic extracted compounds in this study acted preferentially on 
Gram-positive bacteria, in particular Staphylococcus aureus, this may be due to the high lipid 
and low peptidoglycan content in Gram negative bacteria.  
4.4 Conclusion  
With a dwindling arsenal of effective antibiotics and increasing rates of bacterial 
resistance, alternative agents are desperately needed. In the present study, according to the 
presented data, it was found that methanolic Soxhlet crude extracts of Centella asiatica L., 
Imperata cylindrica L., Morinda citrifolia L., and Sauropus androgynus L. demonstrated a 
significant inhibitory effect on both Gram positive and negative bacteria (P< 0.05). Other 
extracts, which were ethanol, chloroform, and hexane, inhibited most of bacterial strains under 
investigation with less to that shown by methanolic extracts, and in some cases there was no 
activity. Quantitative measurements of the effect of the extracts were conducted using various 
assays. According to the results given in this chapter, methanolic Soxhlet extracts were chosen 
for further fractionation and purification to revel the compounds responsible for inhibitory 
effects demonstrated.   
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5.1 Separation and purification of methanolic extracts by (HPLC)  
5.1.1 Introduction  
Methanolic crude extracts of Centella asiatica L., Imperata cylindrica L., Morinda 
citrifolia L., and Sauropus androgynus L. were the most active extracts against tested bacteria. 
In this study, reverse phase, analytical and preparative, high performance liquid chromatography 
(RP-HPLC) was employed for fractionation and purification of the crude extracts. Application 
of HPLC has increased in recent years for the analysis of plant-derived natural products, it has 
proven to be a very powerful technique in the detection and separation of many compounds. 
The success of HPLC separations is due in part to the selection of mobile phases (solvent), 
column type, oven temperature and type of detector. All of these variables are changeable 
depending on the type of compounds trying to be identified.  For plant extracts, the choice of 
column is of the utmost importance as a crude sample could decrease the lifetime of a column, 
which should be protected by the addition of a guard column and following the right protocols 
(Bernal et al., 2011).  
When developing a method for HPLC analysis, there are three import overall goals, an 
adequate resolution of analytes, short running time, and reproducible process that is not affected 
by small variations throughout the process. The stationary phase should be chosen based on the 
compounds present in the sample. In this project, reverse-phase (RP) was chosen, this method 
works best for low molecular mass molecules as well as neutral compounds (Cseke et al., 2006). 
Isocratic elution was selected in this study where one solvent system at a fixed flow rate was 
used throughout the entire elution process. According to the study conducted by Friesen et al., 
(2015), this method is easy to perform, reliable, and sufficient for separations of plant material 
mixtures. However, for a more complex sample, it may be necessary to use a gradient elution, 
which uses two or more different solvents of varying elution strengths.  
5.2 Results 
5.2.1 Optimisation of the solvent system using analytical RP-HPLC  
As an initial step in the separation process, analytical RP-HPLC was performed on the 
absolute methanolic extracts of medicinal plant materials. The aims of this analysis were to 
evaluate the complexity of the mixture of compounds contained within these samples and to 
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develop a method with the best separation possible (see chapter 3/section 3.2.3.2). The 
separations were conducted by injecting an equal amount of sample onto the C-18 analytical 
HPLC column. Three solvent systems were used in this study for optimisation of the analytical 
RP-HPLC parameters. The first system was an isocratic elution using a mobile phase of 0.1 % 
TFA in water: methanol 90:10 (v/v), the second was an isocratic elution run using 0.1 % TFA 
in water: methanol with a ratio of 85:15 (v/v), and the last solvent system was an isocratic elution 
using a ratio 80:20 (v/v) of water: methanol containing 0.1 % TFA. 
The chromatograms of analytical HPLC crude extract profile of Centella asiatica L., 
Imperata cylindrica L., Morinda citrifolia L., and Sauropus androgynus L. (as shown in figure 
5.1, 5.2, 5.3, and 5.4), displayed several major peaks within the first 10 minutes of the 
separation. The chromatograms showed that the early eluting peaks, ranging from 0 min to 20 
minutes, in retention time, were overlapped when the mobile phases of 0.1 % TFA in water: 
methanol 90:10 and 80:10 (v/v) were used, and no separation was achieved. However, from 
visual observation, mobile phase of 0.1 % TFA in water: methanol 85:15 (v/v) produced a better 
separation with sharp and relatively symmetrical peaks. As a result, the 85:15 (v/v) of water: 
methanol containing 0.1 % TFA isocratic system was chosen for a larger scale preparative 
HPLC in this study. 
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Figure 5.1: Analytical HPLC profiles of Centella asiatica L. methanolic extract using different 
solvent system. 
The HPLC column was a reverse-phase C-18 Kinetex analytical column (250 x 4.6 mm and 5 μm particle diameter). 
The solvent systems were: (A) isocratic mobile phase of 0.1% TFA in water: methanol 90:10 (v/v), (B) isocratic 
mobile phase of 0.1 % TFA in water: methanol 85:15 (v/v), and (C) isocratic mobile phase of 0.1 % TFA in water: 
methanol 80:20 (v/v). The injection volume was 20 μl with a sample concentration of 10 mg/ml. The 
chromatograms were recorded at 260 nm for 60 min. 
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Figure 5.2: Analytical HPLC profiles of Imperata cylindrica L. methanolic extract using 
different solvent system. 
The HPLC column was a reverse-phase C-18 Kinetex analytical column (250 x 4.6 mm and 5 μm particle diameter). 
The solvent systems were: (A) isocratic mobile phase of 0.1% TFA in water: methanol 90:10 (v/v), (B) isocratic 
mobile phase of 0.1 % TFA in water: methanol 85:15 (v/v), and (C) isocratic mobile phase of 0.1 % TFA in water: 
methanol 80:20 (v/v). The injection volume was 20 μl with a sample concentration of 10 mg/ml. The 
chromatograms were recorded at 260 nm for 60 min. 
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Figure 5.3: Analytical HPLC profiles of Morinda citrifolia L. methanolic extract using different 
solvent system. 
The HPLC column was a reverse-phase C-18 Kinetex analytical column (250 x 4.6 mm and 5 μm particle diameter). 
The solvent systems were: (A) isocratic mobile phase of 0.1% TFA in water: methanol 90:10 (v/v), (B) isocratic 
mobile phase of 0.1 % TFA in water: methanol 85:15 (v/v), and (C) isocratic mobile phase of 0.1 % TFA in water: 
methanol 80:20 (v/v). The injection volume was 20 μl with a sample concentration of 10 mg/ml. The 
chromatograms were recorded at 260 nm for 60 min. 
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Figure 5.4: Analytical HPLC profiles of Sauropus androgynus L. methanolic extract using 
different solvent system. 
The HPLC column was a reverse-phase C-18 Kinetex analytical column (250 x 4.6 mm and 5 μm particle diameter). 
The solvent systems were: (A) isocratic mobile phase of 0.1% TFA in water: methanol 90:10 (v/v), (B) isocratic 
mobile phase of 0.1 % TFA in water: methanol 85:15 (v/v), and (C) isocratic mobile phase of 0.1 % TFA in water: 
methanol 80:20 (v/v). The injection volume was 20 μl with a sample concentration of 10 mg/ml. The 
chromatograms were recorded at 260 nm for 60 min. 
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5.2.2 Separation of methanolic extracts using preparative RP-HPLC 
According to the analytical HPLC separation results, obtained from previous stage, 
preparative chromatography was conducted on the methanolic extracts of medicinal plants under 
investigation. The HPLC elution used was an isocratic mobile phase consisted of 0.1 % TFA in 
water: methanol 85:15 (v/v). The column used was ACE reverse phase column (C-18, 5µm, 
100Å, 250x21.2 mm, Hichrom Ltd, UK) with a flow rate of 10 ml/min for the period of 60 min. 
Preparative RP-HPLC showed various component elution of methanolic extracts, each peak was 
collected and pooled together manually according to the retention time. Given that, one or more 
of that eluted compounds were responsible for the antibacterial activity shown in previous 
chapter. All fractions were evaporated under reduced pressure and freeze dried. Each fraction 
was weighed, and the percentage yield was calculated relative to the amount of the material 
injected into the column.  
Ten fractions were collected from Centella asiatica L. (figure 5.5), eight of them eluted 
during first 20 minutes of the run. Fraction 9 produced the highest yield (3.3 %) out of the total 
injected material, and the retention time was 30.28 min. While fraction 10 recorded the lowest 
yield of only (1.1 %), with a retention time of 44.50 min. Table (5.1) illustrates the retention 
time (tR) and the names given to the fractions with the percentage yield of each fraction. 
Imperata cylindrica L. methanolic extract produced twelve fractions (figure 5.6). The highest 
yield recorded in fraction 1 (4.6 %) with a retention time of 4.47 min, whilst the lowest yield in 
was recorded in fraction 9 of only (0.7 %) with a retention time of 22.55 min. The yield of this 
fraction was the lowest recorded amongst all fractions collected in this study. Table (5.2) 
illustrates the retention time and the names given to the fractions with the percentage yield of 
each fraction. Ten fractions were collected from Morinda citrifolia L. methanolic extract (figure 
5.7). The highest yield was recorded in fraction 1 (3.5 %) (table 5.3), with a retention time of 
4.40 min, whilst the lowest recorded in fraction 10, (1 %) with a retention time of 46 min. 
Finally, the preparative RP-HPLC of Sauropus androgynus L. methanolic extract produced nine 
fractions (figure 5.8), fraction 1 showed the highest yield in all collected fractions in this study 
(5.3 %), with a retention time of 6.17 min. While, fraction 9 produced the lowest yield in this 
plant (0.9 %) with a retention time of 47.10 min. Table (5.4) shows the retention time and the 
names given to the fractions with their percentage yield. 
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Figure 5.5: Preparative RP-HPLC chromatogram of Centella asiatica L. 
The preparative HPLC of the Soxhlet methanolic extract was performed using a reverse-phase ACE 5 C18 250 x 
21.2 mm column, with 5 μm particle size, the isocratic mobile phase consists of water: methanol 85:15 (v/v) with 
0.1 % TFA (v/v), at a flow rate of 10 ml/ min. The chromatogram was run for 60 min. The injected sample volume 
was 0.5ml, and the concentration was 100 mg/ml. The chromatogram was recorded at 260 nm. 
 
Centella asiatica (L.) fractions 
Number Name of the Fraction Retention time (min) Yield % (w/w) 
1 CA1 7.20 2.6 % 
2 CA2 8.37 2.0 % 
3 CA3 9.26 1.8 % 
4 CA4 10.40 2.9 % 
5 CA5 12.30 2.2 % 
6 CA6 13.40 1.3 % 
7 CA7 14.51 1.9 % 
8 CA8 16.45 2.3 % 
9 CA9 30.28 3.3 % 
10 CA10 44.50 1.1 % 
Table 5.1: The retention time and weight of the compounds separated from the methanolic 
extract of Centella asiatica L. by preparative RP-HPLC. 
 % yield = (weight of the fraction / weight of plant material injected) ×100  
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Figure 5.6: Preparative RP-HPLC chromatogram of Imperata cylindrica L. 
The preparative HPLC of the Soxhlet methanolic extract was performed using a reverse-phase ACE 5 C18 250 x 
21.2 mm column, with 5 μm particle size, the isocratic mobile phase consists of water: methanol 85:15 (v/v) with 
0.1 % TFA (v/v), at a flow rate of 10 ml/ min. The chromatogram was run for 60 min. The injected sample volume 
was 0.5ml, and the concentration was 100 mg/ml. The chromatogram was recorded at 260 nm. 
 
Imperata cylindrica (L.) fractions 
Number Name of the Fraction Retention time (min) Yield % (w/w) 
1 IC1 4.47 4.6 % 
2 IC2 6.12 2.3 % 
3 IC3 7.40 1.5 % 
4 IC4 8.10 2.9 % 
5 IC5 9.25 1.4 % 
6 IC6 16.20 1.8 % 
7 IC7 17.40 0.8 % 
8 IC8 18.45 1.1 % 
9 IC9 22.55 0.7 % 
10 IC10 24.50 2.1 % 
11 IC11 34 1.8 % 
12 IC12 36.10 1.2 % 
Table 5.2: The retention time and weight of the compounds separated from the methanolic 
extract of Imperata cylindrica L. by preparative RP-HPLC. 
 % yield = (weight of the fraction / weight of plant material injected) ×100  
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Figure 5.7: Preparative RP-HPLC chromatogram of Morinda citrifolia L. 
The preparative HPLC of the Soxhlet methanolic extract was performed using a reverse-phase ACE 5 C18 250 x 
21.2 mm column, with 5 μm particle size, the isocratic mobile phase consists of water: methanol 85:15 (v/v) with 
0.1 % TFA (v/v), at a flow rate of 10 ml/ min. The chromatogram was run for 60 min. The injected sample volume 
was 0.5ml, and the concentration was 100 mg/ml. The chromatogram was recorded at 260 nm. 
 
Morinda citrifolia (L.) fractions 
Number Name of the Fraction Retention time (min) Yield % (w/w) 
1 MC1 4.40 3.5 % 
2 MC2 5.25 2.4 % 
3 MC3 6.14 1.7 % 
4 MC4 7.48 2.2 % 
5 MC5 8.35 1.8 % 
6 MC6 13.10 1.6 % 
7 MC7 16.50 2.4 % 
8 MC8 24 1.3 % 
9 MC9 26.40 2.1 % 
10 MC10 46  1 % 
Table 5.3: The retention time and weight of the compounds separated from the methanolic 
extract of Morinda citrifolia L. by preparative RP-HPLC. 
 % yield = (weight of the fraction / weight of plant material injected) ×100 
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Figure 5.8: Preparative RP-HPLC chromatogram of Sauropus androgynus L.  
The preparative HPLC of the Soxhlet methanolic extract was performed using a reverse-phase ACE 5 C18 250 x 
21.2 mm column, with 5 μm particle size, the isocratic mobile phase consists of water: methanol 85:15 (v/v) with 
0.1 % TFA (v/v), at a flow rate of 10 ml/ min. The chromatogram was run for 60 min. The injected sample volume 
was 0.5ml, and the concentration was 100 mg/ml. The chromatogram was recorded at 260 nm. 
 
Sauropus androgynus (L.) fractions 
Number Name of the Fraction Retention time (min) Yield % (w/w) 
1 SA1 6.17 5.3 % 
2 SA2 7.10 3.8 % 
3 SA3 8.30 3.1 % 
4 SA4 10.10 2.0 % 
5 SA5 14 1.9 % 
6 SA6 15.50 2.4 % 
7 SA7 19.40 1.5 % 
8 SA8 31.25 1.9 % 
9 SA9 47.10 0.9 % 
 
Table 5.4: The retention time and weight of the compounds separated from the methanolic 
extract of Sauropus androgynus L. by preparative RP-HPLC. 
 % yield = (weight of the fraction / weight of plant material injected) ×100 
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5.2.3 Antibacterial testing of HPLC purified fractions 
All the HPLC purified fractions from the four medicinal plants under investigation were 
next subjected to an antibacterial screening to see the most active fractions. Three Gram-
negative and three Gram-positive bacterial strains were screened, Gram-negative strains were; 
Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 15442) and Klebsiella 
pneumoniae (NCTC 13438), whilst, Gram-positive strains were; Staphylococcus aureus MSSA 
(ATCC 6538), Staphylococcus aureus MRSA (NCTC 13142), and Enterococcus hirae (ATCC 
10541). All the data under the growth curve, obtained from the Bioscreen-C system, were 
processed using Microsoft Excel, according to the approach described earlier (chapter 3, section 
3.2.2.2), to calculate the MIC of each fraction.  
The results of the antibacterial assay of Centella asiatica L. fractions from preparative 
RP-HPLC revealed that out of 10 fractions (Named as CA1-CA10), only three fractions 
demonstrated significant inhibitory effects against the tested strains. The fractions that showed 
antibacterial activity were CA3, CA4 and CA7 (Figure 5.7). The highest inhibitory activity was 
recorded in fraction CA7. The Gram-positive bacteria were significantly more sensitive than 
Gram negative bacteria. The MICs of fraction CA7 were 16, 21, 23, 17, 19, and 16 μg/ml 
respectively in Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Staphylococcus aureus (MSSA), Staphylococcus aureus (MRSA), and Enterococcus hirae. The 
other two fractions were less active than CA7, Klebsiella pneumoniae was the most resistant 
strain among all three fractions with MICs of 41, 35, and 23 μg/ml respectively in CA3, CA4, 
and CA7.  
The results of antibacterial screening assay of the Imperata cylindrica L. chemical 
compounds revealed that only two fractions (IC6 and IC10) had demonstrated significant 
antibacterial activity (P< 0.05), comparing with the positive control (Figure 5.8). Fraction IC10 
was more active than a fraction IC6 with MIC values of 33, 24, 32, 36, 39, and 32 μg/ml 
respectively in Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Staphylococcus aureus (MSSA), Staphylococcus aureus (MRSA), and Enterococcus hirae. 
However, Enterococcus hirae was more sensitive when exposed to fraction IC6, the MIC value 
recorded was (29 μg/ml), which is less than the value recorded in a fraction IC10 (32 μg/ml) for 
the same bacteria under the same conditions.   
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Figure 5.7: MIC values of Centella asiatica L. fractions (CA3, CA4 and CA7) against six 
different bacterial strains, namely; Escherichia coli (E.C), Pseudomonas aeruginosa (P.A), 
Klebsiella pneumoniae (K.P), Staphylococcus aureus (MSSA), Staphylococcus aureus 
(MRSA), and Enterococcus hirae (E.H). Chloramphenicol (Chl) used as a positive control. 
 Data obtained from the Bioscreen-C system exported to the Microsoft Excel 2013 for MIC 
calculations under the growth curve. 
 The result for each data point represents the average of three replicates, and the standard 
error of the mean (SEM) has been calculated for each dose.  
 
 
 
 
 
 
 
 
Figure 5.8: MIC values of Imperata cylindrica L. fractions (IC6 and IC10) against six different 
bacterial strains, namely; Escherichia coli (E.C), Pseudomonas aeruginosa (P.A), Klebsiella 
pneumoniae (K.P), Staphylococcus aureus (MSSA), Staphylococcus aureus (MRSA), and 
Enterococcus hirae (E.H). Chloramphenicol (Chl) used as a positive control. 
 Data obtained from the Bioscreen-C system exported to the Microsoft Excel 2013 for MIC 
calculations under the growth curve. 
 The result for each data point represents the average of three replicates, and the standard 
error of the mean (SEM) has been calculated for each dose.  
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Antibacterial activity was observed in three fractions only from Morinda citrifolia L., 
namely; MC4, MC7, and MC8 (figure 5.9). The fraction that demonstrated the highest activity, 
was MC4. The MIC values for MC4 were 8, 10, 17, 9, 13, and 7 μg/ml respectively in 
Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus 
(MSSA), Staphylococcus aureus (MRSA), and Enterococcus hirae. All bacterial strains tested 
were sensitive to MC7 and MC8 with variable MIC values. MC7 recorded the highest MIC of 
36 μg/ml in Pseudomonas aeruginosa, whilst the lowest MIC recorded in Staphylococcus 
aureus (MSSA) was 16 μg/ml. MC8 recorded the lowest MIC in Staphylococcus aureus 
(MSSA) with 22 μg/ml, just like MC7, whilst the highest MIC was recorded in Pseudomonas 
aeruginosa of 41 μg/ml. Moreover, MC4 recorded lower MIC in Enterococcus hirae and 
Pseudomonas aeruginosa than the MIC of the positive control, the MICs were 7 μg/ml and 10 
μg/ml in MC4 fraction, while the positive control recorded 8 μg/ml and 12 μg/ml respectively 
in the same strains. Finally, only three fractions demonstrated antibacterial activity in Sauropus 
androgynus L., the fractions were SA2, SA3, and SA7 (figure 5.10). Fraction SA7 showed the 
highest activity, among other two fractions with MICs of 24, 21, 34, 20, 18, and 20 μg/ml 
respectively in Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Staphylococcus aureus (MSSA), Staphylococcus aureus (MRSA), and Enterococcus hirae. 
By looking closely at figure (5.11), the data clearly showed that fraction MC4 of Morinda 
citrifolia L. was the most active fraction against all tested bacteria comparing to the positive 
control (P<0.05). The second most active fraction was CA7 of Centella asiatica L., then 
followed by fraction SA3 of Sauropus androgynus L., and the least active fraction was IC10 of 
Imperata cylindrica L. Now that we have identified active fractions from the four plant extracts, 
the four active fractions had been chosen for the next step of the project to illustrate their 
molecular structure by employing advanced spectrometry techniques including NMR and MS. 
Figure (5.12) showed the MBC values of tested bacterial strains. MC4 fraction of Morinda 
citrifolia L. showed the lowest MBCs of all tested bacteria with a value of 31.25 μg/ml, except 
in Klebsiella pneumoniae where the recorded MBC was 62.5 μg/ml. Figures (5.13 – 5.18) 
represent 1 X and ½ X MIC of the standard growth curve of a particular strain of all tested 
bacteria with MC4 fraction of Morinda citrifolia L., which was shown the highest activity 
among all other fractions.  
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Figure 5.9: MIC values of Morinda citrifolia L. fractions (MC4, MC7 and MC8) against six 
different bacterial strains, namely; Escherichia coli (E.C), Pseudomonas aeruginosa (P.A), 
Klebsiella pneumoniae (K.P), Staphylococcus aureus (MSSA), Staphylococcus aureus 
(MRSA), and Enterococcus hirae (E.H). Chloramphenicol (Chl) used as a positive control. 
 Data obtained from the Bioscreen-C system exported to Microsoft Excel 2013 for MIC 
calculations under the growth curve. 
 The result for each data point represents the average of three replicates, and the standard 
error of the mean (SEM) has been calculated for each dose. 
 
 
 
 
 
 
 
Figure 5.10: MIC values of Sauropus androgynus L. fractions (SA2, SA3 and SA7) against six 
different bacterial strains, namely; Escherichia coli (E.C), Pseudomonas aeruginosa (P.A), 
Klebsiella pneumoniae (K.P), Staphylococcus aureus (MSSA), Staphylococcus aureus 
(MRSA), and Enterococcus hirae (E.H). Chloramphenicol (Chl) used as a positive control. 
 Data obtained from the Bioscreen-C system exported to Microsoft Excel 2013 for MIC 
calculations under the growth curve. 
 The result for each data point represents the average of three replicates, and the standard 
error of the mean (SEM) has been calculated for each dose. 
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Figure 5.11: MIC values of the most active fractions CA7, IC10, MC4, and SA3, from 
medicinal plants under investigation, against six different bacterial strains, namely; Escherichia 
coli (E.C), Pseudomonas aeruginosa (P.A), Klebsiella pneumoniae (K.P), Staphylococcus 
aureus (MSSA), Staphylococcus aureus (MRSA), and Enterococcus hirae (E.H). 
Chloramphenicol (Chl) used as a positive control. 
 Data obtained from the Bioscreen-C system exported to Microsoft Excel 2013 for MIC 
calculations under the growth curve. 
 The result for each data point represents the average of three replicates, and the standard 
error of the mean (SEM) has been calculated for each dose. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12: MBC values of the most active fractions CA7, IC10, MC4, and SA3, from 
medicinal plants under investigation, against six different bacterial strains, namely; Escherichia 
coli (E.C), Pseudomonas aeruginosa (P.A), Klebsiella pneumoniae (K.P), Staphylococcus 
aureus (MSSA), Staphylococcus aureus (MRSA), and Enterococcus hirae (E.H). 
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Figure 5.13: Standard Escherichia coli growth curve with 1 x and ½ x MIC activity of MC4 
fraction of Morinda citrifolia L. under standard condition, 37ºC and 24 h incubation. All values 
represent a mean of three replicate tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14: Standard Staphylococcus aureus growth curve with 1 x and ½ x MIC activity of 
MC4 fraction of Morinda citrifolia L. under standard condition, 37ºC and 24 h incubation. All 
values represent a mean of three replicate tests. 
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Figure 5.15: Standard Pseudomonas aeruginosa growth curve with 1 x and ½ x MIC activity 
of MC4 fraction of Morinda citrifolia L. under standard condition, 37ºC and 24 h incubation. 
All values represent a mean of three replicate tests. 
 
 
 
 
 
 
 
 
 
Figure 5.16: Standard Enterococcus hirae growth curve with 1 x and ½ x MIC activity of MC4 
fraction of Morinda citrifolia L. under standard condition, 37ºC and 24 h incubation. All values 
represent a mean of three replicate tests. 
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Figure 5.17: Standard Staphylococcus aureus (MRSA) growth curve with 1 x and ½ x MIC 
activity of MC4 fraction of Morinda citrifolia L. under standard condition, 37ºC and 24 h 
incubation. All values represent a mean of three replicate tests. 
 
 
 
 
 
 
 
 
 
 
Figure 5.18: Standard Klebsiella pneumoniae growth curve with 1 x and ½ x MIC activity of 
MC4 fraction of Morinda citrifolia L. under standard condition, 37ºC and 24 h incubation. All 
values represent a mean of three replicate tests. 
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5.3 Discussion 
Bioassay-guided isolation integrates the processes of separation of compounds in a 
mixture, using various analytical methods, with results obtained from biological testing. The 
process begins by testing a crude extract to confirm its activity, followed by separation of the 
compounds in the extracts and in-vitro biological testing of purified compounds. In some cases, 
further fractionation will be needed if the high purity level not achieved. Structural identification 
of the pure compounds, then follows (Jamil et al., 2012). During the last few decades, there are 
several compounds have been isolated from different plants, where the bioassay-guided 
isolation has been used, and many of these have been reported to have substantial biological 
activities, some of which are of interest from the point of view of potential drug development 
(Khurram et al., 2015; Ejele et al., 2014; Kang et al., 2013). In a study conducted by Unno et 
al., (2004), they have isolated two bioactive compounds from the aqueous extract of the 
Lagerstroemia speciosa leaves by employing bioassay-guided fractionation approach. These 
compounds are valoneic acid dilactone and ellagic acid. Another study conducted by Malheiros 
and coworkers (2005), used using bioassay-guided fractionation to determine the antimicrobial 
activity of drimane sesquiterpenes from Drimys brasiliensis. Militao et al., (2007) isolated six 
bioactive compounds by using bioassay-guided approach.  
High performance liquid chromatography (HPLC) is an extremely robust, versatile, and 
usually rapid technique. It has the ability to separate, identify, and quantitate the compounds 
that are present in any sample that can be dissolved in a liquid. Nevertheless, HPLC methods 
present some limitations, especially in a very complex samples, thus, an initial separation and 
purification of a complex matrix is crucial prior to instrumental analysis by HPLC (Ignat et al., 
2011). RP-HPLC was used extensively in the separation and identification of the bio-active 
secondary metabolites from medicinal plants, such as, mahanine and mahanimbine alkaloids 
from Murraya koenigii (Pandit et al., 2011), ginkgolide A, ginkgolide B, and bilobalide in 
Ginkgo biloba (Mesbah et al., 2005), some triterpene saponins from Chenopodium quinoa 
(Tiwatt et al., 2008). Analytical and preparative chromatography can be found in many studies 
dealing with the bio-active compounds from natural products. Analytical HPLC is commonly 
used in the early stages, prior to the isolation and purification of the active compounds for 
method development (Gupta et al., 2012). The aim of the preparative HPLC is to produce more 
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yields of collected fractions for later assays. The use of prep HPLC has become an indispensable 
tool nowadays in the isolation of most classes of natural products (Zahid and Satyajit, 2012). 
Bucar and coworkers (2013) stated that RP-HPLC is superior in separating a relatively-
polar substance (such as carbohydrates, amino acids, and alkaloids) and illustrating the profile 
of bio-active compounds in plant extracts. Moreover, this method is a straightforward technique 
that usually does not require complex preliminary sample preparation. Mobile phases used in 
this method need careful preparation, and additives such as formic and acetic acids or 
trifluoroacetic acid (TFA) may be added to the mobile phase for pH adjustment and optimisation 
of the separation (Veronika, 2004). In this study, the data obtained from the Bioscreen-C system 
(section 4.2), provide strong evidence that methanolic extracts were the most active extract, and 
in turn indicates that the compounds contained in methanolic extracts, which are responsible for 
the antibacterial activity, might be of polar constituents. Solvent extraction usually follows the 
rule of like-dissolve-like, where the solubility of solvents of similar polarity can be high.  
The most common eluents used in the RP-HPLC analysis of natural products of plant 
extracts are mixtures of aqueous and water-soluble organic solvent, methanol and acetonitrile 
are mostly used (Dolan, 2000). Methanol-water mixture is the most commonly used reverse-
phase HPLC mobile phase for the isolation of natural compounds. However, there is much 
published research that utilised a mixture of water-acetonitrile in HPLC-based natural products 
isolation. Bucar et al. (2013) have summarised that about half of natural products isolation 
employed methanol-water mixture as a solvent system in a survey study of the period between 
2008 and 2012. Some selective methods have been published in which tetrahydrofuran has been 
selected as the only organic solvent in the mobile phase (Nicolino et al., 1997). 2-propanol, n-
butanol or other organic solvents are used only rarely in the mobile phase and, when used, it is 
usually for selectivity reasons (Bronner and Beecher 1995). Sticher, (2008) argued that 
acetonitrile is better to use compared to other alcoholic solvents for RP-HPLC, due to its low 
UV cut off point, lower viscosity, thus reduces back pressure. However, Gilar and coworkers 
(2014), argued that acetonitrile is relatively expensive, especially the highly pure solvent. 
Furthermore, viscosity properties do not affect the separation quality and it causes no problems, 
neither to the HPLC system, nor to the column. This research group suggested that the use of 
methanol instead of acetonitrile as an alternative choice with the same separation quality.  
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Results obtained in this study confirmed that the mobile phase containing methanol has 
demonstrated a good separation of the natural compounds extracted from medicinal plants. In 
any case, it cannot be recommended to use mobile phases with less than 10 % organic solvent 
in water. (Zahid and Satyajit, 2012). The ionic state of the compounds and the stationary phases 
are critical for producing efficient and reproducible chromatography. 1 % of trifluoroacetic acid 
(TFA) in water: methanol 85:15 (v/v) has been used in this study. Toru and coworkers (2007), 
suggested that the isocratic reverse-phase HPLC separation employing a solvent system 
containing TFA the mobile phase showed a good separation of plant extracts. From the data 
presented in this chapter, the HPLC chromatograms have provided an evidence for the 
hypothesis described before, that several compounds were selectively extracted and isolated in 
the absolute methanolic extract, some of which were responsible for the antibacterial activity. 
Studies have reported Centella asiatica L. as a rich source of bio-active compounds, the 
biologically active ingredients are believed to be its phenolic compounds. Several studies have 
revealed the phenolic derivatives of Centella asiatica L., the main technique used was the RP-
HPLC (Skalicka-Wozniak & Garrard, 2014; Du et al., 2004). HPLC method was set for 
quantitative determination of bio-active components in Centella asiatica L. extracts by 
Schaneberg et al., (2003), a gradient mobile phase of water: acetonitrile in 0.1 % TFA has been 
used. comparative studies have employed RP-HPLC to reveal the variations in secondary 
metabolite in different geographical areas of Centella asiatica L. (Anjana et al., 2010; Devkota 
et al., 2010). Several biologically active substances have been reported to be present in Imperata 
cylindrica L., a very recent study carried out by Nugroho and coworkers (2015), where they 
successfully isolated four compounds from a crude methanolic extract of Imperata cylindrica 
L. using analytical RH-HPLC, compounds were, isoeugenin, ferulic acid, p-coumaric acid, and 
caffeic acid. Jiao et al., (2011) developed a method for the content determination in the extracts 
from Imperata cylindrica L. using RP-HPLC. An isocratic mobile phase was used composed of 
methanol-water 70∶30 (v: v), they concluded that the method was sensitive, reproducible and 
should be used for the isolation of bio-active components from plant natural products. 
Qualitative analytical RP-HPLC analysis of Morinda citrifolia L. was recently performed 
by Serafini and coworkers (2011), they successfully identified some phenolic compounds from 
Morinda citrifolia L., the compounds were characterised by retention times relative to external 
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standards, and comparison of their ultraviolet spectra with the literature. A selective and 
validated reversed phase HPLC method for analysing the contents of major anthraquinones in 
Morinda citrifolia L. leaves was developed and reported by (Deng et al., 2009). Among the 
different options, the methanol: water gradient solvent system offered a good separation with 
symmetrical peak shapes. Further research undertaken by Singh and coworkers (2012) for 
identification of bio-active compounds in ten anatomical parts (bark, branches, flowers, leaves, 
pulp, immature and mature fruit, stem, heartwood and root) of Morinda citrifolia L., using 
reverse phase HPLC. A number of major components were identified in this study, such as 
terpenoids, alkaloids, anthraquinones, flavones, glycosides and amino acids. The mobile phase 
used for HPLC analysis consisted of methanol and acetonitrile 90:10 (v/v) at a flow rate of 1.0 
ml/min. The bioassay-guided HPLC analysis indicated that different parts of Morinda citrifolia 
L. had various number of bio active contents. 
Sauropus androgynus L. is rich in the active chemical compositions. Several studies have 
been conducted to evaluate and isolate the bio-active compounds from this plant, most of which 
used HPLC as the main technique for the separation. A study was conducted by Andarwulan 
and coworkers (2010), to quantify the flavonoid content of Sauropus androgynus L., and to 
evaluate their biological activates. Compounds were isolated and quantified using RP-HPLC as 
a tool to achieve this. Flavonoids were quantified on the basis of comparison to their standards. 
Pewarna and coworkers (2015) employed reversed phase HPLC to analyse the carotenoids 
profile of Sauropus androgynus L., this plant was found to be rich in carotenoids with three 
different compounds isolated, tneoxanthin, violaxanthin and lutein. The group suggested that 
these targeted phytochemical compounds need to be investigated further due to their potential 
biological activity. 
5.4 Conclusion 
In this study, the separation of the methanolic extracts of Centella asiatica L., Imperata 
cylindrica L., Morinda citrifolia L., and Sauropus androgynus L. by preparative RP-HPLC 
resolved many distinct peaks showed in the chromatograms. Each peak represents either an 
individual compound, or more than one which eluted at the same time. Ten fractions were 
collected from Centella asiatica L. (CA1-CA10), twelve fractions from Imperata cylindrical L. 
(IC1-IC12), ten fractions from Morinda citrifolia L. (MC1-MC10), and finally, nine fractions 
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were collected from Sauropus androgynus L. (SA1-SA9). Each plant had more than one 
biologically active fraction, however, fractions CA7, IC10, MC4, and SA3 were the most active 
when compared with the positive control (P<0.05). These finding provided a strong evidence 
that these fractions (Compounds) were responsible for the antibacterial activity seen before. As 
there is a continuous and an urgent need to discover new antibacterial compounds with diverse 
chemical structures and novel mechanisms of action for new and re-emerging infectious 
diseases, any substance that can inhibit pathogens and have little toxicity to host cells are 
considered as a candidate for developing new antibacterial drug. For that reason, fractions CA7, 
IC10, MC4, and SA3 were chosen for structure elucidation in the next stage of this project. 
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6.1 Sample purity analysis 
The separation of the methanolic extracts of Centella asiatica L., Imperata cylindrica L., 
Morinda citrifolia L., and Sauropus androgynus L., produced four very active components, 
which were responsible for the antibacterial activity in-vitro. The isolated compounds CA7, 
IC10, MC4, and SA3, might be the compounds responsible for the activity shown in methanolic 
extracts of these plants. In any biomedical and natural product studies, a truthful description of 
chemical constitution requires coverage of both structure and purity aspects (Pauli et al., 2014). 
Screening for biological activity in pharmaceutical research requires that the compounds being 
tested are pure, where the purity assessment is particularly critical in discovery studies. The 
designation of a substance as experimental material (research grade) makes it clear that it differs 
from material intended for human use (pharmaceutical grade). Purity assessment is perhaps most 
critical in the case of novel compounds to which a biological activity is ascribed, because trace 
impurities of a high potency can lead to false conclusions being made. Obtaining the appropriate 
level of purity is essential for assuring the biological activity of the potential candidates of the 
active compounds, as well as for a high success rate of the molecular structure elucidation 
(Guido et al., 2008). 
For many years, the chromatographic methods such as HPLC were used extensively for 
the compound purity checking in the field of pharmaceutical research, however, these 
techniques require an authentic reference standard for construction of calibration curves, along 
with a specific method for absolute purity determination. On the other hand, for unknown 
compounds, it only gives the area under the curve which is not an indicator of absolute purity 
and depends on many factors, such as the detector response. Furthermore, it does not indicate 
impurities that are not detected or are retained on the column resulting into a misleading 
outcomes, or an impurity that has the same retention time as the sample under the conditions 
employed. The increased availability of high sensitivity analytical techniques, such as NMR, 
facilitated the means to quantify and determine the purity of compounds of interest. Among 
many analytical techniques, NMR has been recently used to determine/estimate and report the 
purity of natural compounds. Over the last few years, quantitative NMR (qNMR) has evolved 
in the pharmaceutical industry and the use of it is increased (Mahajan & Singh, 2013).  
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The results of quantitative NMR (qNMR) can be routinely considered as reliable results 
for purity determination much like other established methods (i.e. HPLC). The qNMR can be 
described as a fast, easy, accurate, and non-destructive alternate technique for purity check to 
speed up the whole analytical process and serves the purpose of both identification and purity 
determination of compounds using a single technique. Another major advantage of this 
technique, is that it can be used for a very small amount of the sample. Among the major 
applications of one-dimensional 1D NMR, proton quantitative NMR (q1H NMR) has become a 
valuable technique for the analysis of complex mixtures and the determination of the purity 
without the need for the chromatography assays (Pauli et al., 2014). 
6.1.2 Results  
All NMR measurements were performed on a Bruker Ultra-shield Avance AMX 400 MHz 
spectrometer, using 5-mm NMR tubes (Wilmad NMR tubes, 5 mm diam., precision 500 MHz 
Sigma-Aldrich, UK). Samples were dissolved in a (600 µl) deuterated DMSO-d6. For purity 
determination of the bio-active compounds isolated in this study, q1H NMR used the Mnova 
NMR software as described in section (3.2.3.3.2). 
 Figure (6.1) illustrates the proton NMR chromatograms of CA7 analysed using the 
Mnova software tools, and table (6.1) contains a description of the chemical shift (δ in ppm), 
intensity, width, area, and classified type of each signal. The purity check analysis of Centella 
asiatica L. active fraction (CA7) revealed a purity of 97.05 %. 
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Figure 6.1: Stacked sub-spectra view obtained from the q1H NMR spectrum of the purity check 
analysis of the active fraction (CA7) in Centella asiatica L.  
1. Containing all the compound and “solvents+impurities” peaks.  
2. Containing only the compound fit peaks. 
3. Containing only solvents+impurities peaks. 
 
1D proton NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer. The sample was 
dissolved in a (600 µl) deuterated DMSO-d6, and data analysed by using Mnova NMR software (V 10.0.2, 
Mestrelab Research) with the aid of a qNMR plugin and the purity auto detect feature, to calculate the purity of the 
fraction. Solvent peaks used as an internal reference and the qNMR process were done automatically. The noise, 
phasing errors, and baseline flatness were improved by using the appropriate functions available in the software.  
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Table 6.1: The reported list of 1H NMR peaks of the active fraction (CA7) in Centella asiatica 
L. The table includes the following information: chemical shift in ppm and Hz, Intensity 
(height), Width (in Hz, at half maximum of the peak), and Type (compound, solvent, impurity).  
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Figure (6.2) illustrates the proton NMR chromatograms of IC10 analysed using the Mnova 
software tools, and table (6.2) contains a description of the chemical shift (δ in ppm), intensity, 
width, area, and classified type of each signal. The purity check analysis of Imperata cylindrica 
L. active fraction IC10 revealed a purity of 95.93 %. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2: Stacked sub-spectra view obtained from the q1H NMR spectrum of the purity check 
analysis of the active fraction (IC10) in Imperata cylindrica L.  
1. Containing all the compound and “solvents+impurities” peaks.  
2. Containing only the compound fit peaks. 
3. Containing only solvents+impurities peaks. 
 
1D proton NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer. The sample was 
dissolved in a (600 µl) deuterated DMSO-d6, and data analysed by using Mnova NMR software (V 10.0.2, 
Mestrelab Research) with the aid of a qNMR plugin and the purity auto detect feature, to calculate the purity of the 
fraction. Solvent peaks used as an internal reference and the qNMR process were done automatically. The noise, 
phasing errors, and baseline flatness were improved by using the appropriate functions available in the software. 
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Table 6.2: The reported list of 1H NMR peaks of the active fraction (IC10) in Imperata 
cylindrica L. The table includes the following information: chemical shift in ppm and Hz, 
Intensity (height), Width (in Hz, at half maximum of the peak), and Type (compound, solvent, 
impurity). 
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Figure (6.3) illustrates the proton NMR chromatograms of MC4 analysed using the Mnova 
software tools, and table (6.3) contains a description of the chemical shift (δ in ppm), intensity, 
width, area, and classified type of each signal. The purity check analysis of Morinda citrifolia 
L. active fraction MC4 revealed a purity of 97.65 %. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Stacked sub-spectra view obtained from the q1H NMR spectrum of the purity check 
analysis of the active fraction (MC4) in Morinda citrifolia L.  
1. Containing all the compound and “solvents+impurities” peaks.  
2. Containing only the compound fit peaks. 
3. Containing only solvents+impurities peaks. 
 
1D proton NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer. The sample was 
dissolved in a (600 µl) deuterated DMSO-d6, and data analysed by using Mnova NMR software (V 10.0.2, 
Mestrelab Research) with the aid of a qNMR plugin and the purity auto detect feature, to calculate the purity of the 
fraction. Solvent peaks used as an internal reference and the qNMR process were done automatically. The noise, 
phasing errors, and baseline flatness were improved by using the appropriate functions available in the software. 
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Table 6.3: The reported list of 1H NMR peaks of the active fraction (MC4) in Morinda citrifolia 
L. The table includes the following information: chemical shift in ppm and Hz, Intensity 
(height), Width (in Hz, at half maximum of the peak), and Type (compound, solvent, impurity). 
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6.2 Molecular structure identification of the isolated compounds 
Elucidating the structure of the bio-active compounds isolated from medicinal plants often 
involves the accumulation of data from numerous sources. A wide range of spectroscopic 
instrumentation currently form the backbone of modern structure analysis. In the present study, 
the identification of the molecular structure was possible, as the purity of the isolated 
compounds was sufficient for spectroscopic analysis. Structure determination of the natural 
compounds was performed by extensive nuclear magnetic resonance (NMR) spectroscopy. 
Additional information was gained by mass spectrometry (MS). Only the combined application 
of these methods allowed a certain determination of the structure. The structure of the 
compounds was confirmed by comparison with spectral data available in the literature and 
databases. Structural elucidation started by recording 1D 1H and 13C NMR spectra. Although 
they are very basic experiments, a lot of useful information about the chemical functions present 
in a molecule can be gained from the obtained chemical shifts. In addition, extensive of 2D-
NMR experiments were performed in this study (COSY, TOCSY, HMQC, HMBC, NOESY, 
and ROESY). They are superior to their 1D NMR counterparts, both for the information on the 
connection of nuclei and for the easier assignment of nuclei resonating in crowded regions of 
the spectra (signal overlapping is much less likely in two dimensions than in one) (Dominique, 
2014). Additional 13C_APT experiment were carried out as well. The number of carbons and 
protons were verified by mass spectrometry.  
The identification of the molecular structure of the CA7 compound from Centella asiatica 
L. revealed a known triterpene, and was assigned as (2α, 3β)-2, 3, 23-Trihydroxyurs-12-en-28-
oic acid, also known as asiatic acid (Figure 6.4). The spectral details and their assignments on 
the molecular structure of 1D NMR as follow; 1H-NMR (DMSO-d6) δ; 0.54 (s, 3H), 0.75 (s, 
3H), 0.82 (s, 3H), 0.93 (d, 3H,  J=6.8), 1.05 (s, 3H), 1.16-1.44 (m, 8H), 1.47-1.62 (m, 8H), 1.73-
1.82 (m, 2H), 1.85-1.98 (m, 3H), 2.11 (m, 1H), 3.04 (m, 1H), 3.18 (d, 1H, J=8.4), 3.48 (m, 
1H),4.19 (bm, 3H), 4.41 (d, 3H, J=8.8), 5.14 (m,1H), 11.94 (brs, 1H); 13C-NMR (DMSO-d6) δ; 
46.93 (C-1), 67.38 (C-2), 75.47 (C-3), 42.45 (C-4), 47.28 (C-5), 17.39 (C-6), 30.74 (C-7), 38.46 
(C-8), 52.33 (C-9), 38.37 (C-10), 21. 6 (C-11), 124.46 (C-12), 138.24 (C-13), 41.70 (C-14), 
27.45 (C-15), 23.29 (C-16), 46.77 (C-17), 40.34 (C-18), 45.94 (C-19), 30.15 (C-20); 36.29 (C-
21), 35.75 (C-22), 63.85 (C-23), 13.9 (C-24), 16.96 (C-25), 17.2 (C-26), 23.76 (C-27), 178.25 
(C-28), 32.14 (C-29), 22.93 (C-30). 
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Figure 6.4: Chemical structures of asiatic acid isolated from Centella asiatica L. 
The assignment of the compound was supported by comparison with the available 
literature data of asiatic acid (Acebey-Castellon et al., 2011). 2D-NMR spectra of this 
compound are available in appendices. The MS spectrum (available in the appendices) gave a 
molecular weight of 488 g/mol, which is appropriate for a molecular formula of C30H48O5. As a 
final confirmation, commercial asiatic acid was purchased from Sigma-Aldrich and used as a 
standard in the proton and carbon 1D NMR test. The comparison between the standard asiatic 
acid and CA7 compound showed very close spectra, results is presented in figures (6.5 and 6.6). 
Thus, the compound present in CA7 fraction was confirmed as asiatic acid. 
 
 
 
 
 
 
 
 
Figure 6.5: 1H NMR spectra of CA7 fraction and standard asiatic acid. 
1D proton NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer, and the sample 
was dissolved in a (600 µl) deuterated DMSO-d6. The data were analysed by TopSpin NMR software (v 3.5) under 
automation controlled by “iconnmr”. The noise, phasing errors, and baseline flatness were improved by using the 
appropriate functions available in the software. 
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Figure 6.6: 13C NMR spectra of CA7 fraction and standard asiatic acid. 
1D carbon NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer, and the 
sample was dissolved in a (600 µl) deuterated DMSO-d6. The data were analysed by TopSpin NMR software (v 
3.5) under automation controlled by “iconnmr”. The noise, phasing errors, and baseline flatness were improved by 
using the appropriate functions available in the software. 
The identification of the molecular structure of IC10 compound from Imperata cylindrica 
L. revealed a known flavonol, and was assigned as 2-(3, 4-dihydroxyphenyl)-3, 5, 7-trihydroxy-
4H-chromen-4-one, also known as quercetin (Figure 6.7). The spectral details and their 
assignments on the molecular structure of 1D NMR as follow; 1H-NMR (DMSO-d6) δ; 6.12 (d, 
1H, J=2.03), 6.34 (d, 1H, J=2.03), 6.83 (d, 1H, J=8.47), 7.48 (d, 1H, J=6.28), 7.61 (d, 2H, 
J=2.18), 9.29 (s, 1H), 9.51 (s, 1H), 10.71 (s, 1H), 12.43 (s, 1H); 13C-NMR (DMSO-d6) δ; 146.73 
(C-2), 135.68 (C-3), 175.78 (C-4), 160.66 (C-5), 98.13 (C-6), 136.84 (C-7), 93.29 (C-8), 156.7 
(C-9), 102.94 (C-10), 121.89 (C-1'), 115 (C-2'), 145 (C-3'), 147.64 (C-4'), 115.54 (C-5'), 119.90 
(C-6'). 
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Figure 6.7: Chemical structures of quercetin isolated from Imperata cylindrica L. 
The assignment of the compound was supported by comparison with the available 
literature data of quercetin (Materska et al., 2014). 2D-NMR spectra of this compound are 
available in the appendices. The MS spectrum (available in the appendices) gave a molecular 
weight of 302 g/mol, which is appropriate for a molecular formula of C15H10O7. As a final 
confirmation, commercial quercetin was purchased from Sigma-Aldrich and used as a standard 
in the proton NMR spectral comparison. The comparison showed a very close similarity in 1D 
NMR spectra, result is presented in figures (6.8 and 6.9). Subsequently, the compound present 
in IC10 fraction was confirmed as quercetin. 
 
 
 
 
 
 
 
 
Figure 6.8: 1H NMR spectra of IC10 fraction and standard quercetin. 
 
1D proton NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer, and the sample 
was dissolved in a (600 µl) deuterated DMSO-d6. The data were analysed by TopSpin NMR software (v 3.5) under 
automation controlled by “iconnmr”. The noise, phasing errors, and baseline flatness were improved by using the 
appropriate functions available in the software.  
                                                                                                                                      Chapter 6 
147 
 
 
 
 
 
 
 
 
 
 
Figure 6.9: 13C NMR spectra of IC10 fraction and standard quercetin. 
 
1D carbon NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer, and the sample 
was dissolved in a (600 µl) deuterated DMSO-d6. The data were analysed by TopSpin NMR software (v 3.5) under 
automation controlled by “iconnmr”. The noise, phasing errors, and baseline flatness were improved by using the 
appropriate functions available in the software. 
 
The identification of the molecular structure of MC4 compound from Morinda citrifolia 
L. revealed a known iridoid glycoside, and was assigned as (1S,4aR,5S,7aS)-5-Hydroxy-7-
(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyr-1-yl-β-D-glucopyranoside, also known 
as aucubin (Figure 6.10). The spectral details and their assignments on the molecular structure 
of 1D NMR as follow; 1H-NMR (DMSO-d6) δ; 2.72 (m, 1H), 2.98 (m, 1H), 3.05 (m, 1H), 3.10 
(m, 1H), 3.14 (m, 1H), 3.17 (d, 1H, J=5.05), 3.42 (m, 1H), 3.66 (m, 1H), 3.96 (m, 1H), 4.13 (m, 
1H), 4.16 (m, 1H), 4.29 (m, 1H), 4.48 (s, 1H), 4.50 (d, 1H, J=8.08), 4.79 (s, 1H), 4.84 (d, 1H, 
J=6.82), 4.94 (d, 1H, J=5.31), 4.97 (s, 1H), 5.01 (s, 1H), 5.4 (dd, 1H, J=6.06, 3.79), 5.65 (m, 
1H), 6.31 (dd, 1H, J=6.06, 2.02); 13C-NMR (DMSO-d6) δ; 96.82 (C-1), 139.94 (C-3), 104.91 
(C-4),44.54 (C-5), 80.38 (C-6), 129.09 (C-7), 146.04 (C-8), 46.34 (C-9), 60.95 (C-10), 97.94 
(C-1'), 73.34 (C-2'), 76.61 (C-3'), 70.02 (C-4'), 77.14 (C-5'), 59.44 (C-6'). 
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Figure 6.10: Chemical structures of aucubin isolated from Morinda citrifolia L. 
The assignment of the compound was supported by comparison with the available 
literature data of aucubin (Gutierrez, Rangel, & Baez, 2008). 2D-NMR spectra of this compound 
available in the appendices. The MS spectrum (Available in the appendices) gave a molecular 
weight of 346 g/mol, which is appropriate for a molecular formula of C15H22O9. As a final 
confirmation, commercial aucubin was purchased from Sigma-Aldrich and used as a standard 
in the proton NMR test. The comparison between the standard aucubin and MC4 compound 
showed almost an identical 1D NMR spectra, result is presented in figures (6.11 and 6.12). 
Therefore, the compound present in MC4 fraction was confirmed as aucubin.  
 
 
 
 
 
 
 
Figure 6.11: 1H NMR spectra of MC4 fraction and standard Aucubin. 
1D proton NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer, and the sample 
was dissolved in a (600 µl) deuterated DMSO-d6. The data were analysed by TopSpin NMR software (v 3.5) under 
automation controlled by “iconnmr”. The noise, phasing errors, and baseline flatness were improved by using the 
appropriate functions available in the software.  
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Figure 6.12: 13C NMR spectra of MC4 fraction and standard aucubin. 
 
1D carbon NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer, and the sample 
was dissolved in a (600 µl) deuterated DMSO-d6. The data were analysed by TopSpin NMR software (v 3.5) under 
automation controlled by “iconnmr”. The noise, phasing errors, and baseline flatness were improved by using the 
appropriate functions available in the software. 
The identification and the molecular structure of SA3 fraction, which was isolated from 
Sauropus androgynus L., still unknown for the time being.  The MS spectrum (available in the 
appendices) of this compound gave a molecular weight of 354 g/mol. 1D NMR spectra are 
presented in figures (6.13 and 6.14), whilst 2D NMR spectra available in the appendices. 
 
 
 
 
 
 
Figure 6.13: 1H NMR spectra of SA3 fraction from Sauropus androgynus L. 
 
1D carbon NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer, and the sample 
was dissolved in a (600 µl) deuterated DMSO-d6. The data were analysed by TopSpin NMR software (v 3.5) under 
automation controlled by “iconnmr”. The noise, phasing errors, and baseline flatness were improved by using the 
appropriate functions available in the software. 
MC 4 
Aucubin 
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Figure 6.14: 13C NMR spectra of SA3 fraction from Sauropus androgynus L. 
 
1D carbon NMR spectra acquired by Bruker Ultra-shield Avance AMX 400 MHz spectrometer, and the sample 
was dissolved in a (600 µl) deuterated DMSO-d6. The data were analysed by TopSpin NMR software (v 3.5) under 
automation controlled by “iconnmr”. The noise, phasing errors, and baseline flatness were improved by using the 
appropriate functions available in the software. 
 
6.3 Discussion 
The biosynthesis and breakdown of proteins, fats, nucleic acids and carbohydrates, which 
are essential to all living organisms, are known as primary metabolism with the compounds 
involved in the pathways known as primary metabolites. In contrast to these primary 
metabolites, the mechanism by which an organism biosynthesises compounds that have a much 
more limited distribution in nature and are less involved in metabolic pathways. Such 
compounds, called secondary metabolites, are also important natural products. They are not 
necessarily produced under all conditions, and in the vast majority of cases the function of these 
compounds and their benefit to the organism are not fully understood (Paul, 2009). Secondary 
metabolites are generally not essential for the growth, development, or reproduction of an 
organism and are produced either as a result of the organism adapting to its surrounding 
environment, or produced to act as possible defence mechanisms against predators to assist in 
the survival of the organism. It is this area of secondary metabolism which provides most of the 
pharmacologically active natural products. It is thus fairly obvious that these metabolites should 
be focused on when discovering and developing new drug candidates and the antibiotics are not 
excluded (Dias, Urban, & Roessner, 2012). 
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The isolation and purification of natural products troublesome and have always been the 
main obstacle in the overall process of the discovery of medicinal active compounds. The reason 
for it is the complexity of the naturally occurring secondary metabolites in plants, and often the 
low concentration of the natural product in plants, this can result in an exhausting and time-
consuming separation and purification process. Finally, the yields usually are often very small 
with relatively low purity levels. That is why researchers in the field of natural products need to 
make an extra effort when isolating and purifying these compounds. If a natural compound is to 
be used for biological testing, it is important to know the degree of purity of the material, as the 
impurities can contribute significantly to any biological activity observed in the bio-screening 
assay (Olivier & Matthias, 2008). If the material is to be used for in-vitro biological activity 
testing and for chemical characterisation, Charles, (2005) stated that the acceptable level of 
purity can range from 95 to 99 percent. Such a range of purity will generally be sufficient for 
the biological activity assays, and for the determination a complex chemical structure via 
various spectroscopic techniques such as NMR and MS.  
When isolating the substances from plants, a purity exceeding 99 % can only be achieved 
with some considerable effort. Usually, each purification step results in the loss of material, and 
when working to achieve a very high level of purity, losses can be extreme. If this the case, it 
may be necessary to take only the very centralised cuts of the peak, by leaving the tail cuts, 
which can be later subjected to reprocessing. This study employed the later approach in an 
attempt to achieve a high purity level of the isolated compounds. The purities obtained were 
97.05 %, 95.93%, and 97.65 %, respectively for the bio-active fractions CA7, IC10, and MC4 
respectively. When purity is less than 90 %, there is a reasonable possibility of the interactions 
between one or more existing component. In this case, it might not be possible to conclude 
whether the activity shown is demonstrated by one compound, or resulted from synergism or 
the antagonistic effect of the containing materials (Satyajit et al., 2006). 
In the study of natural products, researchers mainly rely upon the chromatography 
techniques such as HPLC to determine the quantity of active constituents relative to the 
impurities, with several examples known, (Jain et al., 2008; Sathyaraj et al., 2011; Holkar et al., 
2012). Establishing the purity of samples during the isolation process of the natural products is 
quite difficult. A large effort goes into developing methods using chromatography techniques, 
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rather than trying to find a new promising technique, these methods come with many drawbacks 
as mentioned earlier. It is necessary for monitoring impurities in natural products to be very 
selective in the analytical methodology (Prabu & Suriyaprakash, 2010). The q1H NMR is 
different from other analytical and chromatographic techniques. it considered to be a very useful 
technique for impurity determination of chemical compounds, and is selective, and 
reproducible. Impurities with similar chemical structure may easily be identified and quantified 
by q1H NMR technique, making it very cost effective alternate compared to other analytical 
methods that require the acquisition of separate standard of the target analyte and possible 
impurities, or relies on the calculation of under the peak area for unknown compounds (Bharti 
& Roy, 2012).  
The use of quantitative NMR spectrometry for purity determination has been reported in 
many studies, (Parmar et al., 2014; Wahl & Holzgrabe, 2014; Simmler et al., 2014; Li et al., 
2015; Sahoo et al., 2015). A q1H NMR method was developed and validated by Yang and 
coworkers (2015) for Tadalafil (used for pulmonary arterial hypertension) and impurities 
content determination in different batches of bulk drugs and tablets of various specifications. 
The method was proved to be accurate, precise, selective, and linear over the assessed 
concentration range. A unique aspect of the NMR spectrum is the direct proportionality between 
the peak areas and number of protons responsible for the peak. By comparing the q1H NMR 
results with the HPLC approach results, the contents of Tadalafil in the bulk drugs and tablets 
were almost identical.  In our study, One-dimensional and two-dimensional NMR were utilised 
and examined for structure elucidation of the bio-active natural products isolated in this project, 
and the molecular weights of them were confirmed by using an external MS service (Intertek 
Pharmaceutical Services, Manchester, UK). 
The structure of the bio-active fraction isolated from the methanolic extract of Centella 
asiatica L. (which has given a virtual name CA7) was identified and assigned as asiatic acid, on 
the basis of its NMR and MS spectra, and in comparison with data available in the literature 
(Acebey-Castellon et al., 2011). There are several published studies that have indicated a 
number of secondary metabolites isolated from Centella asiatica L. including asiatic acid. The 
isolated compounds from these studies have demonstrated a number of biological activities with 
some related to the antibacterial activity (Taemchuay & Rukkwamsuk, 2009; Jacob & 
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Shenbagaraman, 2011; Dash et al., 2011; Kalita & Saikia, 2012). The pharmacological activities 
of Centella asiatica L. is thought to be due to a vast number of compounds belonging to different 
chemical classes. The major chemical class found in this plant is triterpene saponosides 
(Alqahtani et al., 2015). The most abundant ones are known as asiatic acid, madecassic acid, 
msiaticoside, madecassoside, and madasiatic acid (Williamson, 2002; Pan et al., 2007; Orhan, 
2012). The presence of several flavonoid derivatives such as kaempferol, patuletin, rutin, 
apigenin, castillicetin, myricetin, and castilliferol has been reported in Centella asiatica L. 
(Kuroda et al., 2001; Matsuda et al., 2001; Subban et al., 2008). More chemical groups have 
been isolated and identified in Centella asiatica L., such as polysaccharides (Wang et al., 2004), 
polyacetylenes (Govindan et al., 2007), sterols (Srivastava and Shukla, 1996), and phenolic 
acids (Subban et al., 2008; Suntornsuk and Anurukvorakun, 2005).  
Asiatic acid (2α, 3β, 23-trihydroxyurs-12-ene-28-oic acid, molecular formula C30H48O5), 
is one of the important bio-active pentacyclic triterpenoids found in Centella asiatica L. Asiatic 
acid was reported to possess a wide range of biological activities such as antioxidant (Ullah et 
al., 2009; Lee et al., 2003), hepatoprotective (Wenjie et al., 2012; Ma Zhang et al. 2009), 
anticancer (Jing et al., 2015; Liu et al. 2006; Hsu et al., 2005), anti-inflammatory (Huang et al. 
2011), neuroprotective (Jew et al., 2000), and anti-Alzheimer (Zhang et al., 2012) properties. 
However, the biological effects and mechanism of asiatic acid actions in human remains 
unknown. It has also reported to lower blood glucose level in type 1 diabetic in the rats 
(Ramachandran & Saravanan, 2013; Liu et al., 2010). 
The antibacterial activity of asiatic acid has been reported in some published studies 
(Djoukeng et al., 2005; Wong et al., 2012; Wojnicz et al., 2013). Garo and coworkers (2007) 
indicated that asiatic acid could enhance the susceptibility of Pseudomonas aeruginosa biofilms 
to tobramycin. These studies suggested that asiatic acid is a potent antimicrobial agent, however, 
action modes of asiatic acid against bacterial strains remain unclear. In a study conducted very 
recently by Liu and coworkers (2015), they have investigated the inhibitory effects of asiatic 
acid against seven bacterial pathogens. In an attempt to illustrate its mode of action, they have 
evaluated the influence of this compound on membrane damage, potassium ions (K+ efflux), 
and nucleotides release in these bacteria. Their findings suggested that asiatic acid might be a 
potent antibacterial agent, and its antibacterial action might be explained by the disruption of 
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the bacterial cell membrane, or enhanced the release of potassium ions and nucleotides from the 
cells. Bacterial cell membrane integrity and permeability play crucial roles for bacterial survival 
and growth. Thus, any agent with the ability to destroy the bacterial cell membrane integrity 
and/or disrupt membrane permeability may cause bacterial cell damage, and even death. The 
rupture of bacterial cytoplasmic membrane easily impairs bacterial critical functions, which in 
turn affects bacterial survival and growth. In addition, it promotes the release of intracellular 
components such as potassium ions and nucleotides, which in turn diminishes bacterial ability 
to repair and replicate (Da Silva et al., 2014). 
The structure of the bio-active fraction IC10 from the methanolic extract of Imperata 
cylindrica L. was identified and assigned as quercetin, on the basis of its NMR and MS spectra, 
in comparison with the data available in the literature (Materska et al., 2014). Imperata 
cylindrica L. is used medicinally in traditional practices to treat bacterial infections, and 
helminths. It is also found effective in conditions like arthritis, diarrhoea, dysentery, gonorrhoea, 
cancer, diuretic, and restorative (Shankar & Aravind, 2015). The major active chemical 
constituents isolated from Imperata cylindrica L. includes carbohydrates, glycosides, 
flavonoids, and triterpenoids (Asolkar et al., 2005; Parvathy et al., 2012). It has been reported 
that Imperata cylindrica L. has some antibacterial properties (Harun et al., 2011; Parkavi et al., 
2012), and plenty of molecules are isolated and characterised from this plant (Wang et al., 1996; 
Rodriguez et al., 2005; Mohamed et al., 2009). Despite that, a detailed review of the literature 
showed that not much work has been done in finding out the best bio-active candidate of these 
molecules. Thus, further research should be done with determination of bioactivity of these new 
molecules which might yield a potential antibacterial agent.  
Quercetin is a polyphenolic molecule belonging to the flavonoid family of compounds, 
which are found inclusively in the aerial part of plants. Flavonoids are low-molecular-weight 
polyphenol substances generally composed of a three-ring structure, till now, more than 4000 
varieties of flavonoids have been identified (Table 6.4). Available reports tend to show that 
secondary metabolites of phenolic nature, including flavonoids are responsible for a variety of 
pharmacological activities (Shashank & Abhay, 2013; Batra & Sharma, 2013). 
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Table 6.4: Structure of flavonoids with some examples (Shashank & Abhay, 2013). 
Quercetin is one of the most abundant flavonoids which is widely exist in many parts of 
plants. Interest in quercetin within the scientific community has increased in recent years due to 
an increase in the popularisation of quercetin’s health benefits (Pawlikowska-Pawlega et al., 
2007). Many studies have shown that it may has a great potential for acting as anticancer (Feng 
et al., 2011), antioxidant (Mei et al., 2011; Mihaylova & Schalow, 2013), anti-inflammatory 
(Choi et al., 2012; Wang et al., 2012), cardiovascular protection (Perez-Vizcaino and Duarte, 
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2010) and antiviral (Johari et al., 2012). Many recent available studies have confirmed that 
quercetin has the ability to inhibit many types of bacteria. The results of these studies are in line 
with the results obtained in this study. Ragunathan (2015) and coworkers analysed the 
antibacterial properties and possible drug target of quercetin against Staphylococcus aureus. 
Eight protein molecules from Staphylococcus aureus belonging to various pathways for cell 
survivability were chosen. These protein molecules were docked with quercetin to find the most 
significant protein target. Their proposed mechanism of action for quercetin is the prevention of 
protein synthesis and folic acid synthesis. However, they stated that these identifications need 
further in-vitro validation before confirmation. 
In studies conducted by (Li and Xu, 2008; Woznicka et al., 2013; Maalik et al., 2014; 
Walid et al., 2015), the quercetin antibacterial activity has been evaluated. The results of these 
studies suggested that quercetin could be an alternative new antibacterial natural drug candidate 
to treat bacterial infections. Although these studies demonstrated a significant antibacterial 
activity of quercetin, the exact mechanism underlying the antibacterial activity for quercetin 
against tested bacteria remained unclear, and it needs to be subjected to further investigations. 
Moreno (2006) and coworkers reported that the antibacterial action of quercetin and other 
phenolic compounds might be related to inactivation of certain cellular enzymes proteins, which 
are responsible for bacterial membrane formation, by forming irreversible complexes. These 
changes lead to a changes in membrane permeability. Increased membrane permeability is a 
major factor in the mechanism of antibacterial action, where compounds may disrupt 
membranes and cause a loss of cellular integrity and eventual cell death. They stated that further 
studies need to be done to confirm their results. 
The structure of the bio-active fraction isolated from the methanolic extract of Morinda 
citrifolia L. (fraction MC4) was identified and assigned as aucubin, on the basis of its NMR and 
MS spectra, and in comparison with data available in the literature (Gutierrez, Rangel, & Baez, 
2008). Morinda citrifolia L. is considered a very rich source of biologically active 
phytochemicals, and a variety of chemical constituents have been identified in the leaves, bark, 
stem, flowers and fruits of the plant. Several classes of compounds have been isolated from 
Morinda citrifolia L., including, anthraquinones (Duduku et al., 2012), terpenoids (Saludes et 
al., 2002; Takashima et al., 2007), iridoids and their glycosides (Sang et al., 2003), and flavonol 
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glycosides (Serafini et al., 2011). Iridoid glycosides are one of the important active chemical 
group found in Morinda citrifolia L. These secondary metabolites have a significant role in the 
area of natural product chemistry and pharmacology, due to their diverse therapeutic efficacies. 
Several researches over the past years indicate their wide range of bioactivity including; 
anithepatotoxic, antiinflammatory, anticancer, antiviral, and antimicrobial (Dinda et al., 2007; 
Debnath et al., 2011; Bhakta et al., 2013).  
Aucubin is one of the iridoid glycosides isolated from Morinda citrifolia L. and many 
more medicinal plants (Barreto et al., 2007; Peng et al., 2010). Aucubin is an active component 
and has been reported in many studies, it has shown wide pharmacological activities. Aucubin 
pharmacological properties encompass a range of therapeutic effects, including; 
hepatoprotective (Chang, 1998), antioxidant (Hong-Yu et al., 2009), antiinflammatory (Maria 
et al., 1994), antispasmodic (Fleer and Verspohl, 2007), antimicrobial (Zheng et al., 2012), and 
promotion of dermal wound healing (Lee et al., 1999). 
The antibacterial activity of aucubin was reported in a few publications, Zheng (2012) and 
coworkers evaluated the antibacterial activity of aucubin extracted from Eucommia ulmoides 
leaves, the extracted aucubin could inhibit the growth of Escherichia coli and Staphylococcus 
aureus, however, aucubin presented weak inhibitory effect on Streptococcus pneumonia. Li 
(2009) and others, studied the antibacterial activity of the aucubin and 10 more compounds 
isolated from the leaves of Scrophularia ningpoensis. An in-vitro study against eight reference 
strains of bacteria, using the disc-diffusion method and micro-well dilution assay, revealed that 
aucubin had a good antibacterial activity against gram positive and gram negative bacteria. After 
a thorough search in the literature, no study has illustrated the aucubin antibacterial activity 
isolated from Morinda citrifolia L. The mechanism of aucubin action is also still unclear with 
no study available to illustrate it. Most of the published studies evaluated iridoid glucosides 
from medicinal plants as a complex material, with only few focused on the pure compounds, 
without any considerable efforts to illustrate the mechanism of its action. 
Although the bioactivity of the SA3 fraction, which was isolated from Sauropus 
androgynus L. has been demonstrated in this study, and discussed intensively in the previous 
chapter, the identification and the molecular structure of this fraction is still unknown for the 
time being. Due to the scale of this project, and some technical issues we have faced throughout 
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the study, we could not identify the SA3 fraction. However, it will be identified later, and will 
be subjected to more biological studies to reveal its antibacterial actions and its potential 
mechanism of action. 
5.4 Conclusion 
In this study, aucubin, was isolated from the separation of methanolic extract of Morinda 
citrifolia L., through the bioassay guided extraction, with a purity level of 97.65 %, it showed a 
significant potency as an antibacterial agent, and recorded the highest activity among other 
active fraction obtained from medicinal plants used in the present study. For this reason, aucubin 
has been chosen for the next step of this project to illustrate its mechanism of action. 
Staphylococcus aureus (MSSA) has been employed as a drug discovery model in the 
mechanistic studies, in the hope of finding a novel drug target to tackle the global problem of 
the antibiotic resistant in general, and the methicillin-resistant Staphylococcus aureus (MRSA) 
in particular. 
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7.1 Introduction  
In this study, aucubin was isolated from the methanolic extract of Morinda citrifolia L., 
through the bioassay guided extraction. As a result, aucubin, with a purity level of 97.65 %, has 
shown a significant potency to act as an antibacterial agent. It had the highest activity (Lowest 
MIC) amongst all active fractions of tested medicinal plants in this study. For this reason, the 
aucubin was selected for mechanism of action studies on Staphylococcus aureus (MSSA). It is 
essential to uncover the fundamental basis of the inhibitory mechanism, by which aucubin 
affects the bacterial growth. Hence, further experiments were conducted, aiming at the 
elucidation of the mechanism of action of aucubin.  
Drug targets are proteins or signal transduction pathways in which an external drug can 
interfere with normal cell activities. Common applications of proteomics in drug discovery 
include target identification and investigations into mechanisms of drug action. This study 
comprehensively analysed the global proteome changes of a susceptible Staphylococcus aureus 
(MSSA) strain, which was affected by the addition of the aucubin to the growth environment 
(see chapter 3/section 3.2.4). There are several approaches generally used for global proteomics 
quantitative profiling including gel electrophoresis and label-free LC-MS/MS total bacterial 
protein analysis. The gel-based separation techniques involve sodium dodecyl sulfate 
polyacrylamide gel (SDS-PAGE) to separate intact proteins or protein complexes followed by 
in-gel digestion of proteins into peptides for LC-MS/MS. SDS-PAGE separates denatured 
proteins depending on the charge and molecular weight. Proteins with low molecular weight 
migrate faster compared to high molecular weight proteins (John, 2002). 
Mass spectrometry (MS) based proteomics has the capability to study total proteins and 
their interactions in order to find significant new targets for future drug discovery. Current MS-
based proteomics technologies have advanced to the point where they are amenable to any 
biological system. With regards to bacterial organisms, they are particularly attractive models 
to apply proteomics based approaches due to their smaller proteomes and limited post 
transactional modifications compared to eukaryotes. This allows for comprehensive proteome 
coverage (Lee et al., 2015).  
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Recent improvements in high throughput and automation of LC-MS instruments and 
especially the development of novel algorithms dealing with LC-MS data have facilitated 
significant challenges in proteomics studies. Recently, there has been a growing interest towards 
label-free mass spectrometry based quantification in the field of proteomics. Following the 
advances in mass spectrometer technology, new techniques for data analysis evolve and new 
tools for quantification and pathway analysis are being developed. Pathway analysis is a rapidly 
developing discipline that combines software tools, database models, and computational 
algorithms, all of which help molecular biologists to convert molecular interaction data into a 
set of computational models. The models are developed for better prediction of cell behaviour 
in response to the drug or other outside stimuli (Pan et al., 2014). 
7.2 Results 
7.2.1 Label-free quantitative proteomics analysis 
Label-free quantitative proteomics was employed in this project to study the aucubin 
responses in Staphylococcus aureus. Although 2D-PAGE has some significant disadvantages 
such as the low load ability, difficulty in separation of hydrophobic proteins, and low 
reproducibility, the initial aim of the study was to apply the two-dimension gel electrophoresis 
to quantify only differentially expressed proteins in bacteria, and detect the most abundant 
proteins in control and treated samples. The reason for this is we tried to stay within the budget 
limit assigned for this project, as the MS analysis is too expensive for the total protein 
quantitation. Unfortunately, after many trials with 2D gel electrophoresis, we could not achieve 
the reproducibility, there was a lot of vertical and some horizontal streaking, even when the 2D 
cleanup kit was used. An example of the 2D-PAGE gels conducted in this study is available in 
the appendices. To tackle this problem, total bacterial protein quantification was employed 
instead. 1D SDS-PAGE was applied for protein separation (Figure 7.1). Bands were excised 
into a fresh siliconised Eppendorf tube with a fresh, clean scalpel blade, followed by In-Gel 
trypsin digestion (see chapter 3/section 3.2.4.5). 
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Figure 7.1: Image of 1D-SDS-PAGE separation of Staphylococcus aureus (MSSA) total 
proteins in two conditions; untreated cells, and treated cells with aucubin.  
Protein samples were solubilised using 2 x Final Sample Buffer then heated at 95ºC for 10 min and allowed to cool 
to room temperature prior to loading. 20 μl of protein marker was used. Separation was performed using 12 % 
polyacrylamide resolving gels and 4 % stacking gel. SE600 Standard Dual Cooled Vertical Unit (GE Healthcare) 
was used at 50 v for 15min then followed by 200 v. The gel was stained with Coomassie Brilliant Blue R-250 
(BioRad) and destined with destining solution. The gel was scanned using GS-800 Calibrated Densitometer (Bio-
Rad) and Quantity One image analyser software was used. 
Standard shotgun proteomics (bottom-up proteomics) technique were used to analyse the 
samples. The resulting peptides mixture, after tryptic digestion, were processed on ultra-high-
pressure liquid chromatography (uHPLC) coupled with mass spectrometry (MS) system 
(BioMicS, University of Sheffield, UK), (See chapter 3/section 3.2.4.6). Data-Dependent 
Acquisition (DDA) approach were applied in this study. The produced MS2 spectra were further 
analysed using Progenesis QI for proteomics software (v 4.1 with a trial license generously 
provided by Nonlinear Dynamics, Waters, UK). The raw data files were loaded into the software 
followed by automatic alignment using the default parameters as recommended by the developer 
(Di Luca et al., 2015). The software processed the raw data where each sample run was 
subjected to alignment, which involved aligning the data based on the LC retention time of each 
sample. This allows for any drift in retention time giving an adjusted retention time for all runs 
in the analysis. The sample run that yielded most features (i.e. peptide ions) was used as the 
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reference run, to which retention time of all of the other runs were aligned and peak intensities 
were normalised. Fractions were recombined at the end of the analysis (Figure 7.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2: Graphical views of the treated sample alignment used in Progenesis QI for 
proteomics software. (A) Ion intensity map, and (B) Total Ion chromatogram shows the 
automatic alignment (green) overlaid on the reference chromatogram (magenta).  
 
The resulting spectra were searched with Mascot engine (Matrix Science) against the 
Swissprot database for peak identification, followed by protein identification and quantification. 
Two different conditions of total bacterial proteome were analysed: untreated and treated group. 
Principal component analysis (PCA), was performed on Progenesis QI for proteomics software 
in order to observe the variation between sample groups (figure 7.3).  
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Figure 7.3: Biplot of Principal Component Analysis (PCA) analysis of MSSA proteome data 
sets. Control group on the left (purple), and aucubin treated group on the right (Blue). 
 
In this study, 827 and 795 quantifiable proteins were identified in Staphylococcus aureus 
(MSSA) in the treated and control group, respectively. Among these proteins, 743 proteins are 
common in both groups, 84 proteins (10.15 %) are unique for aucubin treated MSSA, and 52 
proteins (6.54 %) are unique for control group (Figure 7.4).  
 
 
 
 
 
 
 
 
 
Figure 7.4: Venn diagram of proteome comparison on control sample of Staphylococcus aureus 
(MSSA) and aucubin-treated MSSA. 
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Aligned runs were analysed to create a data set containing the information about all the 
signals identified in all sample runs. In order to compare relative protein level between control 
and treated Staphylococcus aureus proteome, the relative abundance of a protein was calculated 
after normalisation using Progenesis QI software. This was done by calculating the average of 
the integrated intensity of the most abundant peptides for each protein across all their peptide 
ions. In this study, all 1622 proteins were used to normalise the samples. Data was filtered 
according to the p-value ≤0. 05 and fold changes higher/lower than ±2 fold in order to rely on 
proteins that were confidently identified. A cutoff for at least three unique peptides per protein 
was applied (To ensure only high quality data contributed to the analysis). Using these criteria, 
results showed only 74 proteins were differentially expressed in aucubin treated MSSA 
compared with untreated, 47 of which were significantly upregulated and 26 were significantly 
downregulated (Full list of up/down regulated proteins is available in the appendixes). 
Furthermore, in order to obtain a general figure of the distribution of the differentially 
expressed proteins in the aucubin-treated Staphylococcus aureus (MSSA) cells, enrichment 
gene ontology (GO) analysis was undertaken through PANTHER (Protein Analysis Through 
Evolutionary Relationships) classification systems (Huaiyu et al.,2015), using the list of the 74 
differentially expressed proteins. Enrichment Gen ontology is an annotation database, where 
standardised term are grouped under three main ontologies; cellular component, biological 
process and molecular function. The ontology terms are assigned to individual proteins by 
collaboration with numerous databases. The gen ontology annotation database can easily be 
used to identify overrepresentation of proteins set to obtain initial insights in the sample 
characterisation (Burge et al., 2012). The analysis classified the differentially expressed proteins 
into several categories (Figure 7.5).  
According to the protein and gene annotation database available in PANTHER 
classification system, the molecular function classification (Figure 7.5 A) showed that the 
majority of the identified up/downregulated proteins (59.6 %) were categorised as enzyme-
related proteins and shown to have a catalytic activity which are involved in all aspects of cell 
metabolism, this includes the digestion of the large nutrient molecules (such as proteins, 
carbohydrates, and fats), the conservation and transformation of chemical energy, and the 
construction of cellular macromolecules from smaller precursors (Stephen & Hammes, 2003).  
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Figure 7.5: Gene ontology (GO) of the differentially expressed proteins in MSSA. 74 proteins 
were inputted into the PANTHER protein classification software, in order to determine the GO 
terms for (A) molecular function, (B) biological processes and (C) sub-cellular localisation. Pie 
charts are representations of the percentage of proteins within each classification. 
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An example of these enzymes, which were overexpressed in aucubin-treated MSSA are; 
hydrolase (enzymes catalysing hydrolysis of a variety of bonds, such as esters, glycosides, or 
peptides), dehydrogenase (enzyme that oxidizes a substrate by transferring hydrogen to an 
acceptor that is either NAD/NADP or a flavin enzyme.), glycosyltransferase (enzyme that 
catalyses the transfer of a sugar (monosaccharide) unit from a sugar nucleotide derivative to a 
sugar or amino acid acceptor), transaminase (A subclass of enzymes that catalyse the transfer 
of an amino group from a donor (generally an amino acid) to an acceptor (generally 2 keto 
acid)), and ligase (A class of enzymes that catalyse the formation of a bond between two 
substrate molecules, coupled with the hydrolysis of a pyrophosphate bond in ATP or a similar 
energy donor). This high percentage (59.6 %) of catalytic enzymes gives a hint that the aucubin 
might be involved in one or more of the metabolic process (cycles) in Staphylococcus aureus 
(MSSA) cells pathways. Binding proteins have a total share of (21.3 %), which includes nucleic 
acid binding proteins such as ribosomal protein, isomerase, and G-protein. Translation regulator 
activity proteins represent (6.4 %), whilst structural molecules and transporter proteins represent 
(4.3 %), in each group, of all 74 differentially expressed proteins. Antioxidant activity and 
receptor activity proteins represent only (2.1 %) in each group.  
By looking at the protein’s biological process classification results (Figure 7.5 B), the 
majority of differentially expressed proteins (67.4 %) related to bacterial metabolic process. A 
total of (19.6 %) is related to cellular processes proteins, an example of that is the aminoacyl-
tRNA synthetase enzyme (aaRS), which is an enzyme that attaches the appropriate amino acid 
onto its tRNA to form an aminoacyl-tRNA. Biological regulation and localisation represent (13 
%) of the differentially expressed proteins in each of them. The distribution of cellular 
component proteins classification (Figure 7.5 C) showed that the differentially expressed 
proteins fall into only two categories. (63.6 %) classified as macromolecular proteins and (36.4 
%) classified as cell part proteins. The general figure for the distribution of total bacterial 
proteins, in the aucubin-treated Staphylococcus aureus (MSSA) and untreated (MSSA) samples, 
are illustrated in figures (7.6 and 7.7). Enrichment gene ontology (GO) analysis was undertaken 
through the PANTHER classification systems and revealed that the majority of identified 
proteins in both groups were involved in the metabolic process of the cells, and mainly localised 
in the cytoplasm. Other proteins groups were distributed in all other parts of the cells with 
different functionality.  
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Figure 7.6: Gene ontology (GO) of total MSSA proteome in untreated sample. 795 proteins 
were inputted into the PANTHER protein classification software, in order to determine the GO 
terms for (A) molecular function, (B) biological processes and (C) sub-cellular localisation. Pie 
charts are representations of the percentage of proteins within each classification. 
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Figure 7.7: Gene ontology (GO) of total MSSA proteome in treated sample. 795 proteins were 
inputted into the PANTHER protein classification software, in order to determine the GO terms 
for (A) molecular function, (B) biological processes and (C) sub-cellular localisation. Pie charts 
are representations of the percentage of proteins within each classification. 
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7.2.2 Aucubin pathway analysis 
Pathway analysis is a rapidly developing discipline that combines software tools, database 
models, and computational algorithms, all of which help molecular studies to convert molecular 
interaction data into a set of computational models. The models are developed for better 
prediction of cell behavior in response to any external stress, such as an exposure to a drug. The 
development of pathway analysis was triggered by the expansion of high throughput methods 
in genomic/proteomic researches. Due to these technological advances, the emphasis of 
molecular biology has shifted from reductionism to system integration (Anton, 2008). 
Proteomics studies provide the data needed to perform the pathway analysis, by focusing on the 
generation of information about proteins, such as expression levels, interacting partners, PTMs 
and activity, all of which contribute to elucidate pathways active inside the cells, and ultimately, 
to a functional understanding of a biological system of living cells. The first and most important 
thing in the pathway analysis is to provide tools and infrastructure that facilitate building a 
pathway model for a giving set of data. These tools must enable adequate data exchange, 
automatic data integration, communication with central public depositories of pathways, and 
molecular interaction information for better understanding of any changing in cell functions 
(Dimitri & Eric, 2009). 
In the present study, the experimental data obtained from quantitative experiment of total 
bacterial proteome analysis, using a label-free proteomics approach, have shown an enriched 
subset of proteins, whose expressions were increased/decreased in the presence of aucubin in 
the growth environment. All of the differentially expressed proteins might be involved in the 
aucubin inhibitory action in Staphylococcus aureus (MSSA). A comprehensive Gene Ontology 
(G.O.) and enriched pathways analysis of the protein functions was performed and predicted by 
DAVID software (Database for Annotation, Visualization and Integrated Discovery, V. 6.7) 
(Huang et al., 2009), given the set of differentially expressed proteins in aucubin treated 
(MSSA). This analysis gives a deeper insight into the mechanism of inhibitory action of 
aucubin.  
DAVID, is a web based software suite designed to categorise complex, high content, 
genomic and proteomic data sets. It comprises a set of functional annotation tools allowing the 
user to examine the biological meaning behind large list of genes, with common outputs from 
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DAVID including identification of overrepresented biological pathways, visualisation of gene 
lists overlaid onto KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway maps, and 
identification of interacting proteins. An advantage of DAVID is its intend to address several 
issues that other tools have not been able to extensively address; (i) to dramatically expand the 
biological information coverage in the DAVID knowledgebase by comprehensively integrating 
more than twenty types of major gene/protein identifiers and more than forty well-known 
functional annotation categories from dozens of public databases; (ii) to address the enriched 
and redundant relationships among many genes by developing a set of novel algorithms, such 
as the DAVID Gene Functional Classification Tool and the Functional Annotation Clustering 
Tool (iii) to dynamically visualise genes from a user’s list within the most relevant KEGG 
pathways with the DAVID Pathway Viewer (Huang et al., 2007). 
Initially, data subset of the (74) differentially expressed proteins in aucubin treated MSSA, 
were obtained from quantitative proteomics analysis with Progenesis QI for proteomics 
software, out of 827, were subjected to the pathway enrichment analysis by the DAVID pathway 
enrichment tools. The analysis was performed by uploading the differentially expressed protein 
list to DAVID gene analysis tools, which automatically searched for the matched protein IDs 
within the its protein library. If a significant portion (>20 %) of input gene IDs fail to be mapped 
to an internal DAVID ID, a specially designed module (DAVID Gene ID Conversion Tool) will 
start up automatically in order to help map such IDs. This feature enables input gene ID to be 
mapped across the entire database, thus providing comprehensive coverage of gene associated 
annotation. The search retrieved 70 differentially expressed protein hits.  
Subsequently, all identified proteins (up/down regulated) were analysed with enrichment 
analysis tool by setting up Staphylococcus aureus as an analysis background. The principle 
foundation of the enrichment analysis is that if a biological process is abnormal in a given study, 
the co-functioning genes should have a higher potential (enriched) to be selected as a relevant 
group by the high-throughput screening technologies. To decide the degree of enrichment, a 
certain background must be set up (MSSA in this study) in order to perform the comparison, 
and therefore decide if the enriched proteins played any important roles in the study (Huang et 
al., 2009). The resulting pathways list was filtered by using a minimum of 2-fold enrichment 
and p value ≤ 0.01 for the enrichment of data output (Da-Wei et al., 2009). The significant 
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enriched pathways predicted by DAVID (given the set of differentially expressed proteins in 
aucubin-treated MSSA) are summarised in (Table 7.1). These pathways might be the possible 
pathways involved in aucubin mechanism of action. 
Table 7.1: Pathway enrichment analysis by DAVID of the differentially expressed proteins in 
aucubin-treated MSSA compared with its untreated control. Fold enrichment of >2 was 
considered as significant. 
In this study, aucubin isolated from Morinda citrifolia L. was used as an antibacterial to 
study its effect on Staphylococcus aureus (MSSA). Under this condition, aucubin-treated MSSA 
has activated some potential pathways to tolerate the drug and allow the cells to continue 
growing. Proteins that are differentially expressed in MSSA are potentially important as a 
generic tolerance response to the aucubin. We found that seven up-regulated pathways/proteins 
were identified by DAVID for these 70 differentially expressed proteins which matched with a 
DAVID genomic library. The pyruvate metabolism pathway (Figure 7.8) showed the highest 
enrichment score (6.22) with six abundant enzymes involved in this pathway; acetate kinase 
[EC 2.7.2.1], dihydrolipoyl dehydrogenase [EC 1.8.1.4], phosphate acetyltransferase [EC 
2.3.1.8], probable malate: quinone oxidoreductase 2 [EC 1.1.5.4], pyruvate dehydrogenase E1 
component subunit alpha [EC 1.2.4.1], and pyruvate kinase [EC 2.7.1.40], these enzymes are 
Up-regulated Pathways 
Pathway Protein count Enrichment  P value 
Pyruvate metabolism 6 6.22 ≤ 0.01 
Glycolysis / Gluconeogenesis 5 4.47 ≤ 0.01 
Valine, leucine and isoleucine biosynthesis 4 3.6 ≤ 0.01 
Aminoacyl-tRNA biosynthesis 5 3.1 ≤ 0.01 
Purine metabolism 4 2.86 ≤ 0.01 
Citrate cycle (TCA cycle) 3 2.42 ≤ 0.01 
Propanoate metabolism 3 2.34 ≤ 0.01 
Down-regulated Pathways 
Pathway Protein count Enrichment P value 
Ribosome 4 3.66 ≤ 0.01 
Pyrimidine metabolism 3 2.52 ≤ 0.01 
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encoded by the genes; ackA, pdhD, pta, mqo2, pdhA, and pyk, respectively (Zoraghi et al., 
2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.8: Pyruvate metabolism pathway showing the up-regulated genes in aucubin-traded 
MSSA relative to control MSSA. The underlying KEGG pathway was generated by DAVID 
and components of the pathway containing enriched genes are indicated by red stars. 
 
The glycolysis/gluconeogenesis pathway (Figure 7.9) showed the second highest 
enrichment score (4.47) with five abundant enzymes from this pathway involved; enolase [EC 
4.2.1.11], L-lactate dehydrogenase1 [EC 1.1.1.27], phosphoglycerate kinase [EC 2.7.2.3], 
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pyruvate dehydrogenase E1 component subunit beta [EC 1.2.4.1], and dihydrolipoyl 
dehydrogenase [EC 1.8.1.4], these enzymes are encoded by the genes: eno, IctE, pgk, phdB, and 
pdhD, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.9: Glycolysis/gluconeogenesis metabolism pathway showing the up-regulated genes 
in aucubin-traded MSSA relative to control MSSA. The underlying KEGG pathway was 
generated by DAVID and components of the pathway containing enriched genes are indicated 
by red stars. 
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In the valine, leucine and isoleucine biosynthesis and   purine metabolism pathways, four 
enzymes were involved. Whilst in the citrate cycle (TCA cycle) and propanoate metabolism 
pathways, three abundant enzymes were involved. Finally, five abundant enzymes were 
involved in the aminoacyl-tRNA biosynthesis pathway. Other than these pathways, there were 
a few efflux pump proteins detected when the stringency of the analysis being reduced. Several 
studies have suggested that the increase in the efflux pump protein expression is a natural 
activity response of bacterial cells to transport antibiotics out to the intracellular space to help 
cells survive the antibiotic treatment (Piddock, 2006). Two down-regulated pathways/ proteins 
detected in aucubin-treated MSSA, the first one is the ribosome, with an enrichment score of 
(3.66), four proteins were involved in this pathway; 30S ribosomal protein S11, 50S ribosomal 
protein L16, 50S ribosomal protein L29, and 50S ribosomal protein L6. These proteins are 
encoded by the genes: rpsK, rplP, rpmC, and rplF respectively. The second down regulated 
pathway is the pyrimidine metabolism, three enzymes were involved in this pathway way: 
bifunctional protein pyrR, carbamoyl-phosphate synthase large chain, and DNA-directed RNA 
polymerase subunit beta. These enzymes are encoded by the genes: pyrR, carB, and rpoB, 
respectively. A comprehensive list of enzymes/proteins involved in all pathways is available in 
the appendices. 
7.3 Discussion 
Proteins are vitally important components of organisms, which are responsible for 
executing the biological functions, and play important roles in the biological pathways. The 
whole set of proteins in the organism is called proteome, and the large-scale study of all the 
proteins in the organism is called proteomics. Proteomics is involved in different aspects of 
proteins, including protein identification, quantitation, post-translational modification (PTMs), 
structure and protein-protein interaction, and others. (Droit, Poirier, & Hunter, 2005). In recent 
years, label-free quantitative proteomics have become an emerging area, as an alternative to the 
conventional isotopic labelling approach. The scientific world has witnessed tremendous 
progress in this field. Remarkable developments in the state of art MS instrumentation, 
analytical workflows, and data analysis software have made proteomics an important tool for 
answering biological questions. Recently, proteomics has expanded from mere protein profiling 
to accurate and high-throughput protein quantification. With the appearance of a powerful MS 
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fragmentation technology, and the gradual shift from the gel-based to the MS-based proteomics, 
some entirely new methods has become available for quantitative comparisons (Ying et al., 
2015). 
Nowadays, proteomic studies no longer focus only on identifying as many proteins as 
possible in a given sample, but aim for an accurate quantification of them. Especially in clinical 
proteomics, the investigation of variable protein expression profiles can yield useful information 
on pathological pathways or biomarkers and drug targets related to a particular disease. Over 
time, many quantitative proteomic approaches have been established allowing researchers in the 
field to refer to a comprehensive toolbox of different methodologies (Megger et al., 2013). Due 
to these technological advances, quantitative proteomic approaches have become a lead solution 
in medical research, with applications in fields such as cancer research (Gamez-Pozo et al., 
2015), clinical research (Zhang et al., 2015), antibiotic research (Liu et al., 2014), malaria 
(Lindner et al., 2013), and cardiovascular disease (Mirza, 2012). These are but a few of the 
many examples where proteomic approaches have been used in valuable quantitative proteomic 
studies.  
In this study, shotgun proteomics approach, also known as “bottom-up” proteomics, was 
employed. This method is currently the most widely applied workflow in proteomics nowadays. 
It begins with the extraction of the whole set of proteins from the sample of interest. Typically, 
microgram to milligrams of proteins need to be extracted from the cells or tissues for the protein 
analysis. Following the protein extraction, both in solution and in gel digestion can be applied. 
In our workflow, proteins were separated by one-dimensional gel electrophoresis followed by 
the in gel digestion, and the whole protein gel bands were analysed. The digested peptides were 
collected and the LC-MS/MS analysis was performed. Gilmore & Washburn (2010), indicated 
that shotgun proteomics allows global protein identification as well as the ability to 
systematically profile dynamic proteomes. It also avoids the modest separation efficiency and 
poor mass spectral sensitivity associated with intact protein analysis, “top-down based 
proteomics”. However, comprehensive proteomic analysis remains challenging specially with 
mass-limited samples. Shotgun proteomics is a continually changing field to address emerging 
obstacles (Feist & Hummon, 2015).  
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Data dependent acquisition (DDA) has been employed in our study, where the MS picked 
up the most intense peaks (corresponding to more abundant peptide ions) from the MS1 scan to 
fragment and acquire MS2 spectra for those peaks. In this way, the instrument is sampling 
peptide peaks for sequencing, same intense peaks sampling can be avoided by setting the MS to 
exclude the same peak for MS2 during a certain time period after the peak is fragmented (Zhu, 
Chen & Subramanian, 2015). On the other hand, Gillet and co-worker (2012), reported that data 
independent acquisition (DIA) is utilised more typically in targeted proteomics workflows. In 
this method, a wider m/z window in the MS1 scan selected to be fragmented. All the peptide 
precursors within the mass window will be fragmented together to get a complicated MS2 
spectra, even rare peptides will be fragmented and can potentially be detected. Researcher must 
be aware when selecting this method as the data analysis is quite challenging. 
As mentioned before, this study utilised label-free quantitative proteomics approach, 
rather than metabolic labeling approach, to study the Staphylococcus aureus (MSSA) proteome 
changes when treated with aucubin as an alternative antibiotic, and to illustrate the mechanism 
of aucubin action. The two main strategies for label-free quantification are peak area (or ion 
intensity) and spectral counting approach. The first one relies on the comparison of 
chromatographic peak intensities across multiple consecutive LC-MS runs. The second 
estimates relative protein abundance based on the number of relevant peptide fragment MS/MS 
spectra. Karpievitch and co-workers (2009), stated that spectral counts are easy to collect and 
do not require peak area integration like spectral peak analysis or label-based methods. It was 
found that relative protein abundance is mostly correlated with spectral counts when compared 
to other factors such as sequence coverage and peptide number. Lundgren and co-worker (2010), 
indicated that spectral counting method is especially suitable for low mass resolution data, for 
which intensity-based quantification is less reliable due to the difficulty in LC-MS alignment 
and peak integration. They mentioned another advantage of spectral counting over peak area 
which lies in the limited software requirements, whereas peak area needs very sophisticated 
computational algorithms to handle the LC-MS data for feature detection and peak alignment. 
On the other hand, Zhou, Liotta, & Petricoin (2012), argued that the reliability of final results 
strongly depends on peptide identification. In addition, the quality of inferred protein abundance 
depends on software and parameters used for MS/MS acquisition as well as on post-processing 
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of spectral counts. Moreover, spectral counting methods tend to be less accurate and have 
smaller dynamic range than intensity-based based approach. 
Intensity-based quantitation measures the precursor ion intensities or areas belonging to a 
particular protein, and compares the relative quantitation based on the intensities or areas. This 
method will greatly rely on the MS alignment due to the retention time shift between injections. 
The MS alignment will align the peaks and ascertain the reproducibility of the LC-MS runs 
(Zhang et al., 2013). There are different ways and programs, which can perform LC-MS 
alignment. Progenesis QI for proteomics is one of the LC-MS alignment softwares that have 
been used in this project. This tool aligns different runs to compensate for between-run variation 
in the LC separation technique. This results in increased reliability and precision of peak picking 
and peptide abundance measurements. To ensure consistent peak picking and matching across 
all data files, an aggregate data set was created from the aligned runs. This contains all peak 
information from all sample files, allowing the detection of a single map of peptide ions. This 
map is then applied to each sample, giving 100 % matching of peaks with no missing values, 
enabling users to apply multivariate statistical tools to explore the data and measure differential 
analysis. The peak picking algorithm handles complex samples and can discern overlapping 
peptide ions. Then, the survey scan data is used for ion abundance quantification (Oveland et 
al., 2015). 
This study employed label free quantitation based on signal intensity data, to obtain a 
global view of the altered protein expression in treated MSSA with aucubin. Some literature 
suggested that signal intensity data is more robust than spectral counting, as spectral counting 
does not consider retention time, and spectral counting method struggles to assign peptides when 
they are present in more than one protein (Elliott et al., 2010). On the other hand, missing 
peptides are common in MS-based proteomic data according to Karpievitch and co-workers 
(2011), who mentioned that it is common to have 20 % of all attempted intensity measures 
missing. Abundance measurements are missed if a peptide was identified in some samples but 
not in others. This can happen because the peptide is present in low abundance, and in some 
samples the peak intensities are not high enough to be detected or for the corresponding ions to 
be selected for MS/MS fragmentation, another reason is that peptides whose chemical or 
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physical structure cause them to get trapped in the LC column, among others. Therefore, a robust 
LC-MS application is required when using this method (Cappadona et al., 2012).  
Proteomics technologies have been successfully applied to investigate differences in the 
protein expression profiles of cells grown under a different spectrum of growth conditions and 
with different stress factors including antibiotics treatment. The evaluation of protein profiles in 
response to multiple stress mechanisms, such as sensitivity to antibiotics or modifications 
related to antibiotic resistance, could represent a valid and integrating approach for the 
development of new therapeutic strategies (Sleno & Emili, 2008). 
Bandow and co-workers (2003), used proteomics approach to elucidate the complex 
cellular responses of Bacillus subtilis to antimicrobial compounds belonging to classical and 
emerging antibiotic classes. They established their investigation on two-dimensional gel 
electrophoresis. A comprehensive database of cytoplasmic proteins with pIs covering a pH 
range of 4 to 7 were synthesised during treatment with antibiotics or agents known to cause 
generalised cell damage. They suggested that novel compounds with unknown mechanisms of 
action may be classified, as each antibiotic showed an individual protein expression profile, and 
overlaps in the expression of marker proteins reflected similarities in molecular drug 
mechanisms. They concluded that proteomics technique gives new insights into the bacterial 
response toward antibiotics and hints at modes of action of novel compounds. Such a method 
should prove useful in the process of antibiotic drug discovery. 
The complete sequencing of the genomes of many pathogenic bacteria has led to an 
explosion in the knowledge about these organisms on the molecular bases (Monaghan and 
Barrett, 2006). The first whole bacterial genome to be sequenced was Haemophilus influenzae 
in 1995 (Fleischmann et al., 1995). Since then, hundreds of bacterial genomes have been 
completely sequenced, yielding a massive amount of new information. Genomics, which is the 
infrastructure of the proteomics, is used to select potential antibacterial targets and can also be 
used to provide insights into pathogenesis and antibiotic resistance (Coates & Hu, 2007). An 
antibacterial target may be the receptor of a ligand in a bacterial molecule, a specific function 
of a bacterial molecule such as an enzyme, or a metabolic pathway. Target identification is 
achieved in a variety of ways, but the main principle is that the target should not be shared with 
the human host, should be present in those bacteria that cause the disease for which a cure is 
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needed, and if removed or inhibited leads to the death of the bacteria (essentiality) (Bakheet & 
Doig, 2010).   
Recent studies conducted by Shatalin et al (2011) and Belenky & Collins (2011), have 
shown that when bacteria are exposed to an antibiotic, the defences in the bacteria are much 
more complicated than previously believed, affecting not only proteins directly involved in the 
target or specific resistance proteins, but also proteins with no apparent relationship to the 
antibiotic. It is reported that antibiotics can produce more oxidative stress on the cells, and in 
return, combating this stress is a general bacterial response to the antibiotics. Fajardo and 
Martinez (2008); Laubacher and Ades (2008), have employed a transcriptomics approach to 
study the global mRNA changes of bacteria related to antibiotic resistance, they have revealed 
that antibiotics can trigger a wide-ranging of transcriptional responses, including many 
metabolic or signal transduction pathways. These results support the idea that bacterial 
responses to antibiotics involve many different pathways and complicated networks, and should 
be examined from a global point of view. In this point of view, bacterial cells respond to 
antibiotic damage by regulating its metabolic pathways globally to repair the damage caused by 
antibiotic stress. Furthermore, bacteria that survive the antibiotic treatment will develop 
persistent adaptive responses over time, which eventually lead to resistance (Burchmore, 2014). 
The knowledge gained from such transcriptomics and proteomics studies can potentially provide 
new insights into the key players in the antibiotic response of the bacteria, and give a new hope 
for developing a new antibiotic with a potentially new pathway to cope with the uprising 
resistance. 
In three studies conducted by Bonar et al. (2015); Vranakis et al. (2014); and Lima et al. 
(2013) they have reviewed the research applied on proteomics to investigate bacterial response 
to different antibiotics. The vast majority of studies have shown that bacterial responses to 
antibiotic damage are not limited to a few molecular targets but directly related to the known 
antibiotic resistance mechanisms, the effect was global inside the cells. No matter what classes 
of antibiotics were used, large number of proteins involved in various pathways were 
differentially regulated in the presence of antibiotics. Such studies proved that proteomics can 
potentially provide a more comprehensive picture of bacterial responses to antibiotics, and the 
pathways that are responsible for the observed inhibition. 
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Since the first genome sequence of Staphylococcus aureus was published (Makoto et al., 
2001), proteomics has been applied to study the mechanism of antibiotic actions, along with the 
resistance mechanisms. Among the 2600 proteins in Staphylococcus aureus, about 1000 show 
no homology to proteins in other organisms with known functions, and about third of these 
proteins are likely to be a novel virulence factor (Hecker et al., 2010). Most of the proteomics 
studies on Staphylococcus aureus employed 2D-PAGE proteomics to investigate antibiotics 
resistance mechanisms, Singh et al. (2001) studied the antibiotic effects on Staphylococcus 
aureus, and nine proteins were found up-regulated and five of them were identified. Pieper et 
al. (2006), had combined 2-DE gels with MS and identified 65 overexpressed proteins in the 
presence of vancomycin. Fischer et al. (2011), employed transcriptomics and comparative 
proteomics to study the daptomycin and vancomycin mechanism of action on Staphylococcus 
aureus. Liu et al. (2014), investigated how the Staphylococcus aureus respond to antibiotic 
stress. They have applied a shotgun proteomics with spectral counting-based label-free 
quantitative proteomics. 81 proteins were shown differentially expressed in the presence of 
oxacillin, 65 were up-regulated and 16 were down-regulated proteins. The peptidoglycan 
biosynthesis pathway, pantothenate pathway, and CoA biosynthesis pathway were found to be 
up-regulated, along with a series of energy metabolism pathways. 
Based on the knowledge of the most successful antibiotic classes, the ideal drug target 
should be an enzyme with a critical function in a biochemical pathway of central importance to 
the bacterial cell. In the search for novel antibiotics for which there is no pre-existing resistance, 
an obvious starting point is to identify novel targets. Proteomics approach have been utilised to 
identify genes coding for potential essential target functions in relevant pathogen species. The 
ultimate aim is to identify novel and essential targets (not targeted by currently used antibiotics) 
present in most interesting pathogens, whose inhibition will not risk collateral damage to the 
human host. However, there are several cautions and fine points to consider before limiting the 
search for novel drug hits to what might be a very short target list (Hughes & Karlen, 2014).  
Novel targets are not always obvious, for instance, tetracyclines, and aminoglycosides, 
each of which interacts directly with the ribosome to inhibit protein synthesis. However, 
resistance to any one of these antibiotic classes, at the level of alterations to the structure of the 
ribosome, does not give resistance against either of the others, because the targets at the 
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molecular level are different. The ribosome is a large and complex machine, and the actual 
targets for each antibiotic class are structurally distinct (Laureti, Matic, & Gutierrez, 2013). The 
essential features required in a novel antibiotic target interaction are that it should inhibit 
bacterial growth (and preferably be bactericidal) that it should not be affected by existing 
resistance mechanisms, and that it should be available in a wide range of key bacterial 
pathogens. Avoiding targets present in human cells also comes with an important caution 
(Davies & Davies, 2010). 
In our study, the ultimate aim was to investigate the aucubin-treated Staphylococcus 
aureus (MSSA) proteome to reveal the cellular responses and the potential pathways of this 
antibacterial candidate. More than one pathway was detected in the overrepresentation 
enrichment pathway analysis using DAVID enrichment tool. Among the seven upregulated 
pathways, the highest enrichment score detected with pyruvate metabolic pathway (Figure 
7.10), and six enzymes were involved as a response to the aucubin treatment, 
glycolysis/gluconeogenesis pathway came second in the enrichment test with five enzymes 
involved, followed by valine, leucine and isoleucine biosynthesis pathway. Four more pathways 
were detected with lower enrichment scores. Two downregulated pathways were detected: 
ribosome with five proteins involved, and pyrimidine metabolism with three proteins involved 
in this pathway.  
These pathways targeting mainly bacterial central metabolism. Researchers in this field 
are desperately trying to target this route, as an alternate to the conventional antibiotic targets, 
which they act on by inhibiting a limited spectrum of cellular processes essential during 
logarithmic growth. Giving the fact that all bacteria must utilise the energy sources in their 
environment in order to produce ATP (adenosine triphosphate), where ATP is required for all 
of the biosynthetic processes that bacteria use for their maintenance and reproduction. Bacterial 
central metabolism pathways could be the target of the next generation of antibiotics to combat 
the worldwide explosion of drug resistance (Stuart, 2015). In the pyruvate metabolism pathway, 
which showed to be up regulated in the overrepresentation enrichment pathway analysis, of the 
aucubin treated cells, the enzymes involved are: acetate kinase, dihydrolipoyl dehydrogenase, 
phosphate acetyltransferase, malate: quinone oxidoreductase 2, pyruvate dehydrogenase E1 
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component subunit alpha, and pyruvate kinase. These enzymes encoded by the genes ackA, 
pdhD, eutD, mqo2, pdhA, and pyk respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.10: Schematic representation of the pyruvate metabolic pathways in Staphylococcus 
aureus. Pyruvate is metabolised to Acetyl-CoA via PDH complex, which is formed by four 
protein subunits (PdhA, -B, -C, and -D) or reduced to lactate or to butanediol via acetolactate 
and acetoine. Acetyl-CoA is either funneled into the tricarboxylic acid cycle (TCA), used for 
various biosynthetic pathways, or hydrolysed to form free acetate. 
 
Six enzymes showed to be upregulated in the overrepresentation enrichment pathway analysis of aucubin-treated 
Staphylococcus aureus (MSSA). The involved enzymes marked in red.  (ackA) Acetate kinase, (pdhD) 
Dihydrolipoyl dehydrogenase, (pta) Phosphate acetyltransferase, (mqo2) Probable malate: quinone oxidoreductase 
2, (pdhA) Pyruvate dehydrogenase E1 component subunit alpha, and (pyk) Pyruvate kinase. 
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Pyruvate kinase (EC 2.7.1.40) catalyzes the final step in glycolysis with the irreversible 
conversion of phosphoenolpyruvate (PEP) to pyruvate with the concomitant phosphorylation of 
ADP to ATP. As pyruvate kinase plays a major role in the regulation of glycolysis, its inhibition 
leads to the interruption of carbohydrate metabolism and energy depletion. Moreover, both the 
substrate and the product of this reaction feed into a number of biosynthetic pathways, placing 
pyruvate kinase at a pivotal metabolic intersection. Pyruvate kinase in Staphylococcus aureus 
possesses different kinetic properties and regulatory mechanisms than do human isozymes 
(Vander et al., 2010). These differences can be attributed to differences in protein sequences 
and structures. (Zoraghi et al., 2011). 
The first step in the oxidation of pyruvate is an oxidative decarboxylation reaction. This 
reaction is carried out by a very large enzyme complex, the pyruvate dehydrogenase complex 
(PDHC) (EC 1.2.1.4). The reaction catalyzed by the pyruvate dehydrogenase complex is 
irreversible, and is tightly regulated. The pyruvate dehydrogenase complex is closely related to 
the a-ketoglutarate dehydrogenase complex (an important TCA cycle enzyme) and to the 
branched chain a-ketoacid dehydrogenase complex (an important enzyme in the metabolism of 
leucine, valine, and isoleucine). The protein complexes of this family contain three main 
enzymes: E1, E2, and E3. The same E3 gene is used for each of enzyme complexes, while the 
E1 and E2 genes are specific to the different types of substrate (Vilhelmsson & Miller, 2002). 
The pyruvate dehydrogenase complex is inhibited by acetyl-CoA, which is the product of the 
reaction, and can also be inhibited by nicotinamide adenine dinucleotide (NADH). This enzyme 
can be produced by fatty acid breakdown in another route (Patel & Korotchkina, 2006). 
Acetate kinase (EC 2.7.2.1) is another enzyme found to be upregulated in this study which 
involved in the pyruvate metabolism. It is a conserved enzyme that is widespread in bacteria, it 
is responsible for the phosphorylation of acetate (Lawrence & Ferry, 2006). Since acetyl 
coenzyme A is a precursor of fatty acid synthesis, it is acceptable that primary cellular growth 
depends on the activation of acetate through the process of intracellular phosphorylation. 
Acetate kinase has different roles in bacteria, bacteria use acetate kinase for energy generation 
by converting ADP and acetyl phosphate to ATP and acetate (Asgari et al., 2013). This enzyme 
is present in prokaryotic organisms and some eukaryotic organisms e.g. parasites, but absent in 
mammals. For that reason, it has been reported as an attractive drug target for the development 
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of new antibiotic drug (Yadav et al., 2012). The importance of targeting the pyruvate 
metabolism pathway steams from the fact that it is located at a major junction of assimilatory 
and dissimilatory reactions which make it vital pathway for the cells to survive.  
 
7.4 Conclusion 
In summary, current study suggested that more than one pathway being alerted in the 
presence of aucubin, whereas the pyruvate metabolism, upregulated, showed the highest 
enrichment score in the pathway analysis and might be the main route for the drug. Our results 
come in line with many studies (Liu et al., 2014; Lima et al., 2013), these studies indicated that 
bacterial responses against antibiotics involved many pathways other than the main drug 
pathway, as bacterial cells trying to overcome the antibiotic stress which causes some vital 
routes to be inhibited. This study has suggested several important clues in explaining the mode 
of action by which aucubin exert its inhibitory activity against Staphylococcus aureus, and 
confirmed the antibacterial activity of aucubin from natural sources. This project is the first to 
apply label-free quantitative proteomics to study natural antibacterial candidate and illustrate 
the response in Staphylococcus aureus. These new data offer a more complete view of the 
proteome changes in bacteria in response to the antibiotic. Data obtained from the pathway 
analysis will be subjected to some validation methods so it can be confirmed. 
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8.1 General conclusions  
In the field of drug discovery, natural products (secondary metabolites) have been the 
most successful source of potential drug leads. The use of natural products as medicines has 
been described throughout history in the form of traditional medicines, remedies, and oils with 
many of these bio-active natural products still being unidentified. Natural product drug 
discovery leading to robust and viable lead candidates remains a challenging scientific task, 
which is the transition from a screening hit to a drug candidate, the task requires expertise and 
experience. However, the development of new technologies has revolutionised the screening of 
natural products in discovering new drugs. Applying these technologies compensates for the 
inherent limitations of natural products and offers a unique opportunity to re-establish natural 
products as a major source for drug discovery (Dias, Urban, & Roessner, 2012). The present 
study attempted to describe the utilisation of bio-active compounds, derived from natural 
resources, as an antibacterial candidate, with a focus on the most active candidate to illustrate 
its mechanism of action. 
Natural products have been a rich source of antibiotic drugs for many decades, but 
investments in this area have declined over the past three decades. Of all the drugs currently 
approved as antibacterial agents, a significant percentage of those are either natural products 
themselves or derived from a natural product scaffold. Although the discovery of antibiotics is 
one of the biggest medical breakthroughs of the twentieth century, it was immediately followed 
by the unfortunate emergence of bacterial antibiotic resistance. The rapid rate of bacterial 
evolution to overcome the antibiotic action, the ability of a single pathogen strain to resist 
multiple drugs, as well as the stunning frequency of resistance occurring constitute a major 
challenge to the medical profession, and thus raised retrospective discussions of currently 
existing antibiotics. In spite of the fact that there are hundreds of antibiotics on the market, it 
remains a fact that almost all existing antibiotics target only four cellular functions: protein 
synthesis, nucleic acid synthesis, cell walls synthesis or folate synthesis. Repetitively striking 
the same cellular sites leads to defensive bacterial gene mutation, which remains the primary 
cause of the prevalence of antibiotic-resistant bacteria. 
The problems with the antibiotic resistant bacterial pathogens that it became a 
significantly worrying issue and costs thousands of lives if not millions, all around the globe. 
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The latest figures showed that by 2050, the lack of an effective antibiotics will claim 10 million 
people each year, and most of them from the poor countries. For this reason, the World Health 
Organisation (WHO) has called for an immediate action to address this major issue. The current 
shortage of effective antibiotics is not simply a biological problem (evolution of resistance), or 
even a social problem (misuse of antibiotics), but is in large part the result of a long-term lack 
of investment in discovery and development programmes by the large pharmaceutical 
companies. There are currently very few antibiotics in late-phase clinical trials, and nearly all 
of these belong to existing classes. The reasons for this investment gap in novel classes are 
complex, but they are associated with a lack of confidence on the part of the pharmaceutical 
industry in the relative profitability of antibiotics. However, this may be about to change with 
the help of public/private partnership programmers, like the recently launched EU Innovative 
Medicines Initiative (New Drugs 4 Bad Bugs, ND4BB) programme, which represents an 
unprecedented partnership between industry, academia and biotech organisations to combat 
antibiotic resistance in Europe, and eventually in the world, by tackling the scientific, regulatory, 
and business challenges that are hampering the development of new antibiotics. 
This study has been conducted as a contribution to addressing the uprising resistance 
problem, the main focus of this study was on the exploration of Centella asiatica L., Imperata 
cylindrica L., Morinda citrifolia L., and Sourpuss androgynous L.  to pursue the search for new 
antibacterial candidate of natural compound. This was done through a bioassay-guided isolation 
and purification protocols. Initially, the plants were extracted using Soxhlet and maceration 
techniques, to obtain soluble containing materials, as the main constituents of the crude extracts. 
The plant extracts were subjected to the bioscreening test against Gram positive and Gram 
negative bacteria. Upon the initial screening, further isolation and purification procedures were 
performed using an advance chromatography technique (HPLC), in order to purify the most-
active compounds that represent the final candidates of natural product. Finally, this study has 
employed further spectroscopy and label free proteomics studies, in an effort to identify the 
structure of most active components, and illustrate the fundamental principles of the mechanism 
of action of the most active one among them. 
Initial bioscreening tests conducted on the four medicinal plant extracts, the test indicated 
that these extracts have a potency as antibacterial candidate. Methanolic extracts were proven 
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to exhibit the highest potency in inhibiting bacterial growth, and the Gram positive strains were 
the most sensitive ones. Chromatography techniques have applied on methanolic extracts, 
because it showed the highest activity, and collected fractions underwent the bioscreening test 
to reveal the most active fractions against tested bacterial strains. The spectroscopy techniques 
resulted in the identification of asiatic acid from Centella asiatica (L., quercetin from Imperata 
cylindrica L., and aucubin from Morinda citrifolia L. The active fraction of Sourpuss 
androgynous L. yet to be identified. Aucubin demonstrated the highest activity with lowest MIC 
against tested strains, for this reason, it has been chosen to illustrate its mode of antibacterial 
action. Aucubin, is found in a number of medicinal plants and known for its biological activities. 
However, until recently, only few studies have reported its antibacterial properties, and little 
progress has been made with regards to the exploration of aucubin fundamental antibacterial 
activity. Moreover, all the past studies are limited to demonstrate its MIC values only. 
Accordingly, to the best of our knowledge, current study was the first to discover the 
antibacterial activity of aucubin isolated from Morinda citrifolia L.  with an illustration of its 
potential mechanism of action. Moreover, many other active compounds were isolated and 
showed a good antibacterial activity. However, due to the time and budget limitation, this study 
could not elucidate their molecular structure or their mechanism of action at this time. 
The investigation of the mechanism of action of aucubin in Staphylococcus aureus 
(MSSA) suggested that the bacterial cells have responded to the drug by activating several 
pathways to survive the stress. The pathway enrichment test suggested that the aucubin targeted 
the bacterial central metabolism pathways, and the results yet to be verified. Recently, many 
studies suggested that the bacterial central metabolism pathways will be the next generation of 
the antibiotic. Six proteins were involved in the pyruvate metabolism pathway and it might be 
the main route for the drug, followed by the glycolysis/gluconeogenesis pathway in the 
enrichment test, with five proteins were involved in this route. Few other pathways have shown 
to be up/down regulated in the presence of aucubin. Latest studies suggested that it is a normal 
response from bacterial cells to combat the drug and continue the biological processes. In 
summary, this study has investigated in scientific approaches the aucubin activity as an 
antibacterial agent. Moreover, the mechanism of action of aucubin was also studied by applying 
label free proteomics analysis of global bacterial proteome, which was never been reported 
before. In fact, this study is one of the very few studies to apply label free proteomics to study 
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the effects of antibiotics in-vitro.  Finally, the results produced in this study are an additional 
contribution into the natural product and antibiotic researches to help finding a solution to the 
bacterial resistance crisis. 
8.2 Future perspectives 
The results of the antibacterial evaluation of the four medicinal plants suggested that these 
plants have the potential to be a good natural source for antibacterial agents. The future work 
should focus on investigating of other active compounds isolated in this study. Another potential 
idea for future work could be using other extraction techniques with more extracting solvents in 
different polarities to retrieve as many active compounds as possible. This study has proved that 
the bioscreening test using new technologies, such as the Bioscreen-C machine was better than 
the traditional techniques in term of accuracy, such as disc diffusion assay. Regarding the purity 
check analysis of the isolated compounds, the qNMR technique has proven to be fast, easy, and 
reliable method, and might be followed for drug purity checks rather than the traditional 
chromatographic techniques. With regards to mechanism of action studies, label-free 
proteomics method was used to illustrate the mechanism of tested drug action on molecular 
level. The investigation will be continued in the future to identify another active compound from 
medicinal plants used in this study, and illustrate the mechanism of their actions. Another 
approaches will be considered, the protein-protein interactions, and the drug target validation, 
to see the whole picture of the candidate drug. 
Validation of the data is a crucial step in the drug discovery process. Most drugs are 
inhibitors that block the action of a particular target protein. The only way to be completely 
certain that a protein is contributory in a given disease is to test the potential drug In-vivo. 
Obviously, such clinical trials cannot be used for initial drug development, which means that a 
potential target must undergo a validation process. Validating proteomics data can be done in a 
number of ways, western blotting is an accepted standard, and flow cytometry is another 
technique can be used. RT-PCR and transcript level methods are good for complementing 
protein level results. 
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Appendix 1: Product specification of Centella asiatica L. plant material 
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Appendix 2: Product specification of Imperata cylindrica L. plant material 
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Appendix 3: Product specification of Morinda citrifolia L. plant material 
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Appendix 4: Product specification of Sauropus androgynus L. plant material 
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Appendix 5: 2D NMR TOCSY spectrum of CA7 fraction (400 MHz, DMSO- d6) 
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Appendix 6: 2D NMR COSY spectrum of CA7 fraction (400 MHz, DMSO- d6) 
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Appendix 7: 2D NMR HMQC spectrum of CA7 fraction (400 MHz, DMSO- d6) 
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Appendix 8: 2D NMR ROESY spectrum of CA7 fraction (400 MHz, DMSO- d6) 
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Appendix 9: 13C_APT NMR spectrum of CA7 fraction (100 MHz, DMSO- d6) 
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Appendix 10: 2D NMR TOCSY spectrum of IC10 fraction (400 MHz, DMSO- d6) 
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Appendix 11: 2D NMR COSY spectrum of IC10 fraction (400 MHz, DMSO- d6) 
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Appendix 12: 2D NMR HMQC spectrum of IC10 fraction (400 MHz, DMSO- d6) 
 
 
Figure 8: 2D NMR HMQC spectrum of IC10 fraction (400 MHz, DMSO- d6) 
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Appendix 13: 2D ROESY NMR spectrum of IC10 fraction (400 MHz, DMSO- d6) 
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Appendix 14: 2D NOESY NMR spectrum of IC10 fraction (400 MHz, DMSO- d6) 
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Appendix 15: 13C_APT NMR spectrum of IC10 fraction (100 MHz, DMSO- d6) 
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Appendix 16: 2D TOCSY NMR spectrum of MC4 fraction (400 MHz, DMSO- d6) 
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Appendix 17: 2D COSY NMR spectrum of MC4 fraction (400 MHz, DMSO- d6) 
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Appendix 18: 2D HMQC NMR spectrum of MC4 fraction (400 MHz, DMSO- d6) 
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Appendix 19: 2D ROESY NMR spectrum of MC4 fraction (400 MHz, DMSO- d6) 
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Appendix 20: 2D NOESY NMR spectrum of MC4 fraction (400 MHz, DMSO- d6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
243 
 
Appendix 21: 13C_APT NMR spectrum of MC4 fraction (100 MHz, DMSO- d6) 
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Appendix 22: 2D TOCSY NMR spectrum of SA3 fraction (400 MHz, DMSO- d6) 
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Appendix 23: 2D COSY NMR spectrum of SA3 fraction (400 MHz, DMSO- d6) 
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Appendix 24: 2D HMQC NMR spectrum of SA3 fraction (400 MHz, DMSO- d6) 
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Appendix 25: 2D ROESY NMR spectrum of SA3 fraction (400 MHz, DMSO-d6) 
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Appendix 26: 2D NOESY NMR spectrum of SA3 fraction (400 MHz, DMSO-d6) 
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Appendix 27: 13C_APT NMR spectrum of SA3 fraction (100 MHz, DMSO- d6) 
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Appendix 28: Mass spectrometry spectra of CA7 fraction 
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Appendix 29: -Mass spectrometry spectra of IC10 fraction 
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Appendix 30: -Mass spectrometry spectra of MC4 fraction 
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Appendix 31: -Mass spectrometry spectra of SA3 fraction 
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Appendix 32: Differentially expressed proteins involved in the enrichment pathway analysis of aucubin-treated MSSA. 
UNIPROT 
ID 
Gene ID Description 
Fold 
change 
calc. 
pI 
 
Peptide
s 
Coverag
e 
Score 
Unique.  
Peptides 
Area 
PSM
s 
A6QHJ8 valS Valine--tRNA ligase 6.89 4.65 24 67.51 
24543.9
8 24 
96490000
0 718 
A7WXP7 ldh1 L-lactate dehydrogenase 1 7.39 4.86 30 85.53 
16676.9
7 30 
11800000
00 589 
A7X1D8 ileS Isoleucine--tRNA ligase 5.12 4.88 41 72.01 
15969.3
4 41 
34450000
0 468 
A7X1Q1 
infB Translation initiation factor IF-2 8.37 5.02 66 73.63 
13491.7
4 66 
26590000
0 455 
A7X344 aspS Aspartate--tRNA ligase 9.96 6.89 69 60.98 
11987.6
1 16 
23300000
0 364 
A7X396 clpX 
ATP-dependent Clp protease ATP-binding 
subunit ClpX 4.53 5.05 22 80.36 9617.2 22 
16490000
00 278 
A7X4X7 pyrG CTP synthase 11.03 6.21 55 48.47 8146.42 2 
22800000
0 261 
P09616 hly Alpha-hemolysin 3.72 5.35 40 79.66 7612.16 40 
11090000
0 209 
P0A0A1 pdhB 
Pyruvate dehydrogenase E1 component subunit 
beta 6.55 4.82 27 77.87 7237.79 27 
20090000
0 203 
P65236 prs Ribose-phosphate pyrophosphokinase 10.2 5.88 40 89.75 6246.99 39 
17690000
0 209 
Q2FF95 groL 60 kDa chaperonin 9.31 5.24 35 46.5 5581.71 35 49320000 169 
Q2FJ31 adh Alcohol dehydrogenase 6.89 5.03 30 56.65 5016.5 30 
17920000
0 145 
Q2FVK2 hlgC Gamma-hemolysin component C 5.11 5.02 21 63.25 4835.7 21 
24600000
0 152 
Q2FXB0 lukEv Leucotoxin LukEv 13.9 5.45 22 90.32 4069.45 22 
69430000
0 128 
Q2FXB1 lukDv Leucotoxin LukDv 4.68 7.56 27 8.87 3929.51 3 
20950000
0 108 
Q2FZ89 ftsZ Cell division protein FtsZ 5.83 7.64 26 4.79 3927.34 2 20950000 107 
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Q2G296 fhs Formate--tetrahydrofolate ligase 5.44 5.25 28 58.39 3800.18 28 38970000 123 
Q2G2Q0 gyrA DNA gyrase subunit A 7.52 5.12 18 50.29 3746.27 18 11130000 118 
Q2YSB3 tuf Elongation factor Tu 8.32 4.97 25 28.48 3737.43 25 28890000 125 
Q2YSE8 eno Enolase 4.87 9.44 21 57.14 3721.06 21 13280000 114 
Q2YSF1 pgk Phosphoglycerate kinase 6.61 8.73 23 68.97 3605.02 23 68930000 117 
Q2YSX0 adh Alcohol dehydrogenase 14.86 4.73 17 65.54 3588.08 17 45670000 110 
Q2YTC9 ackA Acetate kinase 7.54 9.35 20 60.31 3516.83 17 30580000 118 
Q2YTE3 pyk Pyruvate kinase 11.8 5.33 21 59.85 3427.57 21 74410000 126 
Q2YVL5 guaA GMP synthase [glutamine-hydrolyzing] 9.85 9.96 24 38.87 3313.38 7 12030000 124 
Q2YVL6 guaB Inosine-5'-monophosphate dehydrogenase 5.92 5.24 24 72.35 3257.92 24 17950000 109 
Q2YZ66 arcA Arginine deiminase 16.14 5.16 29 64.09 3214.32 29 14560000 100 
Q49Z50 atpD ATP synthase subunit beta 4.73 5.03 24 48.75 3200.03 24 12970000 92 
Q4L3K8 fusA Elongation factor G 8.06 4.78 26 44.43 3187.48 25 77330000 102 
Q5HDD3 hlgB Gamma-hemolysin component B 8.75 9.85 27 28.8 3125.88 10 98190000 120 
Q5HDD4 hlgC Gamma-hemolysin component C 5.2 4.6 20 58.57 3089.5 1 17210000 93 
Q5HE49 glmS 
Glutamine--fructose-6-phosphate 
aminotransferase 4.88 4.78 14 31.75 3070.63 14 28560000 86 
Q5HFJ5 glyQS Glycine--tRNA ligase 10.47 5.22 27 43.38 3067.59 27 51030000 103 
Q5HGH4 tsf Elongation factor Ts 4.98 5.07 15 54.26 3010.75 15 89230000 89 
Q5HGY8 pdhD Dihydrolipoyl dehydrogenase 6.24 6.55 26 61.45 2987.25 26 10160000 96 
Q5HGZ1 pdhA 
Pyruvate dehydrogenase E1 component subunit 
alpha 13.45 6 24 69.25 2944 24 23760000 97 
Q5HHP5 gapA1 Glyceraldehyde-3-phosphate dehydrogenase 1 7.32 4.59 21 60.36 2917.31 2 17770000 86 
Q5HID2 rpoC DNA-directed RNA polymerase subunit beta' 7.89 4.77 17 50.52 2908.43 17 10460000 80 
Q5HIG2 cysK Cysteine synthase 6.25 5.12 23 61.99 2862.54 23 82430000 100 
Q5HII6 metG Methionine--tRNA ligase 7.3 5.2 17 28.23 2782.89 17 14260000 81 
Q5HMB9 atpD ATP synthase subunit beta 9.48 5.47 17 26.83 2771.4 17 52720000 79 
Q5HQX6 secA1 Protein translocase subunit SecA 1 6.32 9.29 20 61.27 2708.46 18 74030000 91 
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Q6GBP8 pta Phosphate acetyltransferase 7.46 5.52 20 74.4 2671.06 20 24290000 70 
Q6GH64 tkt Transketolase 14.3 5.07 20 37.93 2660.44 20 74550000 68 
Q7A5C5 SA1402 UPF0365 protein SA1402 6.09 5.14 24 54.1 2635.77 24 74440000 90 
Q7A6L4 SA0778 UPF0051 protein SA0778 6.87 5.15 29 33.48 2623.17 29 12280000 86 
Q8NUM4 mqo2 Probable malate:quinone oxidoreductase 2 4.82 6.25 15 53.58 2513.79 15 24130000 63 
O05204 ahpF Alkyl hydroperoxide reductase subunit F -5.63 4.64 18 47.58 2482.6 18 71840000 63 
A6QEP0 NWMN_0550 UPF0447 protein NWMN_0550 -7.32 5 12 48.65 2458.27 12 26740000 66 
A6TYN9 xpt Xanthine phosphoribosyltransferase -4.32 4.98 17 66.41 2451.49 17 97000000 75 
A7X4P1 rsbW Serine-protein kinase rsbW -6.31 5.11 27 34.7 2364.06 27 33380000 87 
A7X432 ligA DNA ligase -4.98 4.63 13 52.86 2321.84 13 67900000 63 
A7X4L6 rex Redox-sensing transcriptional repressor rex -12.37 5.94 13 30.45 2293.12 13 36350000 69 
Q2FH00 ald1 Alanine dehydrogenase 2;1 -4.75 5.14 25 74.36 2261.15 25 86020000 72 
A7X5F4 rplP 50S ribosomal protein L16 -5.08 5.25 24 54.14 2246.89 24 62090000 78 
A6QGY5 ebhB Extracellular matrix-binding protein ebhB -3.98 5.22 17 41.77 2217.18 17 29260000 59 
Q2FJH7 sle1 N-acetylmuramoyl-L-alanine amidase sle1 -5.61 9.22 13 47.71 2171.85 10 22140000 63 
A7X5C5 rpsK 30S ribosomal protein S11 -4.32 8.75 12 46.75 2095.89 12 52520000 68 
Q2FFA2 
SAUSA300_19
75 Uncharacterized leukocidin-like protein 2 -6.05 4.91 20 64.11 2060.08 20 28770000 74 
A7X1K9 rimM Ribosome maturation factor rimM -9.98 5.3 14 53.27 2057.3 13 51580000 62 
A7X1E5 pyrR Bifunctional protein pyrR -4.63 5.2 14 42.89 2050.54 14 29630000 43 
P66954 tpx Probable thiol peroxidase -3.52 5.39 16 36.43 2029.31 16 42390000 67 
P65895 purD Phosphoribosylamine--glycine ligase -4.56 5.21 19 52.03 2014.48 19 33940000 60 
Q2YSH6 secA Protein translocase subunit secA;A1 -7.12 5.12 16 24.43 2003.2 16 17020000 67 
A7X203 sbcC Nuclease SbcCD subunit C -5.23 5.48 19 34.85 1956.59 19 21240000 54 
Q5HGM9 carB Carbamoyl-phosphate synthase large chain -5.3 4.88 16 67.38 1921.44 16 15000000 55 
A7X4U4 atpG ATP synthase gamma chain -4.98 5.2 18 52.47 1885.57 18 89570000 56 
A7X5F2 rpmC 50S ribosomal protein L29 -6.75 4.98 19 33.3 1775.41 19 20450000 63 
P08065 sdhA Succinate dehydrogenase flavoprotein subunit -3.88 5.48 17 46.14 1753.78 17 66060000 51 
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Q2YSB9 rpoB DNA-directed RNA polymerase subunit beta -12.42 4.87 21 44.86 1730.66 21 40600000 60 
A7X5E1 rplF 50S ribosomal protein L6 -4.35 5.88 15 51.98 1698.68 15 13640000 42 
Q06AK7 topA DNA topoisomerase 1 -6.1 5.31 25 58.06 1686.03 25 70210000 68 
P0CZ42 SpyM3_0208 Probable ABC transporter ATP-binding protein  -4.36 5.01 18 35.06 1644.55 18 27750000 68 
           
  Upregulated          
  
Downregulate
d          
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Appendix 33: Up-regulated proteins involved in the pathway enrichment analysis of 
differentially expressed proteins in aucubin-treated MSSA. 
Pyruvate metabolism / Enrichment Score 6.22 
UNIPROT ID Gene ID Protein Description 
Q2YTC9 ackA Acetate kinase 
Q5HGY8 pdhD Dihydrolipoyl dehydrogenase 
Q6GBP8 pta Phosphate acetyltransferase 
Q8NUM4 mqo2 Probable malate-quinone oxidoreductase 2 
Q5HGZ1 pdhA Pyruvate dehydrogenase E1 component subunit alpha 
Q2YTE3 pyk Pyruvate kinase 
Glycolysis-Gluconeogenesis/ Enrichment Score 4.47 
UNIPROT ID Gene ID Protein Description 
Q2YSE8 eno Enolase 
A0A0D6GGD0 IctE L-lactate dehydrogenase 1 
Q2YSF1 pgk Phosphoglycerate kinase 
Q6GHZ1 phdB Pyruvate dehydrogenase E1 component subunit beta 
Q5HGY8 pdhD Dihydrolipoyl dehydrogenase 
Valine, leucine and isoleucine biosynthesis / Enrichment Score 3.6 
UNIPROT ID Gene ID Protein Description 
A7X1D8 ileS Isoleucine--tRNA ligase 
Q5HGZ1 pdhA Pyruvate dehydrogenase E1 component subunit alpha 
Q6GHZ1 phdB Pyruvate dehydrogenase E1 component subunit beta 
A6U2D1 valS Valine--tRNA ligase 
Aminoacyl-tRNA biosynthesis / Enrichment Score 3.1 
UNIPROT ID Gene ID Protein Description 
A7X344 aspS Aspartate--tRNA ligase 
A8Z4A4 glyS Glycine--tRNA ligase 
A7X1D8 ileS Isoleucine--tRNA ligase 
A0A0U1MI40 metS Methionine--tRNA ligase 
A6U2D1 valS Valine--tRNA ligase 
  Purine metabolism/ Enrichment Score 2.86  
UNIPROT ID Gene ID Protein Description 
Q5HID2 rpoC DNA-directed RNA polymerase subunit beta' 
Q2YVL5 guaA GMP synthase [glutamine-hydrolyzing] 
Q2YVL6 guaB Inosine-5'-monophosphate dehydrogenase 
P65236 prs Ribose-phosphate pyrophosphokinase 
  Citrate cycle (TCA cycle)/ Enrichment Score 2.42  
UNIPROT ID Gene ID Protein Description 
Q5HGY8 pdhD Dihydrolipoyl dehydrogenase 
Q5HGZ1 pdhA Pyruvate dehydrogenase E1 component subunit alpha 
Q6GHZ1 phdB Pyruvate dehydrogenase E1 component subunit beta 
   Propanoate metabolism / Enrichment Score 2.34 
UNIPROT ID Gene ID Protein Description 
Q2YTC9 ackA Acetate kinase 
A0A0D6GGD0 IctE L-lactate dehydrogenase 1 
Q6GBP8 pta Phosphate acetyltransferase 
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Appendix 34: Down-regulated proteins involved in the pathway enrichment analysis of 
differentially expressed proteins in aucubin-treated MSSA. 
 
 
 
Appendix 35: An example of 2D-PAGE profile of total Staphylococcus aureus proteins. 
 
 
 
 
 
 
 
 
 
 
 
Ribosome / Enrichment Score 3.66  
UNIPROT ID Gene ID Protein Description 
A7X5C5 rpsK 30S ribosomal protein S11 
A7X5F4 rplP 50S ribosomal protein L16 
A7X5F2 rpmC 50S ribosomal protein L29 
A7X5E1 rplF 50S ribosomal protein L6 
Pyrimidine metabolism / Enrichment Score 2.52  
UNIPROT ID Gene ID Protein Description 
P65945 pyrR Bifunctional protein pyrR 
P63740 carB Carbamoyl-phosphate synthase large chain 
Q2YSB9 rpoB DNA-directed RNA polymerase subunit beta 
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Appendix 36: Pyrimidine metabolism pathway showing the down-regulated genes in aucubin-traded MSSA relative to control MSSA. 
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Appendix 37: ribosome pathway showing the down-regulated genes in aucubin-traded MSSA relative to control MSSA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
